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Abstract
This thesis was motivated by the potential to use “everyday data”, especially that
collected in electronic health records (EHRs) as part of healthcare delivery, to improve
primary care for clients facing complex clinical and/or social situations. Artificial
intelligence (AI) techniques can identify patterns or make predictions with these data,
producing information to learn about and inform care delivery. Our first objective was
to understand and critique the body of literature on AI and primary care. This was
achieved through a scoping review wherein we found the field was at an early stage of
maturity, primarily focused on clinical decision support for chronic conditions in highincome countries, with low levels of primary care involvement and model evaluation
in real-world settings.
Our second objective was to demonstrate how AI methods can be applied to problems in descriptive epidemiology. To achieve this, we collaborated with the Alliance
for Healthier Communities, which provides team-based primary health care through
Community Health Centres (CHCs) across Ontario to clients who experience barriers
to regular care. We described sociodemographic, clinical, and healthcare use characteristics of their adult primary care population using EHR data from 2009-2019.
We used both simple statistical and unsupervised learning techniques, applied with
an epidemiological lens. In addition to substantive findings, we identified potential
avenues for future learning initiatives, including the development of decision support
tools, and methodological considerations therein.
Our third objective was to advance interpretable AI methodology that is well-suited
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for heterogeneous data, and is applicable in clinical epidemiology as well as other
settings. To achieve this, we developed a new hybrid feature- and similarity-based
model for supervised learning. There are two versions, fit by convex optimization
with a sparsity-inducing penalty on the kernel (similarity) portion of the model. We
compared our hybrid models with solely feature- and similarity-based approaches using synthetic data and using CHC data to predict future loneliness or social isolation.
We also proposed a new strategy for kernel construction with indicator-coded data.
Altogether, this thesis progressed AI for primary care in general and for a particular
health care organization, while making research contributions to epidemiology and to
computer science.

Key Words
Artificial Intelligence, Machine learning, Clinical Epidemiology, Descriptive Epidemiology, Primary Care, Primary Health Care, Decision Support, Learning Health Systems

iii

Lay Summary
This thesis was motivated by the potential to use “everyday data”, which is data
generated through activities outside formal research settings, to improve primary
care for clients facing complex clinical and/or social situations. Artificial intelligence
(AI) and its subfield machine learning include techniques that can analyze these data
and provide information to help guide care delivery, such as personalized treatment
recommendations or risk estimates. In our first study we summarized the state of AI
and primary care research, finding the field was at an early stage of maturity with
knowledge gaps for how to best develop, implement, and evaluate AI for primary
care.
Our second study was done in collaboration with the Alliance for Healthier Communities, which provides team-based primary health care through Community Health
Centres (CHCs) across Ontario to clients who otherwise experience barriers to regular care. We performed a large-scale description of sociodemographic, clinical, and
healthcare characteristics of their adult primary care clients from 2009 through 2019
to learn about this population and areas where AI and decision support tools may be
useful. We additionally identified methodological considerations for AI to work well in
primary care settings. To accomplish this we used both simple statistical techniques
traditionally used in descriptive epidemiology and techniques from machine learning
that can capture more complex patterns in the data. Our approach can be followed
to improve population-level descriptions in other settings as well.
In our third study we developed new machine learning methods for analyzing large,
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diverse datasets, such as electronic health records from CHCs. We combined two
existing techniques, feature and kernel learning, into a single hybrid model. We
demonstrated how to interpret our models and use them for prediction and for epidemiological studies, using synthetic data and in a case study to predict social isolation and loneliness for the Alliance population. We also proposed a new way to
capture similarity between clients, for use in the kernel part of our model, in terms
of deviations from population-level expectations.
Altogether this thesis advanced AI for primary care while making methodological
contributions to the fields of epidemiology and computer science.
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Chapter 1
Introduction
1.1

Motivation

Increasing amounts and types of “everyday data” are being collected as a by-product
of activities happening every second: combined with advancements in computational
resources and methods to analyze these data, there are unprecedented opportunities to
inform and improve everyday activities or associated human decisions. Of particular
interest is “everyday data” from healthcare, such as data collected in electronic health
records (EHRs) as a result of clinical contact, and the analysis of these data to improve
care and by extension population health. This could happen at any scale. An entire
healthcare system, specific organization, or single clinic can harness their care-derived
data to better understand health related needs and characteristics of the population
they serve, and to inform or develop tools that will support and improve care delivery
for that population.1–4
The applied setting of interest throughout this thesis is primary care, where the potential for benefit under the above paradigm is particularly motivating for clients with
complex medical and social conditions. In Canada, primary care is first-contact care
provided in a community setting over the life course, serving as the foundation and
entry point to the rest of the healthcare system.5,6 Hence, primary care providers are
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responsible for tasks related to primary prevention and screening, as well as treatment of acute conditions and management of chronic conditions to prevent or slow
progression to health states where secondary or tertiary care is needed.5,7 For clients
experiencing complex health challenges, such as those with two or more chronic conditions (multimorbidity) or who experience social and structural barriers to health,
primary care plays an important role in healthcare access and in coordinating multiple, often competing, care regimes.7–10 Amid this complexity there is a lack of evidence
around prognosis, diagnosis, and treatment, especially that is appropriately tailored
to a client’s social determinants of health.8,11–26
Methods from artificial intelligence (AI) and machine learning, a subfield of AI, may
be applied to health data and fill gaps in complex client care, such as to learn patterns and make personalized predictions to help support care decisions. AI-driven
decision support tools that are appropriately developed, rigorously evaluated, and
used in informed ways have potential to improve care; however, there are also risks of
making things worse, such as through poor-quality tools that reduce client safety or
are biased against minority populations.27–36 Understanding possibilities surrounding
AI for healthcare and methodological subtleties underpinning specific scenarios can
help shift the balance away from harm and towards more potential benefits. Historically, advancements in AI for health have focused on specialty and acute care settings
moreso than primary care37,38 ; there are unanswered questions about how a technology that is expected to revolutionize healthcare will impact the foundation of these
systems, and a need for technical research that is tailored to the unique attributes
of primary care. Both epidemiology and computer science are needed to support
progress.
Understanding and trust of AI models is key for primary care as well as other sectors,
like law or finance, where model outputs are intended to support human decisionmaking.39–41 Particularly since the advent of deep learning, the black box nature of
some AI has come under scrutiny, especially for settings where “success” extends beyond technical performance to also require equity, safety, and human action.39,40,42,43
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Although there have been advances in explanation, these are not yet sufficient. There
is a need for advancements in machine learning methods that allow for incorporating expert prior knowledge and constraints in an interpretable way.39–41 For tasks
where causality is important, such as treatment effect estimation, an inherently interpretable model can be informed or evaluated with epidemiological and subject matter
expertise in ways not possible with post hoc explanation of black box models.
This thesis lays foundations for the field of AI for primary care in general, and for
future AI-related work at a particular health care organization that focuses on care
for clients experiencing complex health challenges across Ontario. It then proposes
new explainable machine learning methodology to target gaps in primary care and
other high-risk decision making types of settings.

1.2

Objectives

We addressed three objectives motivated by the need to better understand how AI
can be developed to support primary care:
1) To identify and summarize existing research that involves AI and primary care.
2) To demonstrate how a combination of simple statistical and more complex unsupervised learning techniques can be used to describe sociodemographic, clinical,
and healthcare use characteristics of a complex primary care population for the
purpose of supporting future initiatives, including the development of decision
support tools.
3) To develop and evaluate an interpretable hybrid feature- and similarity-based
model for supervised learning that takes advantage of rich but heterogeneous
observational data sources and can be used for prediction and for investigation
of causal relationships.
Objectives 2 and 3 were achieved in collaboration with the Alliance for Healthier
Communities, which provides team-based primary health care through Community
Health Centres (CHC) across Ontario to clients who otherwise experience barriers
3

to receiving regular care.44 The population served through CHCs is heterogeneous
and care decisions are often complex and challenging. By vote of their executive
leaders in October 2020, the Alliance committed to using their data to improve care
by adopting a learning health system (LHS) model,45,46 making them one of the first
documented primary care LHSs in North America.4 Combined with their collection
of rich sociodemographic data and motivation for health equity and social justice, the
Alliance is a unique primary health care system in Canada with large potential to
take advantage of their EHRs and various data analysis methods, including AI. An
LHS is formally defined in Chapter 2.

1.2.1

Research contributions

The present thesis is for a combined degree in epidemiology and computer science.
For clarity, the research objectives can be re-organized in terms of contributions to
the two disciplines of interest:
To computer science and more specifically the subfield of machine learning, we contribute 1. hybrid feature- and similarity-based supervised learning methods (Chapter
5), 2. a new framework for thinking about similarity in kernel functions (Chapter
5), and 3. demonstration of how techniques from epidemiology can be used to inform machine learning projects, including the development of decision support tools
(Chapters 3-6).
To epidemiology and more specifically the subfield of clinical epidemiology, we
contribute 4. the first comprehensive review of AI for primary care research (Chapter
3), 5. the first large-scale description of adult primary care clients served by CHCs
across Ontario (Chapter 4), and 6. demonstration of how techniques from computer
science can be used to aid in population-level descriptive studies and in investigation
of causal relationships (Chapters 4-6).
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1.3

Thesis Organization

This thesis is in an integrated-article format. Chapter 2 provides general background on key concepts and terms that are needed to understand the body of work.
Chapters 3, 4, and 5 include integrated articles that address Objectives 1, 2, and
3, respectively. Each of these chapters begins with an extra technical background
section that defines discipline-specific terms and how they are used within the associated article. The general background in Chapter 2 and technical background
sections in Chapters 3-5 are provided to increase accessibility of the work to readers
from different disciplines; some or all of these background sections can be skipped by
readers already familiar with the contents. Chapter 6 concludes the thesis with an
overarching discussion. There are several appendices that contain supporting materials, such as extra information on methods and results. Due to the nature of an
integrated article format, there is some repetition between introductory sections.
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Chapter 2
Background
This thesis relies on and makes contributions to both epidemiology and computer science, and takes place within the applied health setting of primary care. To support
readership from multiple disciplines, brief explanations of key terms and how they are
used throughout the body of work are provided below. While this Chapter provides
explanations at a high-level to support conceptual understanding of the research, additional technical background is presented at the beginning of each integrated article
chapter to review terms that are not used universally between all fields and are needed
to fully understand each specific research study.

2.1

Epidemiology

Greenland and Rothman (2008) define epidemiology as “the study of the distribution
of health-related states and events in populations. With this definition we intend to
capture not only disease and illness, but physiologic states such as blood pressure,
psychologic measures such as depression score, and positive outcomes such as disease
immunity.”47 Two major types of epidemiology are descriptive and analytic. Descriptive epidemiology provides measures to understand health conditions within
a population, such as the prevalence of hypertension. Analytic epidemiology focuses on identifying contributing or protective factors for a health state, for example
6

to obtain a valid and precise estimate of the effect of a potential treatment for slowing
the progression of hypertension. Although much of analytic epidemiology is causal,
there are some questions that may not require explicit causal relationships to be
useful, such as exploratory risk factor analyses.
Our research included and made contributions towards both descriptive and analytic
epidemiology. Epidemiology can also be broken down by application field; the two
most relevant to our research are clinical and social epidemiology.
We describe core concepts in epidemiology, including cohorts, prevalence, and incidence, in the technical background for Chapter 4. In Chapter 5 we additionally
introduce standardization as a way to assess whether outcome rates in a population
under study match expectations based on a reference population.

2.1.1

Clinical epidemiology

Baron (2001) defines clinical epidemiology as “the application of epidemiologic and
biostatistic techniques to clinical problems. In contrast to chronic disease epidemiology, which focuses on the discovery of the determinants of disease on a population
level, clinical epidemiology aims to help clinicians conduct the daily work of caring for
individual patients.”48 This thesis was motivated by the potential to use the collection
and analysis of clinical data to provide information to support further care decisions.

2.1.2

Social epidemiology

Kaufman (2008) defines social epidemiology as “the study of relations between social
factors and disease in populations. . . social epidemiology is characterized by explicit
inclusion of social, economic, or cultural quantities in the exposure definition or the
analytic model, or by explicit reference to social science theory in the interpretation.”49
Our research was informed by social epidemiology and motivated by the potential for
artificial intelligence (AI) to help identify the best care decisions in the context of an
individual’s sociodemographic and clinical characteristics. It is crucial to understand
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how to incorporate factors such as social determinants of health into AI methods both
because they are expected to improve performance and generalizability and because
they are expected to reduce the risk of bias.
2.1.2.1

Social determinants of health

The Canadian Public Health Association defines social determinants of health as,
“the social and economic factors that influence people’s health. These are apparent
in the living and working conditions that people experience every day. The social
determinants of health influence health in many positive and negative ways”.50
Health services are a key determinant of health. Other examples include income and
income distribution, education, unemployment and job security, employment and
working conditions, early childhood development, food insecurity, housing, social exclusion, social safety network, Indigenous status, gender, race, and disability. Social
determinants of health are an explicit component of the Alliance for Healthier Communities care model,51 and information representing several determinants is collected
in their electronic health records (EHRs). Provision of health and social services can
counteract some of the negative social determinants of health and promote health
equity.

2.1.3

Health services research

The Canadian Institutes of Health Research (2019) defines health services research
as “research with the goal of improving the efficiency and effectiveness of health
professionals and the health care system, through changes to practice and policy.
Health services research is a multidisciplinary field of scientific investigation that
studies how social factors, financing systems, organizational structures and processes,
health technologies, and personal behaviours affect access to health care, the quality
and cost of health care, and, ultimately, Canadians’ health and well-being.”52 This
thesis includes analyses that measure and explore health service access at the Alliance
for Healthier Communities, to identify general patterns and those that differ across
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client subpopulations.

2.2

Computer Science

The ACM Task Force on the Core of Computer Science define “the discipline of
computing [as] the systematic study of algorithmic processes that describe and
transform information, their theory, analysis, design, efficiency, implementation, and
application.”53 The focus area of computer science in this thesis is the use of AI to
process digital data.

2.2.1

Artificial intelligence

AI is a rapidly growing area with no single, well-defined definition. The following
brief history provides contextual background and motivations for AI in general; more
concrete descriptions of the subfields used in this thesis are below54 :
From its inception in the 1950s, AI was primarily concerned with processes
by which computers might achieve ‘intelligence’ comparable to that of humans, and how we might recognize such intelligence.55 Turing’s (1950)
seminal paper, ‘Computing Machinery and Intelligence’, was concerned
more with the latter, but the work sparked a rich diversity of research
activities.55,56 The field of AI now encompasses a wide variety of methodology, much of which falls into two broad categories: rule-centred and
data-centred. Rule-centred methods came from the study of logical reasoning, and are intended to capture intelligence by explicitly writing down
the rules that govern it and then deploying that intelligence to carry out
different tasks.55 Data-centric methods like machine learning have focused
more on learning to perform specific tasks using previously collected data
rather than explicitly provided rules.55
Readers interested in learning more about the general types of “intelligent tasks” that
AI methods are able to perform can read our primer on AI for primary care.57 This
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thesis most heavily deals with machine learning, which is a subfield of AI.

2.2.2

Machine learning

Machine learning can be broken down into three (non mutually-exclusive) categories.
2.2.2.1

1) Supervised machine learning

Supervised machine learning models learn to associate labels with observations. In
the context of health, the label is often an outcome, e.g., presence of hypertension,
and the observations are often client characteristics, e.g., EHR history. Labels may
be numeric (in regression problems) or categorical (in classification problems). Supervised learning uses existing labeled data, which contains a collection of observations
with “true” labels, to learn how to predict the label for new, previously unseen observations. Supervised learning methods are able to capture complex (e.g., non-linear,
additive) relationships between inputs and outputs, which is a strength for settings
such as healthcare where a multitude of different factors contribute in different, potentially interacting ways to health states and outcomes. Example supervised machine
learning techniques include Support Vector Machines, K-Nearest Neighbours, Naïve
Bayes Classifier, and Random Forest Decision Trees.55
Chapter 5 presents advances to supervised machine learning methodology. This research included feature-based and similarity-based approaches, with kernel methods
being the similarity-based approach of focus. An introduction to these concepts is
provided in the Chapter 5 technical background section alongside an overview of
model selection and performance assessment.
2.2.2.2

2) Unsupervised machine learning

Unsupervised machine learning models learn patterns from unlabeled data such as an
EHR database with no predefined outcome. Common unsupervised machine learning
techniques include clustering, topic modelling, and association mining to identify observations that tend to occur together.55 Unsupervised machine learning techniques
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are closely related to and overlap with statistical modelling approaches used in epidemiology, including latent class and latent factor models.58,59
Chapter 4 applies unsupervised machine learning techniques with EHR data. The
technical background section includes an overview of unsupervised methods with the
three techniques we applied: Ising models, non-negative matrix factorization, and
K-medoids time series clustering.
2.2.2.3

3) Reinforcement learning

Reinforcement learning involves learning a series of actions to optimize rewards or
punishments.55 In the context of health care, these rewards or punishments could
be benefits or side-effects of medications, and the goal could be to learn an optimal
treatment regime using longitudinal data whereby different types or doses of treatment are administered. Reinforcement learning for tertiary health care settings (e.g.,
intensive care unit) is a rapidly developing area and the techniques are a plausible
extension of the hybrid model research in Chapter 5; however, more foundational
methodological work in supervised machine learning for primary care data is needed
first. Thus, reinforcement learning is an opportunity for future work.

2.2.3

Explainable artificial intelligence

Machine learning has been criticized as being “black box”, which may be problematic
especially in the context of decision making where a predictive model is intended to
augment decision making of a clinician and client. Explainable AI (XAI) emerged to
combat this, such as by providing information alongside an output (e.g., prediction)
that facilitates understanding about how the model is functioning.40,60–62 There is an
active research community around XAI, including for health care specifically, and for
which published reviews and guidelines for researchers exist.39,60–62 We developed our
proposed machine learning methods in Chapter 5 under an XAI paradigm such that
there is an opportunity for explainability.
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2.2.4

Model

The term “model” has widely different definitions used both within and across disciplines. We use model in the context of data analysis: a mathematical or statistical
model that relates inputs (i.e. observed data also referred to as features or independent
variables) to outputs (e.g., probability of a pre-specified outcome).
2.2.4.1

Risk prediction models

Risk prediction models can estimate a client’s risk for a future outcome (e.g., disease development) based on the client’s observed characteristics.63 Analogous terms
include “prognostic predictive models” and “risk engines”. Example clinical action
arising from a risk prediction model for a chronic disease would be to order screening
tests for a client in response to high predicted risk of the disease, or to not order
screening tests for a client in response to low predicted risk of the disease. Chapter 5
develops and tests a series of risk prediction models.
2.2.4.2

Treatment effect models

Throughout this thesis “treatment” is interpreted broadly to mean any action or
intervention taken to try and alter the future state of a client, e.g., medications, social
interventions, and behavioural interventions. Whereas the focus for a risk prediction
model is the absolute risk estimate, the focus for a treatment effect model is the
expected benefit or harm (which could be a change in estimated risk) associated with
starting or changing a treatment. Treatment effect models explicitly aim to be causal,
meaning that changing the treatment will result in a change in the outcome64,65 ;
misinterpreting a non-causal estimate as causal can lead to harm in high-risks decision
making settings such as healthcare. We suspect that under an XAI framework, end
users may interpret a risk prediction model in a causal way as an “upstream treatment
effect model”, e.g., “hypertension is the largest contributor to this patient’s diabetes
risk, therefore I want to intervene on blood pressure to reduce diabetes risk”. This
could be problematic if this is a biased (untrue) relationship between hypertension
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and the outcome and it obscures identification of the next best care decision. We
further discuss these ideas in Chapter 5 with respect to the proposed hybrid models.

2.3

Primary Health Care

Primary health care is “the level of a health service system that provides entry into
the system for all new needs and problems, provides person-focused (as opposed to
disease-oriented) care over time, provides care for all but very uncommon or unusual
conditions, and coordinates or integrates care provided elsewhere or by others.5(pp8-9)
Primary care is a subfield of primary health care that typically focuses on “family
medicine” and includes family physician, nurse, and nurse practitioner care providers;
primary health care additionally includes providers such as social workers, dietitians,
and physiotherapists.66 Chapters 4 and 5 include research with a primary care cohort
situated within the context of a primary health care setting, such that eligible clients
must have received primary care, but their access to broader primary health care
services and providers was considered in analyses. The use of both primary care and
primary health care terminology throughout this thesis is intentional and provides
distinction about the impact or relevance of the associated information.
Clinical problems can roughly be divided into those that are simple, complicated,
and complex.67 Simple problems, such as recording a blood pressure reading, are
those that may require technique and terminology refinement but once solved can
be addressed in a standardized fashion to produce good results each time.67,68 The
main opportunities for technology intervention will include automation that may not
require AI. Complicated problems may include subsets of simple problems but are
more than a collection of simple problems that can be independently solved; they
are challenging due to scale and the need for coordination or specialized expertise,
but formulae to solve them and achieve high certainty of outcomes is possible.68
Complicated problems in healthcare, such as treatment of advanced cancer, are often
addressed by specialty physicians and may be amenable to the development of clinical
practice guidelines.67 Opportunities for technology here include AI, such as to improve
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the efficiency or accuracy of identifying the parameters of a complicated problem (e.g.,
exact diagnosis). While both of the above appear in primary care settings, there
are also a large number of complex problems, such as how to care for older adults
with multiple chronic conditions and limited monetary resources.67 These types of
situations do not lend themselves to straightforward protocols as the intervention(s)
and outcome(s) of interest vary on a person-by-person basis and over time. Complex
problems may include simple and complicated aspects, but multiple outcomes may
need to be taken into account and solutions may not generalize between clients.68
Some of the most hopeful applications of AI-based tools in primary care are to provide
decision support for complex problems, such as by providing additional information
to augment clinical decision making like personalized risk estimates or treatment
suggestions that take into account individual client scenarios and preferences.69,70

2.3.1

Electronic health records

An EHR is “a secure, integrated collection of a person’s encounters with the health
care system; it provides a comprehensive digital view of a client’s health history”.71
EHRs contain historical data on clients over time, including information about sociodemographic characteristics, diagnoses, care provided, and other health outcomes.
EHRs are designed to support clinical care; research is a secondary purpose and
challenges not seen in data collected for research purposes can arise. For example,
clients may be observed at irregular time intervals and what is or is not entered into
a client’s record may be impacted by behavioural or political factors. Advantages
include having data from all clients who received care, which may mitigate selection
biases, and the opportunity to develop models that work with “everyday data” already
present in clinical encounters. Chapters 4 and 5 include research that used EHR data
from the Alliance for Healthier Communities.
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2.4

Learning Health System

The term “learning health system” (LHS) was defined in 2006 by the Institute of
Medicine as, “science, informatics, incentives, and culture are aligned for continuous
improvement and innovation, with best practices seamlessly embedded in the delivery process and new knowledge captured as an integral by-product of the delivery
experience”.72,73
A hallmark of LHSs is a commitment to using data to inform or improve care delivery,
e.g., through research studies, quality improvement initiatives, or development of
decision support tools with EHR data.1,2,4,74,75 This thesis includes research done in
collaboration with one of the first primary health care, LHSs in Canada. An important
aspect of this LHS is their commitment to equity and care for complex or historically
marginalized subpopulations; analyses done with their data are intended to align
with these mandates, such as through careful consideration of social determinants of
health. In Chapter 4 we introduce this health care system and the clients they serve
in more depth.
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Chapter 3
Artificial Intelligence and Primary
Care Research: A Scoping Review
Scoping reviews are recognized as an important intellectual contribution in epidemiology and in health research. This Chapter contains the first scoping review on
artificial intelligence (AI) and primary care research,a which included reviewing thousands of potentially relevant documents to provide the first comprehensive overview
and synthesis of the field. It laid a foundation both for the remaining chapters of this
thesis and for the field more generally. The study was published in the top primary
care journal in North America, the Annals for Family Medicine, was presented in
several contexts, and was used to inform work at the College of Family Physicians
of Canada76,77 and at the American Board of Family Medicine.78 The discussion in
Chapter 6 will highlight key research developments since the time of this review.

3.1

Technical Background

Scoping review: A scoping review uses a rigorous and systematic search strategy to
identify relevant literature on a topic, and then synthesizes or summarizes the located
a

A version of this chapter has been published: Kueper JK, Terry AL, Zwarenstein M, Lizotte
DJ. Artificial intelligence and primary care research: a scoping review. Annals of Family Medicine.
2020;18(3):250-258. doi:10.1370/afm.2518
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literature to answer a research question about that topic.79–81 Scoping reviews are
related to but distinct from systematic reviews, where studies focusing on a specific
research question are collected usually with the goal of conducting a meta-analysis
and obtaining a global effect estimate for a specified exposure or treatment.82 A
scoping review typically captures literature addressing a variety of research questions
related to a topic-area, and the summary of this literature targets objectives such as
to identify the size and type of existing evidence on a topic, to identify any evidence
gaps, and/or to inform future research or related initiatives.79 Scoping reviews serve
as a basis to comment on research practices and the field as a whole.

3.2

Introduction

AI research began in the 1950s, and public, professional, and commercial recognition
of its potential for adoption in health care settings is growing.29,83–88 This application
includes primary care,89–91 defined by Barbara Starfield as “The level of a health
service system that provides entry into the system for all new needs and problems,
provides person-focused (as opposed to disease-oriented) care over time, provides
care for all but very uncommon or unusual conditions, and coordinates or integrates
care provided elsewhere or by others.”(pp8-9)5 Given the recent surge in uptake of
electronic health records (EHRs) and thus availability of data,92,93 there is potential
for AI to benefit both primary care practice and research, especially in light of the
breadth of practice and rapidly increasing amounts of information that humans cannot
meaningfully condense and comprehend.5,27–29,31,83,85–91,94–97
AI’s immediate usefulness is not guaranteed, however: EHRs were predicted to transform primary care for the better, but led to unanticipated outcomes and encountered
barriers to adoption.92,98–100 AI could also harm, for example, by exaggerating racial,
class, or sex biases if models are built with biased data or used with new populations
for whom performance may be poor. Liability, trust, and disrupted workflow are
further concerns.86
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AI initially focused on how computers might achieve humanlike intelligence and how
we might recognize this.55,56 Two approaches emerged, rule centric and data centric.
Rule-centric methods capture intelligence by explicitly writing down rules that govern
intelligent decision making, whereas data-centric methods learn specific tasks using
previously collected data.55 Examples of health applications are presented below.
MYCIN was the first rule-based AI system for health care, developed in the 1970s to
diagnose blood infections using more than 450 rules derived from experts, textbooks,
and case reports.55,101 Although met with initial enthusiasm, rule-centric methods
faltered when faced with increasing complexity. As availability of EHRs increased,
AI shifted toward data-centric, machine learning methods designed to automatically
capture complex relationships within health data. Machine learning methods are now
used in health research to predict diabetes and cancer from health records,96,102–104
and together with computer vision have been applied to skin cancer diagnosis based on
skin lesion images.105,106 Machine learning and natural language processing methods
extract structured information from unstructured text data,95 which could potentially
remove some of the EHR-associated burden from clinicians.87,107,108
These examples predominantly come from referral care settings, not from primary
care, where the spectrum of illness is wider, and clinicians have fewer diagnostic
instruments or tests available. Despite optimism for using AI to benefit primary
care, there is no comprehensive review of what contribution AI has made so far, and
thus little guidance on how best to proceed with research. To address this gap, our
objective was to identify and assess the nature and extent of the body of research
involving AI and primary care.

3.3

Methods

We performed a scoping review according to published guidelines whereby a systematic search strategy identifies literature on a topic, data are extracted from relevant
documents, and findings are synthesized.80,81,109 We followed the Preferred Reporting
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Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMAScR) Checklist (Appendix C),79 and registered our protocol with the Open Science
Framework (osf.io/w3n2b).

3.3.1

Search strategy

We developed our search strategies iteratively and in collaboration with a medical sciences librarian for health sciences, computer science, and interdisciplinary databases.
Strategies included key words and, where possible, subject headings around the concepts of AI and primary care. Terms were identified through searches of the National Library of Medicine MeSH Tree Structures and by discipline experts on our
review team. Appendix C.2 contains an overview of the search strategy development process and final strategies for the 11 published or gray literature databases:
Medline-OVID, EMBASE, CINAHL, Cochrane Library, Web of Science, Scopus, Institute of Electrical and Electronics Engineers Xplore, Association for Computing
Machinery Digital Library, MathSciNet, Association for the Advancement of Artificial Intelligence, and arXiv. Retrieved references were uploaded into Covidence.110
Where possible, English-language limits were set; to estimate the amount of literature
missed, searches were rerun for a subset of the databases (Medline-OVID, CINAHL,
Web of Science) with language limits reset to accept all non-English languages. Each
search retrieved fewer than 10 documents. We used Covidence110 to remove duplicate
results and facilitate the screening process.

3.3.2

Study selection

3.3.2.1

Title and abstract screening

For preliminary screening, two reviewers (JKK, DJL) independently rated document
titles and abstracts as to whether they met our eligibility criteria: (1) reported on
research, (2) mentioned or alluded to AI, and (3) mentioned primary care data source,
setting, or personnel. We pilot-tested the first 25 and next 100 documents, discussing
disagreements to ensure mutual understanding of the eligibility criteria and capture of
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relevant literature. A third reviewer (ALT) resolved remaining initial disagreements.
If two reviewers rated a document as meeting the above criteria, the document progressed to full-text screening. A large number of documents on computerized cognitive
behavioral therapy (37 documents) were excluded because underlying methods were
often unclear and reviews on these systems already exist.111–115
3.3.2.2

Full-text screening

For our full-text screening, two reviewers (JKK, DJL) independently reviewed the
full text of each document for the following eligibility criteria: (1) was a research
study, (2) developed or used AI (Appendix Table C.3 contains subfield definitions),
(3) used primary care data and/or study was conducted in a primary care setting
and/or explicitly mentioned study applicability to primary care. Documents were
excluded if they were narratives or editorials, did not apply to primary care, or were
not accessible in English language full text. As for title and abstract screening,
we performed pilot-testing and refined the eligibility criteria. Disagreements were
resolved by discussion until consensus was reached.
A notable challenge arose from authors’ use of terminology that overlaps with AI when
the methods used are not considered AI; we excluded these studies. For example, one
study referred to simple string matching as natural language processing.116 We also
excluded 34 studies because there was insufficient information to determine whether
AI was involved, even after consulting references cited in methods.

3.3.3

Data extraction and synthesis

We developed the data extraction sheet iteratively to ensure relevant and consistent
information capture, performing pilot-testing and revisions for 3 and then 5 randomly selected articles.106,117–123 Remaining documents were split alphabetically and
extracted independently (100 by ALT, 50 by DJL, 250 by JKK). We extracted the
following information: publication details, study purpose(s), author appointment(s),
primary care function(s), author-intended target end user(s), target health condi20

tion(s), location of data source(s) (if any), AI subfield(s), the reviewer who performed
extraction, and any reviewer notes. We agreed on definitions for each data extraction
field (Appendix Table C.3). For fields except publication details, author appointments, and additional notes, we predefined categories based on the pilot testing and
on content knowledge; studies could belong to multiple categories. An “other” category captured specifics of studies that did not fit into a predefined category, and an
“unknown” category was used if not enough information was provided for category
selection. We summarized results as categorical variables for seven data extraction
fields and performed selected cross-tabulations.

3.4

Results

3.4.1

Searches

We retrieved 5,515 nonduplicate documents for title and abstract screening; 727 met
the eligibility criteria for full-text screening and 405 met the final criteria as shown in
Figure 3.1. Appendix C.4 contains a list of the 405 references. The AI and primary
care study with the earliest date of publication, 1986, developed a supervised machine
learning method to support abdominal pain diagnoses.124 Studies are summarized
below according to the seven key data extraction categories mentioned above.
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Figure 3.1: PRISMA (Preferred Reporting Items for Systematic Reviews and MetaAnalyses) flow diagram.
a: “Not primary care" use as exclusion when multiple criteria applied

3.4.2

Study purpose

The majority of studies (270 studies, 66.7%) developed new or adapted existing AI
methods using secondary data. The second most common study purpose (86 studies,
21.2%) was analyzing data using AI techniques, such as eliciting patterns from health
data to facilitate research. Few (28 studies, 6.9%) evaluated AI application in a
real-world setting.
Some series of studies reported on multiple stages of a project, from AI development
to pilot-testing; these projects included intended end users located in a primary care
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setting.125–132 A small minority of studies (21 studies, 5.2%) had multiple purposes.
Figure 3.2 presents all combinations.

Method development/
adaptation only

Study purpose

Data analysis only

Evaluation only

Method development/
adaptation & data analysis

Method development/
adaptation & evaluation

Method development/
adaptation, data analysis,
& evaluation
0

100

Number of studies

200

300

Figure 3.2: Overall purpose of studies.

3.4.3

Author appointment

We categorized author appointments into 4 categories: (1) technology, engineering,
and math (TEM) discipline, meaning an author appointed in a department of mathematics, engineering, computer science, informatics, and/or statistics; (2) primary care
discipline, meaning an author appointed in a department of family medicine, primary
care, community health, and/or other analogous term; (3) nursing discipline; and (4)
other. Authors were predominantly from TEM disciplines with 214 studies (52.8%)
having at least one author with a TEM appointment compared with just 57 studies
(14.1%) having at least one author with a primary care appointment. Twenty-three
studies (5.7%) had a primary care–appointed author listed first and 27 (6.7%) had
one listed last. These patterns remained when unspecified or general medical appointments (i.e. nonspecialist) were counted as primary care appointments. Four studies
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had authors with nursing appointments. Cross-tabulations between study purpose
and author appointment categories did not suggest that author appointment types
differed by study purpose. Table 3.1 presents a summary of the body of literature
broken into primary care and TEM author disciplines; Appendix Table C.4 breaks
down author appointments into 16 categories.
Table 3.1: Appointments of study authors.
Author Appointment Category

n (%) of Studies

Primary care and TEM
Primary care and no TEM
TEM and no primary care
Neither TEM nor primary care

27 (6.67)
30 (7.41)
187 (46.17)
161 (39.75)

Note: To be included in a row count, a study must have had
at least one author with an appointment in the category or
categories indicated. Legend: TEM = technology, engineering, and math.

3.4.4

Primary care function

Diagnostic decision support was the most common primary care function addressed
in studies (148 studies, 36.5%), followed by treatment decision support (56 studies,
13.8%), and then using AI for extracting information from data sources such as EHRs
(49 studies, 12.1%). The most frequent combination of functions was information
extraction and description (21 studies, 5.2%). Figure 3.3 summarizes primary care
function counts; Appendix Figure C.2 presents more detail.
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Figure 3.3: Primary care functions to be supported with artificial intelligence.

3.4.5

Reported target end user

The majority of studies reported physicians as a target end user, either alone or in
combination with other target end users (243 studies, 60%). There appeared to be
no positive association between having physicians as a target end user and having
at least one author with a medical appointment: the percentage of studies with at
least one author with any kind of medical appointment was similar between studies with physician and exclusively nonphysician target end users (51.9% and 46.3%,
respectively). Twenty-six studies (6.4%) stated that their research was intended for
patients, 25 (6.2%) for administrative use, and 9 (2.2%) for nurses or nurse practitioners, either alone or in combination with other end users. Appendix Figure C.3
shows the number of studies that included each of the target end user categories;
Appendix Figure C.4 presents all combinations on a per-study basis.
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3.4.6

Health condition

About one-quarter of studies (108 studies, 26.7%) focused on developing, using, or
analyzing AI so that it would be relevant for most health conditions seen in primary
care settings. Of studies that targeted a particular condition, chronic physical conditions were more frequent than acute or psychiatric conditions. We condensed target
health conditions into 10 categories, with study distribution shown in Figure 3.4;
Appendix Figure C.5 expands them into 27 categories.
General

Heart/cardiovascular

Health condition of interest

Psychiatric/
cognitive/neurological
Diabetes/
metabolic/chronic
Skin conditions/
skin cancer
Musculoskeletal/
joint
Cancer of
non-skin type
Lung/apnoea/COPD

Gastrointestinal/liver

Other
0

25

50

Number of studies

75

100

125

Figure 3.4: Health conditions studied.
Note: Includes only the 387 studies for which target condition(s) could be identified. Legend:
COPD = Chronic obstructive pulmonary disease.

3.4.7

Geographic location

The location of most data source(s) used in a study or the intended location of
AI implementation was higher-income countries belonging to the Organisation for
Economic Co-operation and Development. Low- and middle-income countries were
poorly represented. Most studies used data from a single country, with the United
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States being the most common source (79 studies, 19.5%). Appendix Figure C.6
summarizes location counts and per capita rates; Appendix Table 3S C.5 contains a
more detailed breakdown.

3.4.8

AI subfield

Most studies (363 studies, 89.6%) used methods within a single subfield of AI, and
of these, supervised machine learning was the most common (162 studies, 40.0%),
followed by expert systems (90 studies, 22.2%), and then natural language processing
(35 studies, 8.6%). There were no articles on robotics. Expert systems had the earliest
median year of publication (2007); data mining had the most recent (2015). Appendix
Figure C.7 presents frequencies and median year of publication for 10 subfields of AI
used by studies captured in our literature review; all AI subfield combinations are
presented in Appendix Figure C.8.

3.5
3.5.1

Discussion
Key findings

We identified and summarized 405 research studies involving AI and primary care, and
discerned three predominant trends. First, regarding authorship, the vast majority of
studies did not have any primary care involvement. Second, in terms of methods, there
was a shift over time from expert systems to supervised machine learning. And third,
when it came to applications, studies most often developed AI to support diagnostic
or treatment decisions, for chronic conditions, in higher-income countries. Overall,
these findings show that AI for primary care is at an early stage of maturity for
practice applications,133,134 meaning more research is needed to assess its real-world
impacts on primary care.
The dominance of TEM-appointed authors and AI methods development research
is congruent with the early stage of this field. An AI-driven technology needs to
be working well before real-world testing and implementation. Good performance is
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achieved through methods development research, which is further reflected by most
studies specifying researchers as an intended end user alongside clinicians—more work
is required before implementing the AI in a practice setting. On the other hand, research focused on AI for analyzing health data is distinct and at a later stage of
maturity. These AI applications are not intended for everyday clinical practice, so although their methodologic performance is important, longer-term health or workflow
outcomes may not need to be assessed before real-world use.
The dominant subfields of AI identified by our review mirror trends in AI advances
and align with other characteristics of the included studies. Expert systems comprise
a substantial portion of the literature but are now less common (median publication year 2007 vs 2014 for supervised machine learning), reflecting a general shift in
AI research from expert systems and rule-centric AI methods to machine learning
and data-centric AI methods.135 The latter are amenable to providing diagnostic and
treatment recommendations as well as predicting future health, which supports primary care activities such as primary prevention and screening. This trend also aligns
with the focus on physicians as target eventual end users.
Underlying drivers of AI research, and by extension maturation, are data availability
and quality, particularly after the shift toward data-driven machine learning methods.
The United States is the single dominant country in the field, which is unsurprising given its population, wealth, and research resources and output.136–139 The high
standing of the United Kingdom and Netherlands despite smaller populations may
be attributable to primary care data availability,140,141 facilitated by high adoption
rates of EHRs,142 and strong information technology academics and industries.143,144
Investments in data generation, quality, and access will increase future possibilities
for AI to be used to strengthen primary care in the corresponding region.

3.5.2

Strengths and limitations

Strengths of our review include a comprehensive search strategy, without date restriction, with use of inclusive eligibility criteria and conducted by an interdisciplinary
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team. Limitations include multiple reviewers extracting data without double coding,
English language restriction, and the lack of single widely accepted definitions for
primary care or AI to guide screening. Proprietary research would not be captured
by our review, nor would research completed after our search date.

3.5.3

Future research

Our next steps include further assessing the quality of the included studies and summarizing exemplary research projects. We additionally recommend a review on AI
for the broader primary health care system that includes clinicians beyond physicians
and nurses (e.g., social workers, physiotherapists).
For the field to mature, future research studies should have interdisciplinary teams
with primary care end user engagement. Value must be placed both on developing
rigorous methods and on identifying potential impacts of the developed AI on care
delivery and longer-term health outcomes. Inclusion of nurses, patients, and administrators needs to increase—identifying relevant nonphysician end user activities that
could be augmented by AI is an outstanding research endeavor on its own.
We expect future AI methods development to shift toward a middle ground between
rule-centric and data-centric methods because interpretable models better support
decisions and trust in the health care setting. For example, explainable AI is a
paradigm whereby one can understand what a model is doing or why it arrives at
a particular output.145–147 Interpretability of models is additionally important from
an equity lens to be able to identify and then avoid AI reproduction of biases in
data, which is a present concern with data-driven methods.148 It is also important
to remember that AI is not always a superior solution: a literature review of studies
published between January 2016 and August 2017 in Medline that compared prognostic prediction models for individualized prediction found comparable performance
of machine learning compared with logistic regression based models.149 This review
further identified that studies generally had poor methodology and reporting, with a
need for more calibration performance assessments.
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3.5.4

Conclusions

Ours is the first comprehensive, interdisciplinary summary of research on AI and
primary care. Two fundamental aims in the body of research emerged: providing
support for clinician decisions and extracting meaningful information from primary
care data. Overall, AI for primary care is an innovation that is in early stages of maturity, with few tools ready for widespread implementation. Interdisciplinary research
teams including frontline clinicians and evaluation studies in primary care settings
will be crucial for advancement and success of this field.
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Chapter 4
Describing a Complex Primary
Health Care Population in a
Learning Health System to
Support Future Decision Support
and Artificial Intelligence
Initiatives
Chapter 3 reviewed the field of of artificial intelligence (AI) and primary care research in general, finding notable gaps in research that is relevant to “real world”
primary care settings. This Chapter focuses on a primary health care organization,
the Alliance for Healthier Communities, to begin investigating possibilities for using
AI and related techniques with their electronic health record (EHR) data to support
care delivery. We generated an overview of their client population to help identify
and support future initiatives, both in terms of substantive findings and in terms
of methodological considerations that are relevant for work with similar populations

31

or primary health care organizations. More generally this Chapter demonstrates the
value of descriptive epidemiology for informing learning health system (LHS) initiatives, and opportunities for unsupervised machine learning to play a role in descriptive
studies of complex populations. The article of this Chapter is under revision for the
International Journal of Population Data Science.a

4.1

Technical Background

This Chapter includes a large-scale descriptive epidemiology study that relies on
standard techniques from epidemiology to characterize a population as well as unsupervised learning techniques to identify complex patterns. Background for both types
of methods is provided herein.

4.1.1

Epidemiology

Integral to the design of an epidemiological study, and to the generalizability or
impact of findings, is the cohort from which data are collected. A cohort refers to
a group of people that are followed or observed over a period of time.150 In a closed
cohort, membership is defined based on eligibility criteria at the beginning of the time
period and cannot change; new members cannot be added. In contrast, members of
an open cohort can be added or removed depending on eligibility criteria that is
assessed throughout the time period of interest. Eligibility criteria should include
person, place, and time specifications.151 The basis of the present study was an open
cohort with membership defined based on being an adult that received primary care
at the Alliance for Healthier Communities at any point in 2009-2019.
Two measures to assess the burden or risk of an outcome for a cohort include prevalence and incidence.
a

A preprint is available: Kueper JK, Rayner J, Zwarenstein M, Lizotte DJ. Describing a complex
primary health care population in a learning health system to support future decision support and
artificial intelligence initiatives. medRxiv. Published online March 2, 2022. doi:10.1101/2022.03.01.
22271714
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• Prevalence rate: the prevalence of a particular outcome, e.g., disease diagnosis, is a count of the number of cases of the outcome in a defined population
divided by the number of people at risk of the outcome in that population at the
specified point in time.151 Period prevalence is the number of “ever happened”
(new, existing, recurrent) cases of an outcome across a specified time period, for
a particular population, divided by the average (or midpoint estimate) size of
the population at risk during that time period.151 Note that for an open cohort
this denominator is different from a count of the number of clients who ever
had membership in the cohort.
• Cumulative incidence rate: the incidence of a particular outcome, e.g., disease diagnosis, is a count of the number of new (and/or repeat) cases within
a specified time period for a particular population, divided by the number of
at-risk members of that population for that same time period.151
Both prevalence and incidence rates depend on the denominator, data source(s), and
outcome definition(s) used.

4.1.2

Unsupervised machine learning

Unsupervised machine learning algorithms are applied to unlabelled data to identify
patterns or trends, which can then be interpreted by humans or used as inputs for
another analysis. We used three well-established techniques in this study: Ising
models to identify common co-occuring conditions, non-negative matrix factorization
to identify patterns of care provider teams, and K-medoids time-series clustering to
explore patterns in visit frequency.
• Ising models: A markov random field expresses a set of random variables
(nodes) as an undirected graphical model.152,153 An Ising model focuses on
the pairwise connections (edges) between the nodes in a markov random field;
learned edge weights between binary node variables represent the tendency for
the two variables to be present as compared to one or both variables being
absent, regardless of the state of the other variables in the graph.154–156 These
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graphs are related to Bayesian networks/directed acyclic graphs, but cyclical
patterns are allowed and the goal is to understand co-occurence patterns rather
than to develop a causal model or understand directions of effects. An Ising
model can be developed by fitting an L1-penalized logistic regression for each
variable and taking the mean of regression coefficients to arrive at “symmetised”
edge weights.156–158
• Non-negative matrix factorization (NMF): NMF is a technique that factorizes a data matrix into two smaller matrices that approximate the original
dataset, whereby all three matrices include only non-negative numbers.159,160
As shown in Figure 4.1, the algorithm creates weighted collections (“topics”)
of codes, e.g., diagnostic codes in client EHRs. A distance metric to minimize the number of topics (k) allowed to explain the original matrix are set
manually.159–161 In our NMF analyses, the H matrix was our main focus, which
has a row for each topic and a column for the amount or weight of each original
code making up that topic: codes that show up together in topics tend to frequently co-occur in EHRs and vice versa. The W matrix can also be useful, such
as for dimensionality reduction, as client EHRs are represented by a reduced
vector of topic weights instead of all original codes.

Figure 4.1: Non-negative matrix factorization example.
• K-medoids time-series clustering: Clustering is used to identify groups
from a dataset such that e.g., clients, within the same group are more similar
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to each other than to clients in other groups.162 In contrast to topic modelling
where a single client may pertain to more than one topic, in clustering the data
are partitioned such that each client belongs to only one group.162 Time-series
clustering involves applying a clustering algorithm to time series data, which
are ordered sequences of events.163 We used K-medoids clustering, whereby each
group is represented by the “prototype” client that has the smallest average
distance to all other clients in their cluster (as opposed to the mean, which
may be a fictitious value, as in K-means clustering).163,164 We used dynamic
time warping distance, which calculates the “best match” in terms of shape and
magnitude between two time-series of possibly different lengths (smallest sum
of absolute distances between indices, matched in a monotonically increasing
fashion).163,165–167

4.2

Introduction

The recognized potential for analysis of EHR data to inform healthcare delivery led
to the formalization of the concept of an LHS in 2007: a socio-technical system
characterized by iterative cycles of data-to-knowledge-to-practice feedback.1,3 LHS
initiatives target quality improvement, research, or decision support; and usually rely
on EHR data from the same population that the findings or end-product are intended
to benefit.1,4,74,75 These initiatives can support populations who have historically been
excluded from medical research and clinical guideline development, such as those with
complex health needs or barriers to participation.21–23,25
Primary care, first contact care provided in a community setting over the life course,
is inherently complex.5,6 The Alliance for Healthier Communities provides team-based
primary health care through 72 Community Health Centres (CHCs) across Ontario
to clients who face barriers to care and challenges, such as poverty and mental illness,
that increase their risk for poor health.9,168,169 Population health is a central element
of their care model, and the Alliance officially adopted an LHS model in October
2020,45,46 making them one of few documented primary care LHSs in North America.4
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An LHS may pursue multiple initiatives to inform and improve care delivery. A
first step towards any initiative is identifying needs of clients and providers, which is
often driven by internal stakeholders.75 Descriptive epidemiology is instrumental in
outlining health states and needs of populations,170 and may be beneficial to add into
these early stages of LHS development both to identify new areas to explore and to
support existing ideas. For example, describing how clients are represented in EHR
data at a population level may complement clinical experience to identify potential
bias or misrepresentation that analyses need to account for to obtain meaningful
results.171–173 In addition to proposed LHS benefits, descriptive studies can contribute
towards closing the gap in understanding about the basic functions of primary care
in general.174
To properly understand complex EHR data, we propose using both simple statistical
techniques traditionally used in descriptive epidemiology and more complex techniques from AI, applied with an epidemiological lens. Simple techniques alone may
provide an oversimplified or incorrect view of certain characteristics, which could lead
to ineffective or harmful decisions later-on. So, in pursuing our primary purpose of
better understanding care provided by the Alliance, we explored the suitability of a
variety of techniques for epidemiology of a separate primary care system with its own
EHR.
We performed the first large-scale descriptive and exploratory study of ongoing
primary care clients served by the Alliance using statistical and machine learning
methodology.

Our objective was to summarize sociodemographic, clinical, and

healthcare use characteristics of this population. We used unsupervised learning
techniques to identify patterns of multimorbidity, care provider teams, and care
access frequency. Findings provide a foundation for future Alliance LHS initiatives,
including those related to their existing interest in using EHR data to segment
populations and tailor care. In addition to substantive findings, this work more
generally demonstrates the application of an epidemiological lens and use of a variety
of methods from statistics and AI to effectively describe a complex population and
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contribute to early stages of an LHS.

4.3
4.3.1

Methods
Study population and data source

We used a de-identified extract of the centralized, structured EHR database from
all CHCs; unique identifiers allowed tracking of client care over time. Issues addressed during care were recorded using Electronic Nomenclature and Classification
Of Disorders and Encounters for Family Medicine (ENCODE-FM)175 and International Classification of Disease (ICD)-10 vocabularies.176 Primary care EHRs represent an open cohort; Supplementary Figure D.1 shows the cohort size along calendarand observation-based time definitions. Clients eligible for inclusion were over 18 years
old in 2009, indicated a CHC as their primary care provider, and had at least one
encounter at a CHC in 2009 to 2019. Any additional eligibility for specific analyses
is described as needed below. We followed RECORD reporting guidelines (Appendix
D).177

4.3.2

General analysis plan

Sociodemographic, clinical, and healthcare use characteristics are defined in Appendix
Table D.1. Methods specific to each category are described below; we performed
“table-based summaries” for all, whereby categorical variables were summarized by
counts and percentages, and continuous variables by the range, median, mean, and
standard deviation. Where specified, findings were stratified by client multimorbidity
status (defined below) or CHC “urban at-risk” (UAR) status, referring to CHCs
located in major urban geographical areas that serve priority populations defined by
homelessness and/or mental health and substance use challenges.178 CHCs without
UAR designation still focus on clients with barriers to care but may be in rural or
urban settings and do not solely serve clients with the aforementioned complexities.178

37

4.3.3

Sociodemographic characteristics

We conducted table-based summaries for select fields from the structured EHR client
characteristic table and certain ENCODE-FM-derived variables. Missingness of the
former occurred at the 1) CHC or provider level, whereby a client was not asked about
the characteristic and 2) client level, whereby a client was asked and preferred to not
respond. Results are presented overall and stratified by UAR and multimorbidity
status.

4.3.4

Clinical characteristics

We investigated 20 chronic conditions that define multimorbidity in primary care
research179–181 and an additional four conditions of interest identified by Alliance
stakeholders. For each condition, clients were assumed to receive related care upon
the first record of a relevant code. We explored conditions in single, composite, and
pairwise manners.
4.3.4.1

Prevalence and incidence

To provide different perspectives on clinical complexity, we calculated two measures of
prevalence and one measure of incidence for each of the 24 conditions. We also calculated prevalence of multimorbidity. Our primary multimorbidity definition, including
for stratification, was presence of at least three of the 20 chronic conditions.179–181 We
also looked at multimorbidity of at least two conditions, as this is another commonly
used definition.180
1) Eleven-year period prevalence, based on calendar time, to assess the burden of
conditions over the entire observation period (2009-2019). For each condition,
we divided the number of clients who ever received a condition indication by
an estimate of the average population size (technical details in Appendix D.4).
Sensitivity analyses included the largest possible denominator: total number
of eligible clients, and the smallest reasonable denominator: starting with the
middle calendar year (2014), additional clients with at least one visit in adjacent
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years were added until no prevalence estimate was over 100%. Results are shown
overall and UAR-stratified.
2) Observation-based period prevalence, based on length of client observation, to
assess the burden of conditions dependent on the number of years clients received care at a CHC. To calculate this, we separated clients into 11 sub-cohorts
based on the number of years (consecutive 365.25 day intervals, rounded up)
between their first and last recorded events. For each sub-cohort and condition,
we divided the number of clients who ever received a condition indication by
the number of clients in the sub-cohort. Results are presented as bar graphs.
3) Cumulative incidence, to assess the rate of condition indications by days of
observation.

We plotted cumulative incidence curves using the R package

survival.182 To prioritize capture of incident condition-related care, we excluded clients with conditions recorded in 2009 from this analysis.
4.3.4.2

Condition co-occurrence patterns

To assess co-occurrence for each pair of conditions while adjusting for all of the
other conditions, we estimated an Ising model using R package MRFcov157,158 for all
conditions except Hepatitis C (Alliance-suggested condition that overlaps with one
of the 20 chronic conditions). We converted coefficients, representing the strength
of association between each condition pair adjusted for all other conditions, to odds
ratios and interpreted size using Chen et al. (2010) guidelines.183 We also viewed the
top frequency-based co-occurrences.

4.3.5

Healthcare use characteristics

We performed table-based summaries of provider and care access characteristics overall and stratified by UAR CHC, Rural Geography CHC, and client multimorbidity
status.
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4.3.5.1

Providers involved

To identify common care provider teams that clients were exposed to across their care
histories, we used NMF 184 to identify frequently-occurring: 1) “Ever-seen” teams
whereby dummy variables were used to indicate whether each provider type was
ever involved in care, and 2) Relative “amount-seen” teams based on volume of care
whereby the number of events associated with each provider type was normalized
within clients. For each version, we ran analyses allowing 2,3,5,10, and 15 topics
(provider teams) with the Python package sklearn.decomposition.NMF and
the Kullback-Leibler divergence distance metric.185 We interpreted resulting topics
by visual inspection. Provider types were maintained as recorded in the EHR except
“Other”, “Unknown”, and “Undefined” were combined. We also summarized the top
frequency-based provider types involved in care and referrals. Eligible clients required
at least one provider type indication in their EHR.
4.3.5.2

Care access patterns

We measured complexity of care as the number of events (distinct issues addressed or
types of care received) per visit (calendar day of access) to a CHC, and care frequency
as the number of calendar days at least one event was recorded per year (365.25 day
intervals) and per quarter-year (90.30 day intervals). To investigate frequency of care
in terms of magnitude and shape (changes in magnitude across care histories), we
performed time series clustering with the K-medoids algorithm and dynamic time
warping distance metric163 for 1) short-term clients with 2-3 observation years and
2) long-term clients with 8-10 observation years. For each time interval and cohort,
we used R package dtwclust166 to identify 2,3,4, and 5 clusters. Performance was
assessed using the silhouette score and visual inspection.

4.4

Results

Of the 881,129 adult clients in the Alliance EHR database in 2009-2019, 232,529
(26.4%) had ongoing primary care client indications, and 221,047 (25.1%) had at
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least one encounter in 2009-2019. Of these eligible clients, 64,504 (29.2%) received
care at least once in 2009, 141,627 (64.1%) in 2019, and 40,704 (18.4%) received care
in both years.

4.4.1

Sociodemographic characteristics

Sociodemographic characteristics are described in Table 4.1, with remaining substrata in Appendix Table D.2. The UAR CHCs tended to provide care to clients who
were more commonly English-speaking, and had lower levels of education, household
income, immigration, stable housing, and/or food security. Clients with multimorbidity tended to be older and more commonly female, reside in rural locations, and
had lower levels of education, immigration, stable residence, and/or food security.
Table 4.1: Sociodemographic characteristics.
Variable

Values

All

UAR

MM

221047

35998

103172

Age in 2015

25-34
35-44
45-54
55-64
65-74
75+

55505
45646
44653
37848
23162
14233

7976
7540
8186
6790
3644
1862

9346 (9.06)
15542 (15.06)
23982 (23.24)
25578 (24.79)
17780 (17.23)
10944 (10.61)

Rural
Geography
Residence

Rural
Urban
Missing

49275 (22.29) 6131 (17.03) 26818 (25.99)
167728 (75.88) 28538 (79.28) 75011 (72.70)
4044 (1.83)
1329 (3.69)
1343 (1.30)

Sex

Female
Male
Other
Missing

127070 (57.49)
93294 (42.21)
331 (0.15)
352 (0.16)

18699 (51.94)
17151 (47.64)
43 (0.12)
105 (0.29)

59946 (58.1)
43124 (41.80)
19 (0.02)
83 (0.08)

Female
Gender
Diverse
Male
Prefer not to
answer
Missing

41352 (18.71)
340 (0.15)

5509 (15.30)
112 (0.31)

21831 (21.16)
144 (0.14)

29366 (13.28)
1001 (0.45)

4585 (12.74)
51 (0.14)

14733 (14.28)
376 (0.36)

n

Gender

(25.11)
(20.65)
(20.20)
(17.12)
(10.48)
(6.44)

(22.16)
(20.95)
(22.74)
(18.86)
(10.12)
(5.17)

148988 (67.40) 25741 (71.51) 66088 (64.06)
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Sexual
Orientation

Highest Level
of Education

Primary
Language

Race and
Ethnicity

Years since
Arrival in
Canada

Bisexual
Gay
Heterosexual
Lesbian
Queer
Two-Spirit
Other
Do not know
Prefer not to
answer
Missing

1578 (0.71)
708 (0.32)
57065 (25.82)
485 (0.22)
323 (0.15)
128 (0.06)
246 (0.11)
924 (0.42)
7561 (3.42)

285 (0.79)
192 (0.53)
8447 (23.47)
70 (0.19)
34 (0.09)
80 (0.22)
34 (0.09)
201 (0.56)
877 (2.44)

690 (0.67)
306 (0.30)
29105 (28.21)
244 (0.24)
91 (0.09)
61 (0.06)
143 (0.14)
485 (0.47)
4078 (3.95)

Postsecondary or
equivalent
Secondary or
equivalent
Less than
high school
Other
Do not know
Prefer not to
answer
Missing

84888 (38.40)

12056 (33.49) 35763 (34.66)

61831 (27.97)

11783 (32.73) 32617 (31.61)

18941 (8.57)

3266 (9.07)

10618 (10.29)

8507 (3.85)
4860 (2.20)
2950 (1.33)

719 (2.00)
1318 (3.66)
422 (1.17)

4078 (3.95)
2350 (2.28)
1585 (1.54)

39070 (17.67)

6434 (17.87)

16161 (15.66)

English
French
Other
Missing

167163 (75.62)
22547 (10.20)
26847 (12.15)
4490 (2.03)

31658 (87.94)
944 (2.62)
2948 (8.19)
448 (1.24)

79599 (77.15)
11091 (10.75)
10710 (10.38)
1772 (1.72)

Black
8861 (4.01)
East/SouthEast 3739 (1.69)
Asian
Indigenous
2944 (1.33)
Latino
4350 (1.97)
Middle
2046 (0.93)
Eastern
Other
567 (0.26)
South Asian
3597 (1.63)
White
38464 (17.40)
Do not know 838 (0.38)
Prefer not to 2649 (1.20)
answer
Missing
152992 (69.21)

725 (2.01)
484 (1.34)

3757 (3.64)
1545 (1.50)

1577 (4.38)
206 (0.57)
344 (0.96)

1641 (1.59)
1708 (1.66)
838 (0.81)

148 (0.41)
323 (0.90)
4531 (12.59)
151 (0.42)
261 (0.73)

306 (0.3)
1852 (1.80)
21504 (20.84)
487 (0.47)
1513 (1.47)

0-5 years
6+ years

1191 (3.31)
4940 (13.72)

152029 (68.78) 25778 (71.61) 67969 (65.88)

13654 (6.18)
51815 (23.44)
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27248 (75.69) 68021 (65.93)
3047 (2.95)
22722 (22.02)

Household
Income

Household
Composition

None
recorded

155578 (70.38) 29867 (82.97) 77403 (75.02)

$0 to $14,999
$15,000 to
$24,999
$25,000 to
$39,999
$40,000 to
$59,999
$60,000 or
more
Do not know
Prefer not to
answer
Missing

40519 (18.33)
21102 (9.55)

8729 (24.25)
3555 (9.88)

17757 (17.21)
11081 (10.74)

20877 (9.44)

2988 (8.3)

10736 (10.41)

17245 (7.80)

2421 (6.73)

8671 (8.40)

28494 (12.89)

3862 (10.73)

12868 (12.47)

15408 (6.97)
27621 (12.50)

2658 (7.38)
4130 (11.47)

6264 (6.07)
14890 (14.43)

49781 (22.52)

7655 (21.27)

20905 (20.26)

Couple with
children
Couple
without child
Extended
Family
Grandparents
with Grandchild(ren)
Siblings
Single Parent
Sole Member
Unrelated
housemates
Other
Do not know
Prefer not to
answer
Missing

53398 (24.16)

6759 (18.78)

20713 (20.08)

39664 (17.94)

5945 (16.51)

22950 (22.24)

7632 (3.45)

1123 (3.12)

3581 (3.47)

1746 (0.79)

247 (0.69)

1183 (1.15)

1622 (0.73)
14445 (6.53)
32782 (14.83)
8622 (3.90)

250 (0.69)
2527 (7.02)
7445 (20.68)
1567 (4.35)

669 (0.65)
6348 (6.15)
18597 (18.03)
2849 (2.76)

8913 (4.03)
2475 (1.12)
3727 (1.69)

1476 (4.10)
643 (1.79)
491 (1.36)

4202 (4.07)
1279 (1.24)
1927 (1.87)

46021 (20.82)

7525 (20.90)

18874 (18.29)

Stable
Residence

True

199349 (90.18) 28227 (78.41) 90479 (87.70)

Food
Insecurity

True

10985 (4.97)

2947 (8.19)

7323 (7.10)

Legend: MM = Multimorbidity; n = Number of clients; UAR = Urban At Risk
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4.4.2

Clinical characteristics

4.4.2.1

Prevalence and incidence

Eleven-year period prevalence estimates ranged from 1.5% (Hepatitis C) to 81.0%
(multimorbidity of two conditions) overall, with generally higher estimates in UAR
strata (Table 4.2). The low sensitivity estimate for the denominator was based on
2012-2015 (n=148,595).
Table 4.2: Eleven-year period prevalence.
Variable

All

UAR

n
Hypertension
Depression or Anxiety
Chronic Musculoskleletal
Arthritis
Osteoporosis
Asthma or COPD or Chronic Bronchitis
CVD
Heart Failure
Stroke or TIA
Stomach Problem
Colon Problem
Chronic Hepatitis
Diabetes
Thyroid Disorder
Any Cancer
Kidney Disease or Failure
Chronic Urinary Problem
Dementia or AD
Hyperlipidemia
Obesity
Hepatitis C
Smoking or Tobacco Use
Substance Use
Lonely or Isolated
MM 2+
MM 3+

165125
68177 (41.29)
23828 (14.43)
104304 (63.17)
37201 (22.53)
11462 (6.94)
43837 (26.55)
23311 (14.12)
7994 (4.84)
2967 (1.8)
36175 (21.91)
24949 (15.11)
13288 (8.05)
35704 (21.62)
24793 (15.01)
14024 (8.49)
8290 (5.02)
59677 (36.14)
4776 (2.89)
67175 (40.68)
38408 (23.26)
2436 (1.48)
37355 (22.62)
20853 (12.63)
17947 (10.87)
133704 (80.97)
103172 (62.48)

27256
12304 (45.14)
5533 (20.30)
18842 (69.13)
6906 (25.34)
1950 (7.15)
9190 (33.72)
4673 (17.14)
1564 (5.74)
585 (2.15)
7620 (27.96)
4974 (18.25)
2954 (10.84)
6912 (25.36)
4217 (15.47)
2636 (9.67)
1555 (5.71)
11131 (40.84)
898 (3.29)
11659 (42.78)
6455 (23.68)
1173 (4.30)
9597 (35.21)
7508 (27.55)
5149 (18.89)
24129 (88.53)
19237 (70.58)
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Note: Denominator was the approximated average population size across
all years (2009-2019). Legend: AD = Alzheimer’s Disease; COPD =
Chronic Obstructive Pulmonary Disease, CVD = Cardiovascular Disease;
MM = Multimorbidity; n = Number of clients; TIA = Transient Ischemic
Attack.
Observation-based period prevalence estimates tended to increase with length of observation; however, cumulative incidence plots for the 156,543 (70.8%) clients without
care recorded in 2009 showed the rate of condition indications notably decreased after the first year of observation. Sample plots are in Figure 4.2; all are in Appendix
Figures D.2 and D.3.
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Figure 4.2: Example observation-based period prevalence and cumulative incidence
plots.
Notes: Left column: Observation-based period prevalence. Right column: Cumulative incidence by
days of observation.

4.4.2.2

Condition co-occurrence patterns

Among the 103,172 (46.7%) clients with multimobidity of at least three chronic conditions, there were 25,162 unique combinations ranging in frequency from 1 (<0.1%)
to 845 (0.4%) clients.
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Figure 4.3: Condition co-occurrence patterns: heatmap representing the results of
the Ising model.
Notes: Shading is relative to the edge weights or strength of condition co-occurrence. The numbers
indicate raw counts in the data; diagonal counts represent clients who only had that single
condition. Legend: TIA = Transient Ischemic Attack; COPD = Chronic Obstructive Pulmonary
Disease.

Figure 4.3 presents the Ising model results. Pairwise associations between conditions
on the log-odds scale ranged from -0.82 (Osteoporosis—Obesity) to 2.93 (Kidney
disease or failure—Chronic urinary problem). There was one large, five medium, 40
small, and 207 very small associations based on odds ratio magnitude. The five largest
positive associations were 1) Kidney Disease or Failure—Chronic Urinary Problem, 2)
Smoking or Tobacco Use—Substance Use, 3) Cardiovascular Disease—Heart Failure,
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4) Hypertension—Hyperlipidemia, and 5) Hypertension—Kidney Disease or Failure.
In contrast, the top five co-occurring conditions based on raw frequency were 1)
Hyperlipidemia—Chronic Musculoskeletal, 2) Hypertension—Chronic Musculoskeletal, 3) Hyperlipidemia—Hypertension, 4) Chronic Urinary Problem—Chronic Musculoskeletal, 5) Asthma or COPD or Chronic Bronchitis—Chronic Musculoskeletal.
These directly correspond to the conditions that had the highest marginal frequencies.

4.4.3

Healthcare use characteristics

Table-based summaries of healthcare use characteristics are in Appendix Table D.3.
In general, UAR CHCs had higher healthcare use while rural geography CHCs were
closer to the overall population. Clients in multimorbidity strata exhibited higher
healthcare use compared with the general base cohort.
4.4.3.1

Providers involved

There were 19,394 unique combinations of the 68 distinct provider types seen across
the 220,806 (99.9%) clients with at least one provider type recorded. In terms of
referrals, 102,088 (46.2%) clients had at least one internal and 143,922 (65.1%) had
at least one external referral recorded. Note internal referrals may not have captured
“hallway referrals”, whereby a nearby provider provides a quick consult that is not
formally recorded.
Figure 4.4 shows results of the NMF analysis, listing the highest-weighted provider
types in each topic down to a weight of three. For the ever-seen provider team
analysis, physician and nursing provider types emerged most prominently overall. In
general, as the number of topics increased, additional provider types emerged and then
split apart to dominate separate topics. Exceptions were the high-weighted pairings of
nurse and physician and of registered practical nurse and nurse practitioner. Overall,
18 of the 68 possible provider types emerged prominently in at least one topic; only
one (respirologist) did not also appear in the amount-seen analysis.
The amount-seen provider team analysis had greater weight distributions between
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(a) Ever-seen provider team analysis
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(b) Relative amount seen provider team analysis

Figure 4.4: Common care provider teams.
Notes: Boxes represent the topics resulting from the non-negative matrix factorization analysis.
Provider types are listed in order starting with the highest weighted provider; for any given topic,
provider types with a weight less than three are not show. Legend: NP = Nurse Practitioner; RPN
= Registered Practical Nurse.
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provider types within topics. For example, the first of the three-topic analysis had an
approximate 1:1:1:6 ratio of care provided by nurse practitioner:nurse:registered practical nurse:physician. In both versions, about half of clients had a non-zero weight for
only one of the first two topics; in the amount-seen analysis more clients maintained a
non-zero weight on only one topic as the number of topics increased, e.g., 16.6% versus 2.5% at five topics. In general, results suggest most clients received the majority
of care from physician, nurse practitioner, or nurse provider types, usually in combination with other provider types at a lower volume of care and with heterogeneous
co-occurrence. An example of patterns that emerged for other provider types include
differences in timing and weight of dietician/nutritionist and social worker providers
between the two analyses. Interpreted alongside the most common provider and referrals types (Appendix Table D.4), findings suggest referrals to dietitian/nutritionist
were more common than to social worker, but frequent or longer-term care was more
commonly provided by social workers.
4.4.3.2

Care access patterns

Complexity of care from a CHC-perspective was primarily low with 80.4% of clientvisits associated with a single-issue and under 1.0% with over five issues addressed
(higher intensity); however, from a client-perspective, 24,204 (11.0%) experienced at
least one visit with over five issues while 38,533 (17.4%) experienced a maximum of
one issue per visit across their care history. The mean care access frequency was 6
days per year (standard deviation=7.4). While 29,191 (13.2%) clients experienced at
least one year with over 25 days, 7,455 (3.4%) averaged over 25 days per year across
their entire care history. There were 8,700 (3.94%) clients with at least one frequent
care period (year with over 25 days care accessed) and complex care episode (visit
with over 5 issues addressed).
For the time series clustering analyses, the short-term cohort included 37,920 clients
and 93,625 client-years of observation; the long-term cohort included 42,855 clients
and 387,035 client-years of observation. The silhouette score was always highest for
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two clusters (Appendix Table D.5). Visual inspection of plots (Figure 4.5) showed
high variability within and between clients.

Figure 4.5: Care frequency clusters.
Notes: Results from the four time series clustering analyses for each cohort and
data-representation combination. Medoids are shown with raw time series data, separated by
cluster number, for the number of clusters that resulted in the highest silhouette score (SS).

4.5

Discussion

We used statistical and AI techniques to summarize sociodemographic, clinical, and
healthcare use characteristics captured in the EHRs of ongoing primary care clients
served by the Alliance. Substantive findings can motivate new topics for future LHS
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initiatives, or help to refine existing ideas and selection of performance measures
for long-term evaluation of implemented interventions. Methods-related findings may
inform the approaches used in these endeavours. While our discussion focuses on LHS
initiatives, as with any epidemiological study, substantive results may be immediately
useful to the population of interest, e.g., to inform clinic-level case management and
onboarding of new clients.

4.5.1

Sociodemographic characteristics

The CHC EHRs contain rich sociodemographic information, both the presence and
absence of which is informative. Social determinants that may increase risk of poor
health including lower household income and education, residence instability, and
food insecurity were more prevalent in UAR CHC and multimorbidity strata. There
appeared to be evidence for the healthy immigrant effect,186 assessed by viewing the
proportion of people in each category of the years since arrival in Canada variable
across the multimorbidity strata: a lower proportion of people with 0-5 years in
Canada had multimorbidity as compared to those with 6 or more years in Canada
or no arrival information recorded (missing or born in Canada). Completeness rates
varied by characteristic and may be due to client, provider, or CHC level decisions. For
example, of the 72,059 (32.6%) clients asked about gender only 1001 (1.4%) preferred
to not answer. In contrast, more clients, 171,266 (77.5%), were asked about household
income but there was a higher tendency to not answer, 27,621 (16.1%). These findings
align with a framework to assess selection bias in EHR data that suggested multiple
mechanisms are usually responsible for missingness so the focus should be on “what
data are observed [instead of missing] and why”.187 While provider-level decisions may
be due to inferring certain characteristics or prioritizing information needed for them
to direct care, completeness rates are important for decision support tool performance,
which can improve with social determinants of health information.188,189
When assessing data quality and completeness, which is emphasized by LHS and
machine learning for EHR guidelines,1,30,75,172,190 the implications of pursuing LHS
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initiatives at different levels should also be considered. For example, a subset of CHCs
capture self-reported measures of health, which are valuable research outcomes.191
While these measures are not suitable for analyses with data from all CHCs (CHC
population-level initiatives), they should be considered for initiatives specific to the
collecting CHCs.

4.5.2

Clinical characteristics

4.5.2.1

Prevalence and incidence

In operationalizing morbidity measures, the denominator must be defined with the
intended end-goal in mind. The eleven-year period prevalence estimates relate to a
CHC-based perspective and are useful for long-term system-level planning, while the
observation-based period prevalence estimates are more aligned with a client-based
perspective and absolute measure of risk. Another consideration is that just as ICD10 or ENCODE-FM codes do not guarantee true condition presence, the absence
of care does not verify absence of conditions.192 For example, clients may not seek
primary care when they are healthy, hospitalized, or experiencing barriers to care.
The cumulative incidence plots demonstrate that “risk” of condition codes is highest
in the first year of observation. Clinically this makes sense, as new clients may have
a build-up of unmet care needs. Nonetheless, there are important takeaways for LHS
initiatives that require cohort construction. For example, predictive models developed
for decision support need to account for the almost qualitative change in risk related
to being a new client. Although this care pattern is somewhat unique to primary
care settings, methods developed for related problems may be useful. For example,
accounting for variable lengths of stay in intensive care unit EHRs,193 or handling
cold-starts and sparse data for recommender systems.194
4.5.2.2

Condition co-occurrence patterns

There was a high prevalence of multimorbidity, but with so many different multimorbidity “compositions” it is hard to see how to make use of the category of
53

multimorbidity. The Ising model demonstrated how to go beyond frequency-based
comparisons and identify relationships between conditions irrespective of others, but
again, this presents as a long tail problem, with very few combinations that are very
prominent. Primary care decision support tools will face the challenge of making
recommendations on many different and possibly co-occurring conditions. Most distinct multimorbidity compositions are rare events, making it unrealistic to generate
standardized responses or specialized evidence bases for each, especially when medical
condition combinations are considered alongside sociodemographics. The majority of
existing decision support tools and clinical guidelines focus on a single condition at
a time; new techniques for providing evidence-based guidelines or recommendations
for these vast numbers of combinations are needed.195–198

4.5.3

Healthcare use characteristics

4.5.3.1

Providers involved

While care for ongoing primary care clients is typically led by physicians or nurse
practitioners, CHCs include many provider types and LHS initiatives may choose to
focus on particular provider type(s). The NMF analyses more easily identify reliable
patterns of commonly seen provider types and teams than manually sifting through
extensive count-based tables. Another use for NMF is dimensionality reduction or
data pre-processing, whereby data are summarized to reduce the number of variables
that need to be included in an analysis.184 For example, NMF-derived topics could be
used as inputs to a predictive model instead of separate variables to represent each
provider type or specific, manually selected combinations.
4.5.3.2

Care access patterns

Complexity of care from a CHC system-level perspective was primarily low intensity
(few problems addressed per visit), although this may be partly due to data quality such as if only one issue was recorded in the EHR when multiple were actually
addressed in the appointment. The subset of clients who experienced higher care
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complexity did not tend to also have high frequency of care. Sporadic visit patterns
may be due to unstable living arrangements or demanding life responsibilities; when
there is uncertainty about when a client will return, providers may pack together
multiple types of care. The marginal distribution of care frequency was right-skewed
without a distinct break; most clients experienced lower care frequency, but higher
frequencies were also observed. In contrast to expectations, we did not identify consistent, distinct client groupings through the time-series clustering, e.g., to indicate a
subpopulation of “frequent visitors.” This may be due to restrictions in the types of
similarity that dynamic time warping captures. Future analyses could try a different
similarity metric or including covariates to account for baseline variability.

4.5.4

Strengths and limitations

Strengths included the strong interdisciplinary approach used to assess complex, longitudinal EHR data. We used chronic condition definitions recommended for primary
care research,179–181 although the algorithms have not been validated for CHCs specifically. Our broad cohort definition supported a high-level overview of the population,
but may not be appropriate for specific research questions.

4.5.5

Conclusions

We demonstrated the use of simple statistics and AI techniques, applied with an
epidemiological lens, to describe EHR data from a budding LHS. Substantive findings
lay a foundation for future Alliance initiatives and may be informative for other
organizations serving complex primary care populations.
Key suggestions for future LHS initiatives include the need to carefully deliberate the
level of analysis, or who a given initiative should be targeted at (e.g., population or
specific CHCs, one or many clinical presentations, all or subset of providers), and the
associated implications for how clients will be represented in the data. Representation
will depend on analytical-, system-, provider-, and client-level factors. Decision support initiatives need to consider heterogeneity in conditions and care access patterns,
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including non-uniform risk of condition indications across observation history.
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Chapter 5
Hybrid Feature- and
Similarity-Based Models for
Prediction and Interpretation on
Large-Scale Observational Data
Chapter 3 concluded with a call for more artificial intelligence (AI) research that is
relevant to primary care settings and Chapter 4 highlighted complexity that can be
present within these settings. Chapter 5 presents machine learning methodology that
is designed to take advantage of rich but heterogeneous observational data sources
like primary care electronic health records (EHRs). Prediction and interpretation
using the proposed hybrid feature- and similarity-based model is demonstrated with
synthetic data and in a case study with the Alliance for Healthier Communities,
informed by Chapter 4. The work in this Chapter will be submitted as a full research
paper to a machine learning conference, whereby it undergoes review and if accepted,
will be published in the associated proceedings.a
a

A preprint is available: Kueper JK, Rayner J, Lizotte DJ. Hybrid Feature- and Similarity-based
models for prediction and interpretation using large-scale observational data. arXiv:2204.06076v1
[cs.AI]. Published online April 12, 2022.
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5.1

Technical Background

This Chapter addresses supervised learning tasks where the outcome of interest y(o)
for a particular observation o can be explained partly by constructed features „(o)
(i.e. scalar or fixed-length vectors that represent a characteristic or property of o)
and partly by more complex information

(o) (e.g., high-dimensional, time-varying,

variable-length data). For example, in a primary health care setting each observation could be a client and the outcome of interest a condition or situation, such as
diabetes or food insecurity, that the client is at risk for and early intervention may
help to prevent. In this setting, „(o)-type information may include sociodemographic
characteristics and current diagnoses while

(o)-type information may include years

of encounter data representing the subset of thousands of possible tests, diagnoses,
and procedures that the client has received in their lifetime.

5.1.1

Feature-based learning

Feature-based supervised models, such as trees, learn a mathematical function that
takes features as input and provides an estimate about the outcome as output.55,153
To use a feature-based approach for the above scenario, the

(o)-type information

must be converted into „(o)-type information. This can be done in a data-driven
way and/or based on medical or social theories of health. For example, a datadriven dimensionality reduction approach such as topic modelling could be applied
to client histories of diagnostic codes and the resulting topic weights for each client
used as features. A theoretical approach may include identifying known risk-factors
for the outcome based on research literature or clinical expertise, and then collapsing
specific subsets of codes to generate binary indicators for whether or not the client
has ever experienced each risk factor. Oftentimes feature construction loses or misses
information and in general the extent to which this is a disadvantage will depend on
the complexity of the data and predictive task.
In this Chapter we use logistic regression (LR) to relate „(o)-type information to the
outcome. A prediction for a client of interest o based on a set of j features can be
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written ŷ(o) = Î

5.1.2

1q

j

2

„j (o)—j where Î is the sigmoid function.55,153

Similarity-based learning

Similarity-based approaches, such nearest-neighbour and kernel methods, can handle
both „(o)-type and

(o)-type information as inputs.55,153 Instead of learning explicit

relationships between individual inputs and the outcome, these methods use similarities or distances between observations by assuming that similar o are likely to
experience the same outcome, and if the same o is entered into the model twice the
same prediction will result. There are potentially two challenging aspects of

(o) that

make similarity-based approaches attractive: the dimensionality and the proper form.
In some situations, the best form for

(o) is known but its dimension is too large or

challenging to construct with traditional feature-based approaches; other times, even
if

(o) is a manageable size, the most useful way to incorporate it into a model is

unknown.
Kernels can handle both of these challenges and are the similarity-based approach
used in the remainder of this Chapter. A kernel function k : Rm ◊ Rm ‘æ R expresses the inner product between two inputs that have been mapped to some high-

dimensional feature space.55,153 The feature mapping defines the notion of similarity
captured by the scalar output, and can be non-linear with infinite dimensions; the
mapping does not need to be made explicit to use a kernel function. A valid kernel
function must be symmetric and result in a positive semi-definite kernel matrix. The
notion(s) of similarity to capture, and whether data pre-processing is warranted, will
depend on the specific scenario.
5.1.2.1

Select kernel functions

The simplest kernel function is the linear kernel, k(oi , oj ) = oTi oj , which can be used
to create a dual formulation of linear regression that uses o directly as features.
An example of a more complex and commonly used kernel function is the Gaussian
or Radial Basis Function (RBF), k(oi , oj ) = e≠
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||oi ≠oj ||2
2
2‡ 2

, which has a feature space

with infinite dimensions and one hyperparameter ‡ to be tuned.153 The RBF kernel
is used in our simulation study experiments.
The Jaccard kernel function, described here, and proposed extension, described
in the article, is used in our clinical case study. The Jaccard similarity between two
sets of codes, A and B, is J(A, B) =

(AﬂB)
.
(AﬁB)

The highest similarity is when all codes

in A are in B and vice versa, and the lowest similarity is when no codes that are in
A are also in B, regardless of the number of codes. The relative prevalence of codes
does not matter, which leads to potentially limiting characteristics in situations with
a large number of possible codes. For example, when trying to capture similarity
with the Electronic Nomenclature and Classification Of Disorders and Encounters
for Family Medicine (ENCODE-FM)175 vocabulary that includes over 4,000 unique
codes to record care activities. Strengths and limitations of the Jaccard are introduced
below through simple examples:
Imagine a scenario where a “model” client comes in for a blood test, receives a diagnosis of hypertension, and then comes in for a follow-up appointment that includes
a prescription renewal. As shown in Table 5.1a, there are three other clients that
have the same diagnosis, but different surrounding treatment. The Jaccard similarity
(Table 5.1b) appears to work well in that:
• Client 1 similarity with others is proportional to the number of codes the other
clients have.
• Clients 2 and 3 have comparable similarity profiles.
Table 5.1: Jaccard similarity score example.
(a) Client care profiles

(b) Jaccard similarity

Client

Blood

Diagnosis

Prescription

C1
C2
C3
C4

TRUE
TRUE
FALSE
FALSE

TRUE
TRUE
TRUE
TRUE

TRUE
FALSE
TRUE
FALSE

C1
C2
C3
C4

C1

C2

C3

C4

1.00
0.67
0.67
0.33

0.67
1.00
0.33
0.50

0.67
0.33
1.00
0.50

0.33
0.50
0.50
1.00

Now imagine there is another code, “Com”, that is so common everyone has it:
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similarity scores all increase, but the ratio in terms of who is most similar to who else
stays the same. While this type of universally present code is not overly concerning
for predictive purposes, a limitation emerges when we imagine what happens to the
similarity score for two clients that do not have a very common code (Table 5.2a and
5.2b):
• Their similarity with everyone else decreases. (This is desirable.)
• Their similarity with each other does not increase even though they share an
“abnormality” from the population expectation. (We hypothesize that this is
not desirable.)
Table 5.2: Jaccard similarity score example with common code.
(a) Client care profiles

Client

Blood

Diagnosis

Prescription

Com

C1
C2
C3
C4
C3b
C4b

TRUE
TRUE
FALSE
FALSE
FALSE
FALSE

TRUE
TRUE
TRUE
TRUE
TRUE
TRUE

TRUE
FALSE
TRUE
FALSE
TRUE
FALSE

TRUE
TRUE
TRUE
TRUE
FALSE
FALSE

(b) Jaccard similarity

C1
C2
C3
C4
C3b
C4b

C1

C2

C3

C4

C3b

C4b

1.00
0.75
0.75
0.50
0.50
0.25

0.75
1.00
0.50
0.67
0.25
0.33

0.75
0.50
1.00
0.67
0.67
0.33

0.50
0.67
0.67
1.00
0.33
0.50

0.50
0.25
0.67
0.33
1.00
0.50

0.25
0.33
0.33
0.50
0.50
1.00

Sharing in the absence of common codes is not explicitly worked into the Jaccard
similarity score. There are situations where the absence of common codes may matter
more than the presence, for example missing check-ups after the diagnosis of a new
condition or not receiving screening tests (when eligible). The same is not true for
rare codes, where the presence of codes is generally expected to be more important
than the absence. So, simply reverse coding everything or removing codes from the
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universe is not a suitable solution. A modification to the Jaccard function to account
for limitations is presented in this Chapter’s article.

5.1.3

Model selection and performance

Supervised machine learning model development for predictive tasks typically includes
training and then comparing several different candidate models to select the best one
for use or perhaps further development and testing. For the purposes of this section,
“best” refers to predictive performance.
Model selection refers to the process of training and comparing several different
models, such as a feature-based model with a similarity-based model, and/or comparing models that have the same form but different hyperparameters, such penalization
strength.162 A key component of model selection is that models are trained on different
data than used to assess predictive performance, so that potential issues like overfitting can be identified.162,199 Two main ways to achieve this are with data splitting
and cross validation.
• Data Splitting is when a dataset is segmented into separate training and validation sets.162,199 The training set is used to learn parameters (e.g., feature
coefficients), and then the trained model is applied to the validation set to
get predictions with new observations.162,199 Performance is compared using the
validation set predictions.
• Cross validation (CV) uses resampling to generate multiple (k) training/validation splits of a dataset, often referred to as “folds”.162,199 The entire dataset is
divided into k equal sized subsets; each subset is given a turn at being the validation set, whereby predictions are made from models trained on the remaining
k ≠ 1 subsets.162,199 Model comparison is typically based on the average per-

formance across the k validation sets. Nested CV is when the CV process is
performed for each of the training folds; the model selected based on the “inner
loop” is re-trained on all “outer loop” training fold data before making predictions on the outer loop validation data. An example use of nested CV is
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to select hyperparameters on an inner loop, so that the “best form” of several
different model types can be compared on the outer loop validation folds.162,199
Model performance: Three common performance metrics to assess a model that
predicts the probability (risk) of a binary outcome:
• Discrimination refers to the ability to assign a higher probability of the outcome to an observation with the outcome present as compared to one without
the outcome.200,201 Discrimination performance can be summarized by the area
under the receiver operating characteristic curve (AUROC ) or c-statistic.200,201
• Calibration assesses how well predicted probabilities match observed proportions.

For a well-calibrated model, of observations assigned a given prob-

ability of the outcome, a similar proportion will truly be assigned with the
outcome.200,201 Calibration can be assessed with a calibration plot. The intercept indicates whether the predicted probabilities are generally overestimates
(< 0) or underestimates (> 0) and the slope represents whether the estimates
are generally too high (< 1) or low (> 1).201
• Precision is the proportion of correct positive predictions made from all positive predictions (true and false) and recall is the proportion of correct positive predictions made from all possible positive cases (true positive and false
negatives).202,203 A precision-recall curve plots these two metrics across different
probability thresholds, with the area under the curve (AUPRC ) serving as a
summary performance metric.202,203
Of note, if a single cut-off value is selected, such that probabilities above the threshold
are considered positive outcome predictions, a confusion matrix can be constructed
and additional metrics like accuracy and positive predictive value calculated.
Above describes the model selection process and performance metrics that may inform
the selection as well as more general evaluation. Once a final model is selected, an
estimate of its generalization error should be obtained using data that were not part
of the model selection process. In internal validation, this would be a held out subset
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of data from the same data source used for model training and selection.162,204,205
In external validation this would be data from a different data source, e.g., different healthcare system population.162,204,205 Note that for models intended for use in
healthcare, clinical validation is also needed.204,205

5.1.4

Standardization

Standardization is a technique used in epidemiology to investigate outcome rate(s),
such as to estimate how many cases of an outcome are in a subpopulation where
data are not available or to assess whether the number of cases differs from what
would be expected based on rates from a reference population. Rates may be adjusted for characteristics, such as sex or age, by which the outcome prevalence is
expected to differ. In the following study we use indirect standardization to calculate standardized morbidity ratios, which assess the sex-adjusted rate of the outcome
in a subset of the eligible cohort as compared to the rest of the eligible cohort.
Standardized M orbidity Ratio =

Observed Outcome Cases
Expected Outcome Cases

q

xi
= q (Mi i ún
where xi reprei)
i

sents the number of outcome cases in strata i of the population under investigation,
M represents the outcome rate in strata i of the reference population, and n rep-

resents the number of clients in strata i in the population under investigation.206 If
SM R = 1 then the sex-adjusted rates are the same in the two populations.

5.2

Introduction

Health care settings generate large amounts of data and yet it can be challenging to
fully harness these data for machine learning applications. For machine learning tasks
with large-scale observational data, there are often known, informative features as well
as additional data that may be useful for the task but are challenging to summarize
into meaningful features due to size or complexity. For example, EHRs capture client
characteristics (e.g., year of birth) in structured fields and record information arising
from each encounter (e.g., date-stamped diagnosis and procedure codes) in dynamic
tables. The former may be well suited for features while the latter high-dimensional,
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variable length data may be better represented in terms of similarity to other clients
in the database. Explainable, reproducible methods that take full advantage of these
rich data are needed to support further advancements in the field of machine learning
for healthcare.32,38–41,43,207
Feature- and similarity-based models have complimentary characteristics. Featurebased approaches, such as logistic regression (LR), tend to be more familiar to endusers, less susceptible to overfitting, and easier to interpret (e.g., viewing regression
coefficients or the structure of a decision tree); however, not all valuable information
can be captured with features and model performance may suffer from underfitting,
especially for heterogeneous populations. In contrast, similarity-based approaches
such as multiple kernel learning have a higher computation cost but can incorporate
more complex or time-varying data that may account for additional variability in
the outcome.208–210 Interpretation of similarity-based approaches is not as straightforward as for feature-based methods, but can include strategies such as summarizing
characteristics about the most similar training examples used to train a model to
the one for whom a prediction is being made.40,211 . Similarity-based approaches are
not interpreted on their own for the purpose of causal inference, while feature based
approaches may be, either explicitly in estimating a treatment effect or implicitly by
interpreting feature coefficients to identify risk factors to intervene on.
We present two variations on an intrinsically interpretable hybrid feature- and
similarity-based model (HFSM ) and demonstrate their use with synthetic data and
with EHR data from a complex primary health care population. The model form
is able to support traditional causal interpretations of feature coefficients while
reaping additional benefits from similarity based approaches, such as improved
absolute risk prediction while maintaining traditional feature interpretations, or
adjustment for complex confounders. Our experiments found the HFSM approach
can outperform solely feature- or similarity-based methods while retaining or
enhancing interpretability.
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5.2.1

Generalizable insights about machine learning in the
context of healthcare

Our primary contributions are through the hybrid model, both in being the first to
present the model structure, and in describing the types of supervised learning scenarios where combining feature- and similarity-based approaches within an inherently
interpretable model may be beneficial. Our hybrid model enables incorporation of
key prior knowledge in ways not possible with existing methods. Applications include
prediction-oriented tasks, e.g., to underlie a clinical decision support system, and exploratory or causal analyses, e.g., to learn about a population. We describe how our
model can be used for “traditional” clinical epidemiology modelling and use simple
examples to demonstrate situations where feature coefficients may become more or
less biased depending on other characteristics of the model—these concepts apply
to HFSM as well as to any other multivariable/multicomponent model that may be
interpreted for decision making.
Additional contributions are made through our clinical case study, wherein we applied
HFSM using a new strategy for building kernels that assesses similarity in terms
of both the presence of rare care characteristics and the absence of common care
characteristics. Assessing similarity in terms of what expected characteristics are
missing may be useful for other settings (e.g., public health, emergency room triage)
where two people that deviate from population-level expectations are more similar
than if they fit the expected profile. We discuss additional challenges encountered in
our applied setting that are relevant to other health care contexts as well, such as the
open cohort nature of primary health care and decisions related to features that are
informative but rare.

5.3

Related Work

Our hybrid model approach contributes to two general areas of research: 1) methods
designed to incorporate multiple sources or types of data and 2) combining simple and
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complex models to make a single prediction. Our approach to measuring similarity
in the clinical case study additionally contributes to research on kernel functions for
clinical data.

5.3.1

Integrating multiple types of data

Recommender systems, e.g., for movies or products, are often designed for settings
with two distinct types of data: 1) user attributes, such as demographic information
and 2) time-varying, high-dimensional information arising from user interactions with
a system, such as histories of movie viewings or ratings. Fan et al. (2017) developed
RIT-UA, which makes predictions based on a weighted linear combination of two
similarity scores: one based on a weighted count of common attributes and one based
on sigmoid functions applied to historical data about user preferences and ratings.212
Our HFSM approach is designed to handle data with a similar structure; however,
the RIT-UA generates scalar similarity scores to combine information from the two
data sources whereas HFSM maintains separate model structure to use information
from features directly.
Multiview learning combines multiple data types to improve predictive performance.
Lian et al. (2015) proposed a framework that assumes all feature and/or similarity
matrices contribute a different “view” of the data.213 A shared latent factor matrix
is learned to serve as a global representation of the data. Multiple kernel learning is a special case within this framework where each view is treated as a kernel
matrix.208–210,213 While there is overlap in the similarity-based part of this approach
to HFSM, including the possibility to incorporate multiple kernel learning techniques,
HFSM maintains separation of the feature matrix in a way that also prioritizes interpretation of individual feature coefficients.

5.3.2

Combining model types

Boosting approaches may also handle diverse data types by combining complimentary model forms to improve predictions. Hothorn et al. (2010) developed mboost, a
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component-wise boosting algorithm that combines penalized least square estimates
and/or regression tree base learners in an additive model structure.214 Each component may be applied to all or a subset of data, is weighted in the fitted model,
and can be interpreted separately.214,215 Our sequentially-optimized HFSM approach
is similar to mboost, but uses different components and does not employ an overall
weight for each model component. Building on mboost, Sigrist et al. (2021) developed
KTBoost, which learns both a regression tree and a reproducing kernel Hilbert space
regression function on all available data in each iteration, and then adds the one that
is expected to result in better performance to the ensemble of base learners.216 This
approach does not segregate data and does not allow for feature and kernel coefficients
to be jointly optimized as in our simultaneous HFSM approach. A popular gradient
boosting technique is XGBoost, which continues to fit new decision tree models to account for residual errors from previous models until performance stops improving.217
XGBoost has demonstrated excellent predictive performance in several settings, but
as with the other boosting techniques, the focus is on predictions. Our HFSM is parametric with a fully convex objective function; this supports reproducibility, which is
particularly important when interpretation of the model may be used to learn about
a population or to support clinical decision making.

5.3.3

Kernel functions for clinical data

Kernel functions are commonly used to capture similarity or distance, and several
functions exist that could be applied to indicator data in healthcare, such as diagnostic
and procedure codes from client care histories. Shawe-Taylor and Cristianini (2004)
review standard kernels for sets or strings that could be applied (e.g., intersection
kernel, union complement kernel, agreement kernel); however, these are solely based
on present elements, all equally weighted.208 For many clinical scenarios, tailoring
similarity measures based on the frequency or type of input data elements is expected
to be advantageous.
Klenk et al. (2010) proposed using regression techniques to weight the importance of
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each input variable for assessing overall similarity between two clients.218 Belanche et
al. (2013) defined a similarity score for input variables that depends on their probability of occurring in the training data; “rarer” variables are given higher weights.219
Similar to these two studies, we are interested in applying weights derived based on
training data to differentiate the treatment of input variables; however, while these
methods focus solely on presence of variables we additionally explore similarity due
to shared absence of common variables. Our kernel approach is also related to work
that applies different functions to different types of input variables, e.g., ordinal versus nominal,220,221 and to work on learning composite kernels as a structure discovery
problem.222 We have not found previous work considering both presence and absence
of input variables for similarity assessments within an indicator dataset.

5.4

Methods

We address supervised learning tasks where the outcome of interest y(o) for a particular observation o can be explained partly by constructed features „(o) (i.e. scalar
or fixed-length vectors that represent a characteristic or property of o) and partly by
more complex information

(o) (e.g., high-dimensional, time-varying, variable-length

data). For example, in a primary health care setting each observation could be a client
and the outcome of interest a condition or situation, such as diabetes or food insecurity, that the client is at risk for and early intervention may help to prevent. In
this setting, „(o)-type information may include sociodemographic characteristics and
core diagnoses while

(o)-type information may include years of encounter data rep-

resenting the subset of thousands of possible tests, diagnoses, and procedures that
the client has received in their lifetime.
Additional technical background on feature- and similarity-based approaches was provided at the beginning of this Chapter. These two approaches can also be contrasted
from a clinical standpoint, whereby there are often documented risk factors for a given
outcome that can be assessed for each individual client; however, clinicians may also
assess clients by thinking about similar clients they have previously cared for. When
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developing a model, similarity-based approaches may be advantageous over featurebased approaches when there are a large number of data elements or characteristics to
consider and/or when the proper way to enter data into a model is unknown. Example applications include using kernel methods to capture genomic similarity223,224 or
to improve-upon threshold-based alerts for intracranial hypertension in the Intensive
Care Unit.225

5.4.1

The hybrid feature- and similarity-based model

The proposed HFSM combines a feature-based component and a similarity-based
component with an additive model structure. Prediction ŷ(o) for observation o is
given by
Q

ŷ(o) = h a

ÿ

„j (o)—j +

j

ÿ
i

–i

ÿ

kl (

l (o),

l

R

1

2

b = h „(o)T — + k(o)T –
l (oi ))

where j indexes the features; i indexes the observations or clients in the training data;
l indexes the kernel domains, if there are multiple; and h is a monotonic function,
e.g., sigmoid or identity. k(o) is the vector of kernel values between o and each
training data point. All analyses in this paper use the sigmoid function to estimate
the probability of a binary outcome occurring. Thus, the estimated probability of
an outcome occurring for o is based on 1) their feature values and the corresponding
coefficients (—j ) and 2) similarity to clients from the training data and the overall
influence (–i ) of each client.
To train the model, we optimize a penalized log likelihood training criterion given by
LL(—, –; ⁄) =

A
ÿ
i

„(oi )T —+k(oi )T –

yi („(oi )T — + k(oi )T –) ≠ log(1 + e

B

) /n ≠ ⁄||–||1 .

The L1-penalty on – controls overfitting and produces a sparse model whose kernel component only depends on a subset of the training data; this is different from
the original kernel logistic regression formulation which penalizes the norm of the
regression function in its Hilbert space but does not induce sparsity.226 Training oi
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that maintain non-zero – can be thought of as “representatives” for groups of similar
clients. We solve this problem using the convex programming language cvxpy in
Python.227,228 An illustrative example relating the hybrid model to a special case of
kernel logistic regression and Python code for HFSM are provided in Appendices E.1
and E.2, respectively. Required memory for model fitting, assuming n clients and m
features, is O[mn + n2 ] for HFSM as compared to O[mn] for LR and O[n2 ] for kernel
logistic regression (KLR). Solve time will be compared in the experiments.
5.4.1.1

Fitting and interpretation

We consider two variations on fitting HFSM that have different interpretations: 1)
HFSM-Sequential (HFSM-Seq), which learns the feature coefficients fixing – = 0
and then fixes the learned feature coefficients while learning the kernel coefficients,
and 2) HFSM-Simultaneous (HFSM-Sim), which optimizes the feature and kernel
coefficients jointly. The simultaneous model fit is expected to result in better predictive performance since there is more flexibility to maximize the objective function,
but the resulting model has a more complex causal interpretation. In HFSM-Seq,
the feature coefficients represent their impact on the outcome adjusted for all of the
other features in the model but averaged over the information in the kernel, whereas
HFSM-Sim feature coefficients are additionally adjusted for the information in the
kernel. We discuss the implications for interpretation below. If the feature and kernel
matrices are orthogonal, the models produced by the two procedures will be identical.
A series of illustrative examples contrast the performance and interpretation of
HFSM-Seq and HFSM-Sim in terms of causal inference. For each example there was
a binary outcome y, one continuous feature X1 ≥ N (0, 1) that maintained a direct
relationship with y, and a binary feature X2 whose relationship with y and K was
manipulated. For simplicity, K was unpenalized and constructed from a linear kernel
function applied to a single binary variable. We designed four examples, represented
in Figure 5.1:
1. Independent contributions. P (Y ) = Î(0.25 ≠ 1X1 + 2X2 + 3K) where X2 ≥
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B(p = 0.5), and K ≥ B(p = 0.5).

2. The kernel operated as a confounder between the second feature and the
outcome. P (Y ) = Î(0.25 ≠ 1X1 + 3K) where K ≥ B(p = 0.5) and P (X2 ) =
Î(2K).
3. The kernel operated as a collider between the outcome and on the second
feature. P (Y ) = Î(0.25 ≠ 1X1 ) where P (K) = Î(3Y + 2X2 ) and X2 ≥ B(p =
0.5).

4. The kernel operated as a mediator between the second feature and the outcome. P (Y ) = Î(0.25 ≠ 1X1 + 3K) where P (K) = Î(2X2 ) and X2 ≥ B(p = 0.5).
For each example, feature coefficients were compared for HFSM-Seq, HFSM-Sim, and
LR fit on 3,000 training examples and predictive performance was compared based
on AUROC for 1,000 new test examples.

Example 1

Example 4

Example 2
Example 3

Figure 5.1: Data generating mechanisms used to contrast sequential and simultaneous
hybrid model optimization.
As seen in Table 5.3a, HFSM-Sim had the best predictive performance for all examples; however, as seen in Table 5.3b the corresponding HFSM-Sim feature coefficient
estimates could be closer to the truth, further from the truth, or similar to the feature
coefficients learned in HFSM-Seq. While the impacts of adjusting the feature coefficients by the kernel were predictable for these simple experiments, in practice the
direction of bias, if any, may be hard to determine. This uncertainty is analogous to
situations with solely feature-based approaches where the relationships between the
features and the outcome are unknown, or when automatic feature selection methods
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are used.229–232
Table 5.3: AUROCs and coefficients for interpretation example.
(a) Test AUROCs

LR HFSM-Seq HFSM-Sim
Ex.
Ex.
Ex.
Ex.

1
2
3
4

0.758
0.721
0.777
0.739

0.860
0.834
0.800
0.852

0.863
0.854
0.845
0.888

(b) Coefficients

HFSM-Seq HFSM-Sim

True

Ex. 1: Independent Contributions
—0
1.345
0.395
0.25
—1
-0.796
-0.995 -1.00
—2
1.515
1.896
2.00
Ex. 2: K was a Confounder
—0
0.595
0.264
—1
-0.723
-0.960
—2
1.044
0.092

0.25
-1.00
0.00

Ex. 3: K was a Collider
—0
0.382
-2.325
—1
-0.950
-0.979
—2
-0.020
-0.578

0.25
-1.00
0.00

Ex. 4: K was a Mediator
—0
1.213
0.295
—1
-0.793
-0.984
—2
1.246
0.158

0.25
-1.00
2.00

Note: HFSM-Seq and logistic regression coefficients are equal. Legend: HFSM-Seq = Hybrid
Model - Sequential Fit, HFSM-Sim = Hybrid Model - Simultaneous Fit, True = Coefficients used
to generate the data.

An interpretation advantage of the HFSM-Sim approach over solely feature-based
approaches is the opportunity to adjust for more complex types of confounding information than can be adequately captured through features. When the information
captured by the kernel is uncertain, HFSM-Seq can be used to maintain straightforward feature coefficient interpretation while still improving the absolute risk prediction through the addition of the kernel. Thus, hybrid models may be used much in the
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same way that logistic regression can be used for prediction or inference depending
on whether one focuses on the predicted outcome or model coefficients, respectively,
with the advantage of using a kernel to account for additional variability. Closeness
to the truth needs to be assessed on a model-by-model basis.
The kernel coefficients – may also be informative in and of themselves. Whereas
applying an L1-penalty to features is a form of feature selection, applying an L1penalty to – selects “representative observations” to include while adjusting for the
features. The higher the penalty, the fewer observations are allowed. The most
influential clients in the training data (highest magnitude –) can be investigated
to explore kernel behaviour. A prediction for an individual client is based on their
feature values and corresponding —, and then will be further increased or decreased
depending on similarity in terms of the kernel to clients in the training data that have
non-zero –. Similarity to clients with positive – will increase the predicted probability
while similarity to clients with negative – will decrease the predicted probability of
the outcome.

5.5

Evaluation

We compared the performance of the HFSM approach to solely feature- or similaritybased approaches with 1) a simulation study of three synthetic data scenarios where
the relative importance of the feature- and kernel-based data was varied and 2) a
clinical case study with EHRs from a primary health care organization in Ontario.

5.5.1

Simulation study

This study compared the HFSM approaches to the two most direct sub-component
models as in an ablation study. We followed the ADEMP framework for planning and
reporting on this study.233 The data generating mechanism was based on a parametric
model that most closely corresponds to Example 1 (independent contributions) in
the illustrative examples above, with four binary features and additional complex
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information that cannot be well represented by features in a linear model. This
latter information was based on the classic Monk-1 data problem, which includes
6 categorical variables (two-level variables: a3, a6; three-level variables: a1, a2, a4;
four-level variable: a5) and an outcome M that is the result of the Boolean statement
(a1 = a2)‚(a5 = 1).234 The outcome was used in the data generating mechanism. For
models with a similarity-based component, the RBF kernel function was applied to the
six categorical variables. We selected the RBF kernel due to its popularity in machine
learning applications and its use in previous work with Monk’s data problems.219,235
The data generating mechanism was P (Y ) = Î(—0 + 0.3X1 + 0.4X2 + 0.6X3 + 0.7X4 +
”M ). Coefficients were decided such that if —0 = 0, ” = 0, and

q4

m=1

—m =2
˜ then P (Y )

ranges from 0 to 0.88 and ” can be used to further increase the maximum probability
of the outcome. Across the three experiments the — were fixed and ” was changed
to vary the relative importance of the feature- and kernel-based data. The intercept
—0 was used to bring the prevalence of the outcome below 50% to be more similar
to most clinical outcomes. Three scenarios were set up with 10,000 observations
generated from each, which is similar to the number of clients expected across a few
small primary health care clinics:
1. Kernel had a similar effect to a single feature: ” = mean(—) and —0 = ≠1.5

2. Kernel had a similar effect to the set of features: ” = sum(—) and —0 = ≠2.1

3. Kernel had a larger effect than the set of features: ” = 2·sum(—) and —0 = ≠3.2
For each scenario, we implemented a nested CV procedure whereby for each of five
outer folds, the outer fold training data were split 75/25 into inner fold training and
validation data. To reduce random variation between the models, the same outer
and inner CV folds were used for each model; seeds were re-set between scenarios.
Hyperparameters, if any, were selected through a grid search for the best AUROC on
the inner validation data. Models were then re-trained with the selected hyperparameter(s) on all outer fold training data, and predictions of the target binary outcome
were made on the outer fold test data. Folds were trained in parallel using the python
package multiprocessing.236,237
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Four models were compared: 1. Feature only model: LR, 2. Similarity only model:
KLR, 3. HFSM-Seq, and 4. HFSM-Sim. For kernel-containing models, three candidate hyperparameters ‡ for the RBF kernel were considered (0.01, 0.1, 1). These
values provided a range of similarity patterns on the Monk’s data, based on a measure
of matrix diagonal dominance and visual exploration of the RBF kernel calculated for
a random sample of 1000 observations (Appendix E.3.1). For each ‡, five candidate
values for the L1-regularization strength ⁄ on the kernel coefficients, ranging from
0.001 to 1, were considered.
Model performance was compared using measures averaged across the five outer test
folds. The primary metric of interest was discrimination, assessed through AUROC.
Secondary metrics of interest included AUPRC, calibration plot slopes and intercepts,
and time to re-train the model with selected hyperparameters. Predictive performance
metrics were also calculated for a “best possible model” that made predictions based
on applying the known coefficients to all data. Hyperparameters and parameters were
viewed and compared between models.
The expected trends emerged across the three scenarios: the hybrid models always
performed similar to or better than the single component models, with a notable
advantage for the second scenario (Table 5.4). Selected hyperparameters and learned
parameters are in Appendix E.3.2. In the two extreme scenarios, the hybrid models
performed similarly to whichever single-component model captured the more important portion of the data. In the “feature heavy” scenario 1, HFSM performance came
with an increase in computation time (seconds vs. hours) as compared to LR. In the
“kernel heavy” scenario 3, the discrimination performance of LR approached a dummy
classifier while KLR showed similar predictive performance to the hybrid models and
increased fitting time as compared to HFSM-Sim. In the “middle ground” scenario 2,
HFSM demonstrated the best discrimination and precision-recall performance, but
neither HFSM version outperformed LR in terms of calibration. These findings show
the advantage of using HFSM when both feature- and kernel-based data are important
and when there is uncertainty about their relative importance. For all models with
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a feature component, as the relative importance of the kernel-based data increased,
the feature coefficient estimates got further from the truth (Appendix E.3.2).
Table 5.4: Synthetic data study results.
LR

KLR

HFSM-Seq HFSM-Sim

Best

Scenario 1: Kernel data had
AUROC
0.647
AUPRC
0.571
Calibration Slope
-0.025
Calibration Intercept 1.035
Time (hours)
<1

similar effect to a single feature
0.504
0.648
0.647
0.655
0.436
0.572
0.573
0.581
-0.362
-0.032
-0.013
-0.008
-0.517
1.038
1.031
0.989
6.553
7.815
7.177

Scenario 2: Kernel data had
AUROC
0.614
AUPRC
0.587
Calibration Slope
-0.001
Calibration Intercept 0.993
Time (hours)
0.001

similar effect to the set of features
0.712
0.725
0.726
0.781
0.672
0.708
0.710
0.759
0.043
0.044
0.008
0.027
1.415
1.305
1.257
1.017
9.901
10.574
9.316

Scenario 3: Kernel data had
AUROC
0.558
AUPRC
0.538
Calibration Slope
-0.001
Calibration Intercept 0.980
Time (hours)
<1

a larger effect than the set of features
0.872
0.877
0.877
0.903
0.825
0.840
0.846
0.879
0.010
0.012
-0.058
0.018
1.557
1.575
1.534
1.018
7.148
7.419
5.111

Note: AUPRC = Area Under Precision Recall Curve, AUROC = Area Under Receiver Operating Characteristic Curve, Best = Hardcoded true coefficients applied to all data, HFSM-Seq
= Hybrid Model - Sequential Fit, HFSM-Sim = Hybrid Model - Simultaneous Fit, KLR =
Kernel logistic regression, LR = Logistic Regression.

5.5.2

Methods for clinical case study

We present a case study with EHR data from the Alliance for Healthier Communities, which provides inter-professional, team-based primary health care through
Community Health Centres (CHCs) across Ontario, Canada.9,238 All CHCs record
standardized sociodemographical information (e.g., birth date, education, household
income) and appointment details (e.g., care provider type, diagnosis codes) in a centralized, structured EHR database. We used de-identified data from January 1, 2009
to December 31, 2019 to predict two-year risk of first incidence loneliness or social isolation for middle-aged clients being served by the “urban-at-risk” (UAR) peer group
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of CHCs. This subgroup of CHCs provides care to clients with pre-existing substance
use, homelessness, or mental health challenges. This study was approved by Western
University ethics board (project ID 111353).
Although this case study was primarily intended to test the proposed methods, we
selected this outcome because it aligns with the Alliance and it is increasingly recognized as a serious health challenge in the literature. Research has largely focused on
sequelae and comorbidities in older adults, finding associations with several other poor
health outcomes.239–246 There are a range of services and programs offered through
CHCs that may help mitigate the risk of social isolation and loneliness, such as their
social prescribing initiatives.247–249 Identifying people at risk of social isolation or
loneliness may provide an opportunity for early intervention; this case study did not
result in a model ready for deployment, but substantive findings may inform future
work in the area.
5.5.2.1

Cohort

The cohort of interest included ongoing primary care clients at UAR CHCs without
the outcome at baseline. To restrict the sample to new or newly returning, midto long-term clients, only those whose first event was recorded in 2010 or later and
who had at least one event three years from the first recorded event were eligible
for inclusion. Primary health care is provided at all stages of life and health and
social isolation or loneliness may occur at any point, so we randomly selected twoyear periods from each client’s observation history to serve as the prediction interval.
Feature and kernel input data used to make predictions were from the first recorded
event to the beginning of the randomly selected prediction interval. The start of the
prediction interval had to be at least one year from the first recorded event as the
first year of care provision in this population is associated with a distinct risk profile,
likely due to “catch-up” on unresolved care and diagnoses.250 We restricted our cohort
to those 45-64 years old at the end of their baseline period as age is associated with
the outcome and may influence the risk factors and potential interventions to help
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someone at high-risk.
5.5.2.2

Feature choices

We identified 19 candidate features based on evidence in the literature,239–242,244,245,251
perceived importance with input from Alliance stakeholders, and feasibility to construct with available data. Features from the client characteristic table were handled
with complete case analysis if under 1% missingness and with a missingness indicator
approach otherwise for 1) client was asked the question and preferred not to respond
and 2) client was never asked. Features constructed using International Classification
of Disease (ICD-10)176 and Electronic Nomenclature and Classification Of Disorders
and Encounters for Family Medicine (ENCODE-FM)175 vocabularies were assumed
absent if no appropriate codes were present during baseline. Three of these features
had under 1% prevalence in baseline data and were excluded from the model (people
with the features present were not excluded from the cohort); we performed indirect
standardization to assess sex-adjusted risk in associated subpopulations.
We also constructed a feature to represent general clinical complexity as the count
of the number of chronic conditions identified as important for multimorbidity research in primary care present during baseline,179 scaled to 0,1 range. This type
of non-specific, complex information was what we designed the kernels to capture;
this composite feature represented what we may try to include instead for a solely
feature-based model.
5.5.2.3

Kernel choices

In addition to the specific conditions identified for features, there is a sense that
general health complexity may be positively associated with the outcome. We used
three types of kernel input data based on appointment-associated care characteristics
to capture this additional complex information: 1) the provider type(s) involved in
care (e.g., nurse practitioner, social worker), 2) the service type(s) provided during
an appointment, which represents the general type of care functions provided (e.g.,
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assessment, treatment management) without specifying conditions, and 3) both 1
and 2. There are many ways data could be pre-processed and combined for kernel
inputs; we worked with sets and added together distinct codes experienced at least
once during baseline care.
A valid kernel function must be symmetric and result in a positive semi-definite kernel
matrix. Additional properties that we wanted our kernel function to have include:
1. Holding all else constant, two clients who both have or do not have a specific
code should be more similar than when only one of them has the code present.
2. Two clients who do not have a code that is common in the population of interest should be more similar than two people who both have the common code
present.
3. Two clients who have a rare code present should be more similar than if they
did not, but sharing in the absence of rare codes should not have a large impact
on similarity.
We developed kernel functions based on Gower’s (1971) work on the coefficient of
similarity.252 The similarity between two individuals i and j based on character c can
be assigned the similarity score Si,j,c ranging from 0 (no similarity) to 1 (the same).
An indicator ”i,j,c is used to represent whether or not a comparison can be made.
In the case of a binary variable, if one or both people have the variable present the
indicator is 1; if neither person has the variable present the indicator is 0 and Si,j,c is
set to 0.252 Gower (1971) further demonstrated that a weight can be introduced for
each code wc ; if there are no missing values and all wc Ø 0 the following allows for a
positive semidefinite similarity matrix with entries Si,j =

qv

c=1

qv

Si,j,c wc /

c=1 ”i,j,c wc .

The commonly-used J similarity is equivalent to setting wc = 1 for all c. In the
case where both people’s sets are empty, we set Si,j to 1. It meets the first of our
desired properties and is the first candidate kernel function we used. The second
property can be addressed by reverse coding common data elements and assigning
weights such that only common codes are considered; the third property is addressed
by maintaining traditional coding based on presence and setting weights such that
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only rare codes are considered. We used a cut-off based on prevalence in the training
data to define common (prevalence Ø 0.70) and rare (prevalence < 0.30) codes such

that codes above/below the threshold are assigned wc = 1 and remaining codes are
assigned wc = 0. Our second candidate kernel function (SCR) adds together the
“common absence” and “rare presence” similarity scores.
5.5.2.4

Application 1: Prediction

We assessed predictive performance using a similar nested CV procedure as was used
for the simulation studies, with 80/20 splits to define inner training/validation data
for each of five outer folds. The same four models of interest (LR, KLR, HFSMSeq, HFSM-Sim) were compared alongside two additional models: LR-E, which was
LR with the extra count of chronic conditions feature; and a more complex model
(XGBoost) that included all features and all kernel data input represented as dummy
variables. Hyperparameters for kernel-containing models selected based on a grid
search for the highest AUROC on the inner fold validation data included L1 penalty
strength (0.0001, 0.001, or 0.01), kernel data inputs (providers involved, service types,
or both), and kernel function (J or SCR).
5.5.2.5

Application 2: Interpretation

To demonstrate model interpretability, we re-trained HFSM-Seq and HFSM-Sim on
all data using the Jaccard kernel function on both types of data, using the mode of
the selected L1 penalty in Application 1 divided by five to scale for the increase in
amount of data. We examined whether feature coefficients changed between the two
models similar to in the illustrative examples. We then moved our focus to HFSM-Seq
to examine the type of information captured by the kernel after accounting for the
features. We split the cohort into clients with positive, negative, and zero-valued kernel coefficients. Feature-based characteristics were compared with descriptive tablebased summaries across the three strata. Kernel-based characteristics were explored
by applying non-negative matrix factorization with five topics, using Python package sklearn.decomposition.NMF and the Kullback-Leibler divergence distance
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metric, to each of the three strata.185

5.5.3

Results for clinical case study

There were 5,070 eligible clients with a 5.4% cumulative incidence (n=276) of the outcome across all client-specific two-year prediction intervals. See Appendix Figure E.2
for a cohort flow diagram and Appendix Table E.8 for select baseline characteristics.
5.5.3.1

Application 1: Prediction

Performance metrics are in Table 5.5. The SCR kernel function was selected three
times for HFSM-Seq and KLR, and two times for HFSM-Sim; for all models the combined provider and service type data were selected the majority of the time (Appendix
Table E.9).
Table 5.5: Clinical case sudy predictive performance results.

AUROC
AUPRC
Calibration Slope
Calibration Intercept
Time (minutes)

LR

LR-E

KLR

HFSM-Seq HFSM-Sim

XGBoost

0.753
0.146
0.852
-0.367
<1

0.754
0.148
0.848
-0.378
<1

0.734
0.139
0.698
-0.788
42

0.774
0.185
0.788
-0.521
115

0.727
0.137
0.868
-0.621
<1

0.778
0.184
0.875
-0.294
89

Note: Results were averaged across the five outer folds. Legend: LR = Logistic Regression; LR-E =
Logistic Regression-Extra Clinical; KLR = Kernel Logistic Regression; HFSM-Seq = Hybrid Featureand Similarity-based Model-Sequential; HFSM-Sim = HFSM-Simultaneous.

General trends across predictive performance metrics from worst to best were
KLR and XGBoost, LR, HFSM-Seq, and then HFSM-Sim. For discrimination and
precision-recall performance, HFSM-Seq and HFSM-Sim were best. Calibration was
best for HFSM-Sim; all models tended to overestimate risk. While there were some
instances of a model having notably worse performance in terms of calibration, there
were no instances of one model that had very large performance gains over all other
models; discrimination performance was comparable across all models. LR and LR-E
performed similarly on all metrics. Kernel containing models were the least efficient,
even with pre-computed kernel matrices, but still ran within a feasible amount of
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time.
5.5.3.2

Application 2: Interpretation

In general, HFSM-Seq feature coefficients (Appendix Table E.10) were larger in magnitude and consistent in direction to those of HFSM-Sim, suggesting that the kernel
information adjusted for some of the feature relationships. We suspect that for some
of the coefficients with the largest change in magnitude the kernel (capturing health
care use information) was acting as a mediator (e.g., stable housing), and for others it
was acting as a confounder (e.g., depression or anxiety). This or colliding bias could
also explain features where associated coefficients tended to increase in magnitude
when adjusted for the kernel (e.g., primary language) and features where there was a
qualitative change (e.g., food insecurity; coefficient switched from positive to negative
after adjusting for the kernel). Importantly, we did not set up this model to be causal
and do not know which feature coefficients are closer to the truth; we would not want
to deploy it in its current form for clinical decision making.
Examining HFSM-Seq, – coefficients ranged from -1.70 to 1.30 and when rounded to
five significant digits there were 5,038 zero, 13 positive, and 19 negative. Feature and
outcome values stratified across these three groups are in Appendix Table E.11. Distinct trends for clients with negative –, and thus decreased the predicted probability
for similar clients, were that none had the outcome, all lived in an urban geography,
and they tended to have higher levels of obesity than the other strata. Clients with
positive –, and thus increased the predicted probability for similar clients, all had
English as their primary language and tended to have lower household income and
higher levels of stable housing, substance use, smoking or tobacco use, and food insecurity. The top ten weighted codes (from provider type and service type data, coded
for presence) from NMF for the three subgroups are in Appendix E.4.3. The group
with negative –’s had a unique topic characterized by diagnosis and treatment with
physician and nurse providers; a topic related to counselling and foot care with counsellor and chiropodists; and one related to counselling with nurse practitioners. The

83

group with positive – had a unique topic strongly characterized by external referral
and consult; and a topic strongly characterized by social worker, nurse practitioner,
and individual counselling. Codes related to diagnosis, treatment, and management
were not as prominent in topics as for the other groups. The zero – topics included
one strongly characterized by community resources and community health workers,
which only weakly entered topics for the other subgroups.

5.6

Discussion

The HFSM approach captures relationships within large-scale observational data in
an interpretable form when some but not all data and desired information to capture
are suitable for simple feature representation. Simulation studies confirmed that
HFSM is best suited for situations where the feature- and kernel-based data are both
important for the outcome, and our clinical case study demonstrated how it can be
used to build a predictive model and develop understanding of risk drivers within a
complex primary health care population. Of note, while our case study was situated
in primary health care, the methods are applicable to other sectors as well.

5.6.1

Hybrid model methodology

The predictive performance of HFSM-Sim is always expected to be as good or better
than HFSM-Seq, assuming appropriate set up and tuning, while HFSM-Seq provides
more certainty in feature coefficient interpretation when the role of the kernel in terms
of causal structures is uncertain. If the goal is to prioritize absolute risk predictions,
HFSM-Sim is recommended; however, if the model is intended to support decision
making with interpretation of feature coefficients, then greater care is needed. Feature
coefficients learned under HFSM-Seq as shown in this paper are adjusted for each
other and averaged over the kernel, so can be interpreted analogously as for LR. An
additional option is to fix some or all of the feature coefficients based on previous
research studies or epidemiological analyses, and learn the rest from the training
data. The feature coefficients for HFSM-Sim are adjusted for each other and adjusted
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for the kernel matrix, which may be favourable for interpretation in situations such
as when the kernel is constructed to adjust for complex confounders. Frameworks
commonly used in clinical epidemiology studies, such as directed acyclic graphs, may
help guide model development.253 The degree to which the kernel and feature matrices
are independent will determine the difference between HFSM-Seq and HFSM-Sim.
The Illustrative Examples demonstrating feature coefficient changes depending on the
“causal role” of the kernel reinforce the importance of careful modelling not only for
explicit causal inference but also when a risk prediction model might be interpreted as
an “upstream” treatment effect model. For example, if feature coefficients are interpreted as identifying modifiable risk factors (e.g., hypertension, smoking) important
for a client’s estimated outcome, and then inform risk prevention strategy selection.
Formal techniques for multiple causal inference, such as the deconfounder approach
informed by a directed acyclic graph based on clinical and epidemiological input, may
be useful here.65,254,255 Future work is needed to determine what “pragmatic” level of
causality is sufficient to support decisions in these settings. Avenues for future work
on the hybrid model structure include interactions between features and the kernel,
other outcomes types (e.g., time to event), multilevel modelling, and adding an L2
penalty to the kernel coefficients. The most closely related work to the latter applies
an elastic net penalty to the dual form of the problem only.256

5.6.2

Clinical case study

Predicting the rare outcome of social isolation or loneliness in middle-aged clients
served by UAR CHCs is a challenging supervised learning problem. The HFSM
models performed as well or better than solely feature- and similaritly-based models,
including XGboost, while providing superior interpretability. Our proposed kernel
function that calculates similarity based on the absence of common codes and the
presence of rare codes was selected more often than Jaccard, which considers presence
of all codes. We used a basic cut-off to define rare and common codes, but future work
could expand this to obtain more sophisticated weightings, such as with a probability
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mass function on the training data,219 and to explore methods to identify the ideal
switching point between presence and absence coding.
We explored model behaviour and learned about the cohort by viewing feature values
and NMF-derived topics on kernel data stratified by positive, negative, or zero –.
Of note, the kernel data included provider types; some, e.g., social work, may have
a higher index of suspicion for the outcome and care for correlated conditions, but
these data are only from baseline and all providers could code the outcome. We could
extend this work into the causal setting and intentionally set up the model to use
the features and kernel to capture relationships between some or all of the features
and the outcome. Future work could compare coefficients from HFSM that e.g., uses
to kernel to adjust for complex potential confounders, against other approaches or
known effect estimates.
In addition to insights about HFSM and the kernel, our clinical case study demonstrates insights relevant to future primary health care machine learning applications.
In contrast to settings where care is initiated due to a problem (e.g., cancer diagnosis,
emergency room visit), primary health care is sought out during all stages of health,
there is variability in visit patterns, and risk patterns change across across the care
history due to cumulative and acute factors.250,257 Outcomes such as ours are relevant
across the entire care trajectory, which induces challenges for determining a prediction interval as “lifetime risk” is unhelpful. Future research is needed on the best way
to define prediction intervals for these types of outcomes in primary health care; we
selected two-year prediction interval periods to support generalizability of the resulting model across the care continuum within a time frame that allows preventative
intervention, but the most appropriate choice will depend on context.
A significant challenge we encountered, which is relevant to other health sectors,
is rare features. Three features (Sensory Disability, Social Phobia, Dementia or
Alzheimer’s Disease) representing characteristics that literature suggests are risk factors for social isolation and loneliness had less than 1% prevalence in the baseline
cohort data. The standardized morbidity ratios (SMR), representing the ratio of
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observed to expected number of outcome cases based on sex-specific rates in the remaining eligible population, showed higher than expected risk in each of the rare
feature sub-populations (Sensory Disability SMR = 2.44; Social Phobia SMR = 3.27,
Dementia or Alzheimer’s Disease SMR = 2.11). The number of clients with these
characteristics was too small to meaningfully do statistics with, and we could not
find an explainable AI framework that addressed this type of scenario. If the model
were implemented, it would be important to communicate to care providers that
these risk factors are not considered by the model, such as with a flag when making
predictions for a client with one of the characteristics present. Qualitative research
could investigate risks and needs of these subpopulations specific to the health care
setting of implementation.

5.6.3

Limitations

We have not provided confidence intervals or hypothesis tests particularly in
the case of HFSM-Sim because although the objective function is convex, the
non-smoothness of the L1 penalty is expected to require use of techniques like the
m-out-of-n bootstrap258 or potentially a selective inference framework259 to account
for non-regularity in the estimators. Developing these is beyond the scope of this
work.
In our clinical case study, we restricted based on age and CHCs within the UAR peer
group; however, remaining variability within these strata was not taken into account.
Some feature construction was based on the client characteristic table, which included
rich sociodemographic information but was not time stamped in our data extraction.
Outcome recording was not blinded and can only be considered a proxy for “true”
social isolation and loneliness. The majority of clients excluded for having less than
three years of observation had their first event in 2017 or later so there was not enough
calendar time for sufficient observation. There were 1,430 clients with a first event
early enough and who met other eligibility criteria. If we were to proceed with this
model we would perform sensitivity analyses to assess whether there is bias due to
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their “true” loss to follow up.

5.7

Conclusion

We presented a hybrid feature- and similarity-based model that combines wellestablished approaches (LR and KLR) into a single machine learning model. The
hybrid approach provides a way to take advantage of large-scale datasets information
about features where the relationship with the outcome can be specified in a linear
model (e.g., known informative risk factors or structured one-time question fields), as
well as more complex data that may be better captured in terms of similarity to other
training examples (e.g., historical data on care and diagnoses received). Maintaining
separation of feature and similarity based components supports interpretability of the
final model, and the option to fix or learn feature coefficients in advance of the kernel
coefficients provides additional flexibility over feature coefficient interpretation.
The inherent model interpretability and the reproducibility due to a fully convex
objective function supports the extension of model use from prediction to causal
inference tasks both within health care and in other domains with complex data and
causal structures.
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Chapter 6
Discussion
This thesis integrated epidemiology and computer science through three research
studies, each of which built upon the other: first, a summary of the state of artificial
intelligence (AI) and primary care research at the outset of this body of work; second,
the first large-scale descriptive and exploratory study of adult primary care clients
served by the Alliance for Healthier Communities; and third, proposed supervised
machine learning methodology that combines feature and kernel learning for prediction and interpretation. The major contributions of this work can be organized by
those primarily to computer science and to epidemiology, noting that altogether the
work constitutes an interdisciplinary contribution to primary care:
To computer science and more specifically the subfield of machine learning, we contributed 1) the two forms of the hybrid feature- and similarity-based model (HFSM),
which can be extended to any setting with large-scale observational data; 2) a new
framework for thinking about kernel based similarity in terms of rare and common
characteristics; and 3) demonstration of how techniques frequently used in epidemiology (scoping review and population level descriptions) can help select and inform
problems or projects that involve AI, including development of decision support tools
with electronic health record (EHR) data.
To epidemiology and more specifically the subfield of clinical epidemiology, we con89

tributed 4) the first comprehensive overview of AI and primary care research; 5) an
extensive description of sociodemographic, clinical, and healthcare use characteristics
of adult primary care clients served by Community Health Centres (CHCs) in Ontario from 2009 through 2019; 6) demonstration of how unsupervised machine learning techniques can be used in this type of population-level exploration of a complex
population, and demonstration of how the hybrid model can be used to investigate
causal relationships or further explore population characteristics within a supervised
learning task.
Throughout the body of work three themes emerged. First, AI for primary care is at
an early stage of maturity, but progressing, both in terms of the field in general and in
terms of individual primary care systems being able to harness value from their data.
Second, primary care is complex in ways that are unique within the healthcare system and requires innovative, careful approaches to study design and methods. Third,
epidemiology and computer science are complementary fields, as seen in our choice
of methods and approaches for various problems and sub-problems. Each theme is
elaborated on in turn before discussing future directions and final conclusions.

6.1
6.1.1

Summary of Major Themes
Artificial intelligence for primary care is at an early
stage of maturity, but progressing

Primary care is understudied in comparison to other sectors of health care and AI is
no exception.174,260–262 The scoping review in Chapter 3 summarized all research until
2018 that included AI and primary care, finding that the field was at an early stage
of maturity in terms of widespread adoption of AI in practice, with few examples
of studies in “real-world” primary care settings, and not enough interdisciplinary
collaboration. Since then progress has been made. There are more and more examples
of research with genuine primary care involvement, such as a study by Wingrove et
al. (2020) to develop and test a machine learning model to predict family medicine
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specialty from Medicare data;263 or the use of machine learning to predict frailty
from the Canadian Primary Care Sentinel Surveillance Network database by AponteHao et al. (2021).264 Another type of progress has been increased knowledge about
organizations, such as the Alliance for Healthier Communities, that are motivated to
use their data to improve care; we demonstrate steps taken to inform and support
success of future AI-related initiatives in these types of settings.
In addition to an increase in activity of primary care communities with respect to
AI research in general, work has been conducted that provides additional direction
to the field. A scoping review by Rahimi et al. (2021) took a deeper dive into AI
applications that have been tested or deployed in community practice settings up
to 2020, highlighting gaps to address in future evaluation research;265 Ronquillo et
al. (2021) established the Nursing and AI Leadership (NAIL) Collaborative and held
an international think-tank to identify implications, opportunities, and needs in AI
for nursing;266 Yang et al. (2022) held a two day virtual meeting that resulted in the
“IDEAS” framework outlining major domains for AI integration in primary care in
the United States;267 and Kueper et al. (2022) conducted a one-day multi stakeholder
event to identify priorities for AI and primary care in Ontario, Canada.268 These more
recent research studies built upon the scoping review to fill some of the knowledge
gaps around AI for primary care, although in general, there is still a lot of work to
be done.
Chapters 4 and 5 of this thesis make additional contributions, especially in terms of
identifying methodological considerations for AI in primary care settings. We have
not found other research that explicitly outlines what primary care complexity means
for machine learning methods.

6.1.2

Methodology needs to account for primary care complexity

The large-scale descriptive and exploratory study in Chapter 4 showcased the rich
data collected through care encounters at CHCs across Ontario, and found complex91

ity in all domains that were explored: sociodemographic characteristic explorations
identified high prevalence of social determinants of health; clinical characteristic explorations highlighted the heterogeneity in co-occurrence of conditions; and care characteristic explorations found variability in care provider teams and in care access frequency. While findings were primarily intended to support work within the Alliance,
they also contributed to primary care and AI research literature more broadly. First
in terms of substantive findings, the population-level overview based on over a decade
of care encounters at CHCs provides a unique look into client and care profiles for
team-based primary care, which may be similar or different than other care models
in Ontario and CHCs in other geographical regions.9,178,262,269 Second, the associated
methodological insights can inform machine learning work both within the Alliance,
as exemplified through decisions made for the case study in Chapter 5, and in other
primary care settings.
The methodological considerations of primary interest for this discussion are those
that may be unique or exacerbated in primary care as compared to other sectors of
healthcare, and especially for clients experiencing clinical and social complexity. Table
6.1 presents considerations for machine learning or decision support tool problem
selection that arise due to the wide breadth or scope of team-based primary care,
with examples from the thesis work. Each of the contributing primary care challenges
are studied in the primary care literature outside of the context of AI, and how to
best account for or select areas of focus amid heterogeneity and scope will require
interdisciplinary collaborations and a clear understanding of the intended impacts of
a potential machine learning project. Table 6.2 presents additional methodological
challenges for prediction of future events that arise due to the provision of primary
care across the life course. Each of these challenges highlights the need for more
research to understand how to best develop machine learning for primary care; this
research can build off of existing work and solutions from other sectors. For example,
phenotyping to identify “true” client characteristics from EHRs is an active machine
learning research field,270 covariate shift is a well-established problem of study related
to differences between the data used to train a machine learning model and testing
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or “real life use” data,271 and there are existing theories and techniques for outcome
measure development, evaluation, and selection in clinical epidemiology that can be
extended or applied to AI for healthcare settings.272

93

94

Generalizability of models across populations
within primary care in terms of performance and
utility.

Heterogeneity in client characteristics and care needs, e.g.,
screening healthy people vs. caring
for palliative or complex clients.
Furthermore, within an organization certain providers or clinics may specialize towards certain
populations.
The type of end user for a given tool may differ by
client.

There are hundreds of conditions cared for in primary care that machine learning could be developed
for; developing separate models for each condition
is not practical. Potential benefits of AI may be
highest for complex clients or rare conditions, but
these are more challenging settings for AI.

Care
team
compositions
(type(s) of provider(s), family
members, etc. involved in any
single client’s care) may differ by
client needs and/or preferences.

Similar to other sectors of healthcare, alert fatigue and care
provider burn out has been exacerbated by EHRs.

Differential data collection based on person
and care context.

Machine learning considerations

Primary care characteristic

Chapter 4 found thousands of distinct multimorbidity compositions among Alliance clients, and the
most “prominent” grouping of conditions differed
depending on prioritization of frequency (countbased table) or tendency to co-occur after adjusting
for other conditions (Ising model).

NMF on provider types in Chapter 4 showed that
client care was often lead by a medical doctor or
nurse practioner, and may have included seeing several other types of care providers in a variety of
amounts.

The case study in Chapter 5 to predict social isolation and loneliness was restricted to adults aged
45-64 at UAR CHCs; unsure if the trained models would be applicable in non-UAR clinics, which
serve similar clients to UAR CHCs as well as other,
lower-risk clients.
Completeness of sociodemographic characteristic
data varies due to client, provider, and clinic level
factors.

Example from thesis work

Table 6.1: Machine learning or decision support tool problem selection challenges due to the breadth of team-based primary
care practice.
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Machine learning or related methodological
considerations
Timescale of something truly starting to impact a
client may differ from when it is recorded in their
EHR.

Different data elements/domains may need to be
treated differently, and the proper treatment/operationalization may depend on the problem. For
example, childhood trauma may be operationalized
as an “ever-happened” variable vs. the “number of”
chronic conditions present vs. the “most recent” xray being more important than older ones vs. lab
results being most informative when analyzed as
“trends over time”.
Cohort and prediction interval construction requires deciding 1) when someone starts being “atrisk”, e.g., always vs. once they are X years old vs.
if diagnosed with Y; and 2) what a meaningful “risk
prediction” interval is, e.g., is it on the scale of days,
years, number of visits.

Primary care characteristic

Variable visit frequency between clients (e.g., some clients
come multiple times a month; others have years between visits) and
within clients across their lifetime
(e.g., a single client may experience periods with frequent care).

Many different types of data are
collected across a potentially
long period.

Outcomes of interest happen
on different intervals or
timescales.

The case study in Chapter 5 predicted first-episode
social isolation and loneliness. Someone is at risk
of this across their entire life course, but predicting
“lifetime risk” is not meaningful. Instead, we selected two-year risk intervals across the observation
history (excluding first year).

The hybrid model in Chapter 5 addresses the need
for a single model to be able to take into account
different types of data. The rare-common kernel
function introduces the idea that the presence of
some codes may be most informative whereas the
opposite may be true for others.

Cumulative incidence plots in Chapter 4 showed a
higher “risk" profile associated with being a new or
newly returning client. It is not that being a new
client increases risk for conditions; it is that being
a new primary care client includes assessments and
catch-up on unmet care needs and diagnoses. This
may be exacerbated for clients with barriers to care
access. The case study in Chapter 5 excluded “year
1” of observation history from potential prediction
intervals.

Example from thesis work

Table 6.2: Methodological challenges for prediction of future events related to providing care across the life course.

Some of these challenges additionally highlight the importance of explainable AI
(XAI) for primary care. Not only is XAI important for the same reasons that it
is important to understand how a model is behaving in other contexts, but it is
also important because end-users may need to do an additional assessment on the
relevancy or recency of the data that an EHR-embedded machine learning model
is using to arrive at a prediction for a given client. Primary care clients may have
long periods between appointments during which their social circumstances may have
changed since the last time data were recorded in their EHR. An additional challenge
not explicitly explored in our work is related to the presentation of conditions to
primary care often being early-on, before symptoms and signs are clearly developed;
it may take a while to arrive at a diagnosis, or problems may be resolved before a
final diagnosis is reached. Distinguishing signal from noise at these early stages and
arriving at performance between over- and under-diagnosis will be challenging for
diagnostic tools.
In addition to methodological considerations, AI for primary care populations has
sociocultural and ethical implications. The Alliance for Healthier Communities developed an evidence-informed Model of Health and Wellbeing that is used to guide
care delivery and their research initiatives.51 Example components of the model include equity and social justice, population needs-based, and care that is based on the
determinants of health.44 Tools that are developed for pilot testing and implementation in clinical settings need to maintain the Model from project outset through to
long-term evaluation of whether the developed tool supports their care model and
values. A learning health system (LHS) as a socio-technical system; even the best
technology will be useless if it does not match the needs and values of the end-users
and beneficiaries.1,3,273 Nash et al. (2022) performed semi-structured qualitative interviews with Alliance stakeholders, finding organizational goals and culture as one of
three foundational elements (in addition to data quality and resources) for the success
of them becoming an LHS, with the potential to improve care as a key motivational
factor.274
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6.1.3

Epidemiology and computer science are complementary fields

This thesis relies on and contributes towards epidemiology and computer science. At
the core of this intersection is the rapidly increasing amount and types of “everyday”
health data being generated, the strength of epidemiology in investigating healthrelated questions, and advancements in computer science to support the processing,
storage, and analysis of these data. The number of ways these disciplines have already
and are expected to work together extends far beyond the scope of this thesis.275–277
Nonetheless, a few examples of how both fields were integral to this body of work are
highlighted below.
First, the use of descriptive epidemiology to understand a population and inform
future machine learning and related data-driven projects, combined with the use of
unsupervised learning techniques from computer science to do these types of descriptive studies more effectively for a complex population. While our work was situated
in the context of an LHS, the value of early-stage descriptive studies is expected to
apply in other settings where data-driven initiatives are being developed for known
populations. Chapter 4 and the discussion above outline some of the more generalizable insights derived from this intersection, such as the need to carefully consider
heterogeneity and visit patterns in primary care. Machine learning for healthcare
guidelines emphasize co-development and early stage end-user engagement, as well
as post hoc analyses to assess machine learning model performance across different subgroups.30,172,190,278–280 These practices are partially motivated by the desire
to produce relevant, meaningful tools that do not exacerbate inequities.34,279 Early
stage descriptive study findings can be brought into conversations with end-users and
community advocates, to inform specific projects and preemptively highlight potential
equity issues, as well as to track progress over time for a system-wide transition into an
LHS framework. For example, we used findings from Chapter 4 to inform the clinical
study in Chapter 5, such as outcome definition, predictors, and cohort construction
and eligibility criteria. Of note, while our findings from Chapter 4 constitute novel
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contributions, they are based on well-established epidemiology and machine learning
techniques.
Descriptive epidemiology has a rich history of being integral to understanding health
related states and needs of a population, such as by identifying the burden of disease
to aid in resource planning for a particular geographical region, or identifying subsets of a population that have higher than expected rates of disease and may require
tailored intervention. It is also a mainstay in public health practices, for example,
in efforts related to the current COVID-19 pandemic, including the identification of
heath inequities.281–283 In its simplest presentation, although not necessarily simple
to conduct, descriptive epidemiology includes summary counts and proportions related to a health outcome of interest for a carefully defined population.206,281 Despite
widespread utility and demonstrated value, research to advance methods for descriptive epidemiology is far less prominent than that to advance analytic epidemiology
objectives, such as causal modelling. In comparison is unsupervised machine learning,
which sees a larger methods research focus,284 but there is also a need to better understand how existing, well-established techniques may advance other disciplines that
are now using larger and more heterogeneous datasets. We found some of these unsupervised learning techniques to be useful in understanding the Alliance adult primary
care population, e.g., non-negative matrix factorization of provider types involved in
care, while others left us with outstanding questions to follow-up on, e.g., K-medoids
time-series clustering with dynamic time warping distance on visit frequency. There
is an opportunity for future research to further refine techniques for these types of
population-level descriptions.
Moving from a descriptive to an analytic focus, the hybrid models directly addressed
to the need for explainable machine learning methods with observational data such as
that from healthcare. The models combined the well-established techniques of logistic regression, which is heavily used by both computer science and epidemiology, and
kernel learning, which is more common in computer science. Our HFSM represents
a contribution to the subfield of machine learning as well as a new tool for analytic
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epidemiology, including to investigate individual causal relationships or prediction.
Prediction is a core goal of supervised learning methods, whereby performance is
impacted both by the specific methods involved and by the many decisions made
throughout the process to get from the form of a function or algorithm to a trained
model that is ready for use. In addition, to those from computer science and endusers, inputs based on epidemiology can be used to arrive at the best possible model
for a given scenario. For example, the body of literature pertaining to a particular
outcome could be critically analyzed to arrive at suggestions for feature and kernel
based parts of the model, as well as to assess the potential causal role of a given
kernel and the implications for sequential as compared to simultaneous model fitting.
Causal inference from observational data is an active topic of study in both machine
learning and epidemiology communities.285–287 Another more general example of this
intersection is our use of thinking from epidemiology about population-level characteristics to begin exploring the potential of extending a common computer science
technique, kernel functions, into capturing similarity that is based on deviations from
broader population health expectations.

6.2

Avenues for Further Study

Each integrated article included discussion about future directions specific to that
study; herein we focus on additional or more general future work related to 1) AI for
primary care, 2) the Alliance for Healthier Communities, and 3) methods research at
the intersection of epidemiology and computer science.

6.2.1

Artificial intelligence for primary care

Despite growing recognition that there are potential benefits of AI for primary care,
there are fewer examples of AI research or implementations in primary care settings
as compared to other sectors. Progress may be supported by understanding what is
similar and what is different about AI for primary care as compared to other sectors,
both within and outside of healthcare, and by describing these challenges in terms
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of specific research problems. The above discussion demonstrates how some of the
unique characteristics of primary care can be broken down and described in terms of
challenges for machine learning; on a fundamental level many of these challenges exist
in other settings and solutions may be applied or adapted for primary care purposes.
In addition to technical questions, there are other areas in need of study, such as to
understand ethical, workflow, and legal implications of AI-based tools intended for
long-term implementation in primary care settings.
The scoping review in Chapter 3 found a need for more interdisciplinary collaboration in AI for primary care research; future work could focus on two facilitators of
this: incentives and education. There needs to be infrastructure, such as research
funding, and recognition of discipline-specific needs, such as promotion requirements,
to support and sustain deep interdisciplinary work. Education may include basic
training to understand what different fields, including one’s own, have to offer towards solving a particular problem. In addition to supporting multidisciplinary and
interdisciplinary teams, where each member contributes their disciplinary expertise
to the formulation or solving of a problem, there is a need for training of individuals
in multiple disciplines, to be bridges for the aforementioned, and to strive for transdisciplinary thought, where problems can be approached from a new way of thinking.
This thesis provides one example of infrastructure and training that supported the
combination of multiple disciplines to tackle challenges related to primary care for
complex populations.

6.2.2

The Alliance for Healthier Communities

Future work with the Alliance will include further consultations with stakeholders
regarding the substantive findings from Chapter 4, to better understand how identified
characteristics do or do not align with current perceptions of their primary care
population, and to identify priority areas for future engagement. This knowledge
sharing can inform current and future projects at the CHC and/or Alliance-wide
level. For example, certain CHCs may have greater capacity to investigate potential
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next steps on a project that is specific to their client population or priority care
areas. An area of general interest across the Alliance is how to best care for clients
who seek care more frequently than expected or necessary. CHCs provide various
individual and group programs that may benefit these “frequent visitors”, such as
social prescribing initiatives to address upstream drivers of care access.46,247,249
Two analyses were done to investigating factors associated with high frequency of
care visits to primary care providers (nurse practitioner or medical doctor). First,
table-based comparisons of sociodemographic, clinical, and healthcare use characteristics of all-time frequent visitors with those not meeting that definition. For each
CHC, frequent visitors included clients in the top 10% of average days of primary
care provider visits per observation year. Second, a risk factor analysis for a period
of frequent visits. This analysis treated each quarter-year as a possible episode of
interest: being in the top 10% of the maximum quarter-year care access frequencies
(not including the first year) across all clients from the same CHC as the client of
interest. To estimate the risk of frequent visitor status in the next quarter-year, multilevel modelling was performed using logistic regression and blocked variable entry.
Detailed method and results are in Appendix F. A key finding was an association
between social isolation or loneliness with frequent visits, which partially motivated
social isolation or loneliness as the outcome in the Chapter 5 case study.
Of note, this thesis frames the population served by the Alliance in terms of complexity. Other areas where complexity is a focus and advanced methods may be able
to contribute to is syndemics, where co-occurrence of clinical conditions is viewed
in conjunction with social conditions, and research investigates how multiple intersecting factors can contribute towards exacerbated health disparities.288 The methods
used in the present thesis may be useful in syndemics and techniques and theory from
syndemics may be able to contribute towards understanding of complex primary care
populations. For example, CHC clients with mental health and/or substance use
disorders have been found to have higher healthcare use than people receiving care
elsewhere.169 Social determinants of health are expected to play a large role in these
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types of findings, and likely have an influence on the types of interventions that will
or will not work well.

6.2.3

Epidemiology and computer science methods research

A first avenue for future research is the predictive and interpretation impacts of
penalization on features as compared to kernel coefficients. In our HFSM work we
placed an L1 penalty on the kernel coefficients to obtain a sparse model that is
more practical to deploy; feature coefficients were left unpenalized as we developed
these models under a framework where feature selection was done based on theory
rather than purely data-driven methods. Nonetheless, penalization of features, such
as with lasso logistic regression, is a well-known practice.289 Feature data entered into
a linear kernel as compared to logistic regression are equivalent if left unpenalized
(primal vs. dual forms); however, an L1-penalty operates slightly differently on the
two forms. An L1-penalty applied to features roughly represents selection of client
characteristics to maintain in the model as compared to the selection of entire client
records from training data, as is the case for an L1 penalty on kernel coefficients.
A second area for future work includes how to best capture similarity in highdimensional indicator data for complex populations. In Chapter 5 we introduced
the idea of using population-level prevalence to inform whether it is the presence
or absence of any given indicator that may be most informative. In addition to
extending this work, research could explore how to best incorporate recency of codes
and temporality. The latter is related to work on similarity based on sequences,
where the exact code sequence matters223,224,290,291 ; in primary care temporality
may matter for certain outcomes but the ordering is likely only informative up to
a certain point, after which it becomes noise. For example, lab values entering
abnormal ranges may matter on a short-term scale while the order that chronic
conditions are diagnosed in may only matter on the scale of years; the ordering
of these types of diagnoses within a short time period is likely more due to care
characteristics than preventable or long-term changes in underlying physiology. This
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work is also expected to be related to that on missing data, both missingness in terms
of individual data elements and in terms of the timescale between when something
becomes true or relevant for a client and when it appears in their EHR.
Finally, most information derived from clinical epidemiology and machine learning is
population-specific, and how far outside of the population represented in a particular
research study or training dataset the information pertains to is a challenging question. The two fields approach these knowledge generalizability questions from slightly
different angles, and there may be value to investigating and expanding their overlap.
For example, can techniques intended to prevent or assess selection bias in epidemiology be used to proactively inform or improve machine learning model generalizability
planning or assessment; can post hoc machine learning fairness assessments help understand situations where epidemiological findings may apply outside of the original
target population; and can new statistical techniques be developed that apply to both
settings?

6.3

Conclusions

Over the past few years, the state of AI for primary care has been transitioning; this
thesis is positioned within that transition. We began with the first scoping review
on AI and primary care research, which called for an increase in high-quality, interdisciplinary research with more primary care leadership. The Alliance for Healthier
Communities is an example of an organization that is committed to learning from
their data to support and improve care for the clients they serve; we provided the
first large-scale description of this population, demonstrating the use of both simple
statistical and unsupervised learning techniques to properly capture complexity, and
deriving insights to inform future LHS initiatives. We then proposed hybrid featureand similarity-based supervised learning methodology for prediction and interpretation, demonstrating and testing their use with synthetic data and in a case study to
predict social isolation and loneliness within the Alliance. These interpretable methods are well-suited for co-design studies around predictive models, and can serve as
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a tool for investigation of relationships in epidemiological studies. Finally, we began thinking about how best to capture similarity among primary care clients by
extending the coefficient of similarity to consider rare and common codes differently.
In summary, motivated by the potential to improve primary care for complex clients,
this thesis integrated epidemiology and computer science to understand the state of AI
for primary care, to identify opportunities and challenges to AI and other data-driven
initiatives within a complex primary care population, and to develop novel machine
learning methodology for prediction and interpretation with large scale observational
data.

6.4
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AI: Artificial Intelligence
AUPRC: Area Under the Precision Recall Curve
AUROC: Area Under the Receiver Operating Characteristic Curve
CHC: Community Health Centre
CV: Cross Validation
EHR: Electronic Health Record
ENCODE-FM: Electronic Nomenclature and Classification Of Disorders and Encounters for Family Medicine
HFSM: Hybrid Feature- and Similarity-Based Model
HFSM-Seq: Hybrid Feature- and Similarity-Based Model - Sequential
HFSM-Sim: Hybrid Feature- and Similarity-Based Model - Simultaneous
ICD-10: International Classification of Disease - Version 10
KLR: Kernel Logistic Regression
LHS: Learning Health System
LR: Logistic Regression
NMF: Non-Negative Matrix Factorization
PCP: Primary Care Provider
TEM: Technology, Engineering, and Math
UAR: Urban At-Risk
XAI: Explainable Artificial Intelligence
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Appendix B
Combined PhD Agreement
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Epidemiology &
Biostatistics
Thesis-based
Master's degree
(not necessarily in
epidemiology) or
equivalent from an
accredited
university and
provide evidence of
research potential.
Minimum 80%
average for all
graduate-level
coursework and
strong performance
in a recent statistics
course.

Entrance
requirements

Program A
Epidemiology &
Biostatistics

Home program

Name

Undergraduate or
master’s degree in
computer science

Computer Science

Program B
Computer Science

Final degree awarded: Combined PhD in
Epidemiology & Biostatistics and Computer
Science.; However, the first student to
complete this will receive 2 PhDs.

comments
Transcript will read under “Academic
Program History”:
Program: Epidemiology & Biostatistics and
Computer Science
Plan: Combined Doctor of Philosophy
Epidemiology & Biostatistics and Computer
Science
Status: Active in Program (or later,
“Completed Program”)

Home program is the fall-back program in
case combined degree is not working. Choice
of home program may also have funding
consequences.
Master's degree or equivalent Accepted into home program and then
in one of the two disciplines. transfer into combined degree program.
Requires wide coverage of
CS which may be
supplemented with an
appropriate portion of the
Postgraduate Diploma
Program when needed;
decided in consultation with
advisory committee.

Admitting program

Combined program
Epidemiology & Biostatistics
and Computer Science

Combined PhD degree template - Epidemiology & Biostatistics and Computer Science

For external
candidates, of the
4.0 credits, 3.0 are
specified required
courses, and 1.0 are
electives within the
department (or

Supervisor to be
assigned at
acceptance.
Committee formed
by supervisor and
student; size
dependent on need
but requires at least
one member of the
Department of
Epidemiology &
Biostatistics who
holds SGPS
Teaching and
Advisory
Membership.
Each PhD
candidate must
complete a total of
4.0 credits, or 2.5
credits if they have
previously
completed a
Master’s within the
department.

Advisory
committee
structure

Course
requirements

4 years

Duration of
degree

2.0 credits

2 members

4 years

Satisfy the specified required
courses for EpiBio, plus 1.5
graduate credits from CS.

At least 3 members. At least
one committee member from
Computer Science and at
least one from Epidemiology
& Biostatistics. (See below
for supervisory
requirements.)

Note that there is typically no undergraduate
education in Epidemiology & Biostatistics,
hence more courses are typically required in
the subject. (Note however that UWO has one
of the few undergraduate epidemiology
programs worldwide.)

4 years, 5 years if additional WGRS is paid by the home department.
background required (e.g. via Computer Science will provide two TAs and
portion of Postgraduate
the supervisor will provide research funding.
Diploma courses.)

Additional
program
requirements

Comprehensive
examination(s)

English Language
Proficiency
Certification TOEFL, IELTS,
etc. (program exit
requirement; before
thesis)

Thesis proposal
document and
examination.

For candidates with
UWO EpiBio
Masters, of the 2.5
credits, 0.5 are
specified required
courses and 2.0 are
electives approved
by the graduate
chair.
Two-day written
examination
typically
undertaken in Fall
of second year.

elsewhere with
permission.)

Must present in a
public forum at
least once a year

A PhD Research
Topics
Survey/Proposal
(TSP)

None; if a student
has a gap in
knowledge they
must take
undergrad courses

All modules required by the
School of Graduate Studies
and by individual programs

EpiBio seminar milestone.

Must present in a public
forum once a year.

Epidemiology & Biostatistics
thesis proposal document
and examination. The
format, length, and learning
objectives of the EpiBio
thesis proposal and
examination are equivalent
to the CS TSP. At least 1
proposal examiner from CS,
and at least 1 from EpiBio,
plus one additional for total
of 3 examiners.

Epidemiology & Biostatistics
comprehensive examination.

Epidemiology & Biostatistics thesis proposal
public lecture may count as one of the CS
public forum presentations.

Although format would follow the EpiBio
thesis proposal in terms of form and timing,
the expectation is that there will be sufficient
Computer Science content at the PhD level.

Thesis
requirements

Must meet official
SGPS thesis
guidelines.

Health and Safety
Awareness Training
(Worker), Safe
Campus
Community,
Accessibility in
Service or
Accessibility in
Teaching),
introduction to
Biomedical
research milestone
By convention, the
thesis will typically
contain content that
is equivalent to 2 5 research papers in
reputable
epidemiology,
biostatistics, or
public health
journals.

Thesis proposal
public lecture.

Progress reports
(end of terms 3 and
5 and every Winter
term after term 6.)

Seminar milestone.

Makes a substantial
and novel
contribution to
research in
Computer Science.

Thesis will contain content
equivalent to at least 3
research papers and make
contributions to both the
fields of Epidemiology &
Biostatistics and Computer
Science.

must be completed, but will
not need to be repeated
separately for each program.

Thesis Intent to Submit forms will be
submitted to the home department.
Coordination of defense examiners, chair,
public lecture, and date will be organized by
the Academic Programs Coordinator of the
home department. A single Certificate of
Exam will be issued and signed by the
supervisor(s), all thesis examiners, and the
chair of the defense.

Teaching
assistantship

Funding

Supervisor(s)

Thesis
examination
committee

Optional.

Additional funding
acquired through
scholarships and/or
GTA positions may
reduce the amount
of funding from the
above sources.

SGPS PhD
supervisory
credentials in
Epidemiology &
Biostatistics
department.
Minimum:
Tuition & Fees –
WGRS.
GRA – supervisor.

Contain a critical
literature review
chapter (may count
as one of the
research papers.)
Two members of
the Program + 1
university examiner
+ 1 external to
Western examiner

Monograph or
integrated article
format.

TAs available

Standard
department funding
for PhD
GRA – supervisor.

SGPS PhD
supervisory
credentials in
Computer Science
department.

Two members of
the Program + 1
university examiner
+ 1 external to
Western examiner

TAs available

Primary funding to come
from Home Department as
per usual, with non-Home
Department offering TAships for additional support.

One from each program or a
single supervisor with SGPS
supervisory credentials in
both departments.

3 internal – one from CS, one
from Epidemiology &
Biostatistics, one from
outside of CS/EpiBio; The
(University Examiner) and
one external

According to the GTA collective agreement,
once Epidemiology & Biostatistics PhD
students complete a TA-ship, Epidemiology &
Biostatistics is required to give them the same

.

The U. examiner can be from CS or EpiBio or
from a third unit.
The external examiner may be from CS or
EpiBio or a third discipline provided they
have qualifications to examine the thesis.
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Appendix C
Objective 1 Extended Informationa

a

A version of this appendix has been published as supplementary material for: Kueper JK, Terry
AL, Zwarenstein M, Lizotte DJ. Artificial intelligence and primary care research: a scoping review.
Annals of Family Medicine. 2020;18(3):250-258. doi:10.1370/afm.2518
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C.1

PRISMA-ScR Checklist

SECTION
TITLE
Title
ABSTRACT
Structured
summary

PRISMA-ScR CHECKLIST ITEM

REPORTED ON
PAGE #

1

Identify the report as a scoping review.

1

2

Provide a structured summary that includes (as
applicable): background, objectives, eligibility
criteria, sources of evidence, charting methods,
results, and conclusions that relate to the review
questions and objectives.

2

ITEM

INTRODUCTION
Rationale

3

Objectives

4

Describe the rationale for the review in the context
of what is already known. Explain why the review
questions/objectives lend themselves to a scoping
review approach.
Provide an explicit statement of the questions and
objectives being addressed with reference to their
key elements (e.g., population or participants,
concepts, and context) or other relevant key
elements used to conceptualize the review
questions and/or objectives.

1-2

2

METHODS
Protocol and
registration

5

Eligibility criteria

6

Information
sources*

7

Search

8

Selection of
sources of
evidence†

9

Data charting
process‡

10

Data items

11

Critical appraisal
of individual

12

Indicate whether a review protocol exists; state if
and where it can be accessed (e.g., a Web
address); and if available, provide registration
information, including the registration number.
Specify characteristics of the sources of evidence
used as eligibility criteria (e.g., years considered,
language, and publication status), and provide a
rationale.
Describe all information sources in the search
(e.g., databases with dates of coverage and
contact with authors to identify additional
sources), as well as the date the most recent
search was executed.
Present the full electronic search strategy for at
least 1 database, including any limits used, such
that it could be repeated.
State the process for selecting sources of
evidence (i.e., screening and eligibility) included in
the scoping review.
Describe the methods of charting data from the
included sources of evidence (e.g., calibrated
forms or forms that have been tested by the team
before their use, and whether data charting was
done independently or in duplicate) and any
processes for obtaining and confirming data from
investigators.
List and define all variables for which data were
sought and any assumptions and simplifications
made.
If done, provide a rationale for conducting a
critical appraisal of included sources of evidence;
describe the methods used and how this
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2

2,3

2

Supplemental
Appendix 2
2,3

3

3, Supplemental
Appendix 3
NA

SECTION
sources of
evidence§
Synthesis of
results
RESULTS

ITEM

13

PRISMA-ScR CHECKLIST ITEM
information was used in any data synthesis (if
appropriate).
Describe the methods of handling and
summarizing the data that were charted.

REPORTED ON
PAGE #

3

Selection of
sources of
evidence

14

Give numbers of sources of evidence screened,
assessed for eligibility, and included in the review,
with reasons for exclusions at each stage, ideally
using a flow diagram.

3, Figure 1

Characteristics of
sources of
evidence

15

For each source of evidence, present
characteristics for which data were charted and
provide the citations.

3-5; Table 1;
Figures 2 – 4,
Supplemental
Appendix 3

Critical appraisal
within sources of
evidence

16

If done, present data on critical appraisal of
included sources of evidence (see item 12).

NA

Results of
individual sources
of evidence

17

For each included source of evidence, present the
relevant data that were charted that relate to the
review questions and objectives.

Synthesis of
results

18

Summarize and/or present the charting results as
they relate to the review questions and objectives.

NA (too many
studies to do in a
meaningfully
interpretable way)
3-5; Table 1;
Figures 2 – 4;
Supplemental
Appendix 3

DISCUSSION
Summary of
evidence

19

Limitations

20

Conclusions

21

Summarize the main results (including an
overview of concepts, themes, and types of
evidence available), link to the review questions
and objectives, and consider the relevance to key
groups.
Discuss the limitations of the scoping review
process.
Provide a general interpretation of the results with
respect to the review questions and objectives, as
well as potential implications and/or next steps.

5,6

6
5,6,7

FUNDING
Funding

22

Describe sources of funding for the included
sources of evidence, as well as sources of funding
for the scoping review. Describe the role of the
funders of the scoping review.

7

JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses
extension for Scoping Reviews. * Where sources of evidence (see second footnote) are compiled from, such as
bibliographic databases, social media platforms, and Web sites. † A more inclusive/heterogeneous term used to
account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert
opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be
confused with information sources (see first footnote). ‡ The frameworks by Arksey and O’Malley (6) and Levac and
colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting.
§ The process of systematically examining research evidence to assess its validity, results, and relevance before
using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable
to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used
in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document).
From: Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR):
Checklist and Explanation. Ann Intern Med. ;169:467–473. doi: 10.7326/M18-0850

C.2

Search Strategies

Figure C.1: Development of search strategies.

Legend: AI = Artificial Intelligence; PC = Primary Care.

Databases used:
i.
ii.
iii.
iv.
v.
vi.
vii.
viii.
ix.
x.
xi.

Medline-OVID
EMBASE
Cinahl
Cochrane Library
Web of Science
Scopus
IEEE Xplore
ACM Digital Library
MathSciNet
AAAI (https://aaai.org/ocs/index.php/index/index/search/advanced)
arXiv

Database searching notes:
The databases listed above have different search capabilities in terms of keywords and
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subject headings. We used the most rigorous approach possible for each database,
whereby approaches can be broken down into three general categories:
1) Search with keywords and subject headings:
• Medline-OVID
– Keywords were used to search title, abstract, and author keywords.
• Embase
– Keywords were used to search title, abstract, and author keywords.
• Cinahl
– Keywords were used to search title and abstract.
• Cochrane
– Keywords were used to search title, abstract, and keywords.
• ACM Digital Library
– No wildcard (*), use full spellings.
– Only used artificial intelligence subject headings (CCS); health related
headings are too broad and captured too many irrelevant documents to
maintain review feasibility.
– Search “The ACM Full-Text Collection.”
Search strategy for category 1: i) Keywords and subject headings for artificial intelligence concept were searched with OR. ii) Keywords and subject headings for primary
care concept were searched with OR. iii) i) and ii) were combined with AND.
2) Search with keywords only:
• Web of Science
– Keywords in “Topic” field were used to search title, abstract, author keywords, and keywords plus.
• Scopus
– Keywords were used to search title, abstract, and keywords.
• MathSciNet
– Keywords in ‘Anywhere’ field were used to search author, author/related,
title, review text, journal, institution code, series, MSC primary/secondary, MSC primary, MR number, and reviewer.
• arXiv
– arXiv API was accessed using python.
– Keywords in ‘all’ field were used to search title, author, abstract, comment,
journal reference, subject category, report number, and id.
Search strategy for category 2: i) Keywords for artificial intelligence concept were
searched with OR. ii) Keywords for primary care concept were searched with OR. iii)
i) and ii) were combined with AND.
3) Search with limited keywords only:
• IEEE Xplore
– Limited to 12 keywords.
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– Keywords were used to search metadata (abstract, index terms, bibliographic citation data.)
– No wildcard (*) within phrase searching, so we wrote out the 12 terms in
full.
• AAAI
– Limited to 254 characters.
– Used only primary care concept keywords because redundant to search
artificial intelligence terms in artificial intelligence proceedings.
– Case sensitive; spelled out keywords that are most important and most
likely to be capitalized differentially by different authors using upper
and lower case first letter(s) and spelled out less important or less
capitalization-ambiguous keywords using only lower case.
Search strategy for IEEE Xplore: i) Keywords for artificial intelligence concept were
searched with OR. ii) Keywords for primary care concept were searched with OR. iii)
i) and ii) were combined with AND.
Search strategy for AAAI: i) Keywords for primary care concept were searched with
OR.
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(Artificial Intelligence
OR Computer Heuristics OR Expert System* OR Fuzzy Logic
OR Machine Learning OR Support Vector Machine OR Natural Language Processing OR Neural Network* OR Robotic*
OR Deep Learning OR
Knowledge Representation OR Automated
Reasoning OR Computer Vision OR Data
Mining OR Bayesian
Network* OR Bayes
Network*).ti,ab,kw.

Artificial
gence

Intelli-

Key Words
(syntax for MedlineOVID and EMBASE)

Concept

exp Artificial Intelligence/ OR Data Mining/ OR exp Decision Making, Computer Assisted/ OR
exp Decision Support
Techniques/

Medline-Ovid

Exp Artificial Intelligence/ OR Expert
System/ OR Fuzzy
Logic/
OR
Exp
Machine
Learning/
OR Natural Language
Processing/
OR Robotics/ OR
Computer
Assisted
Diagnosis/ OR Exp
Computer
Assisted
Therapy/ OR Knowledge
Base/
OR
Knowledge Base/ OR
Ontology
Development/

EMBASE

(MH “Artificial Intelligence+")
OR
(MH “Data Mining")
OR (MH “Decision
Making,
Computer
Assisted") OR (MH
“Diagnosis, Computer
Assisted+") OR (MH
“Therapy, Computer
Assisted+") OR (MH
“Decision
Support
Techniques+")

CINAHL

Table C.1: Search terms for health sciences databases.

[mh “Artificial Intelligence"] OR [mh “Decision Making, Computer Assisted"] OR
[mh “Decision Support Techniques"] OR
[mh “Data Mining"
not exploded; separate
line]

Cochrane Library
(default explods subject headings)
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(Primary Care OR
Primary Health Care
OR Primary Healthcare OR Primary
Medical Care OR
Family Medicine OR
Family Healthcare OR
Family Health Care
OR Family Physician*
OR Family Pract* OR
General Practitioner*
OR Nurse Practitioner* OR Family
Doctor* OR Family
Nurse* OR Community Medicine OR
Community
Pract*
OR
Ambulatory
Care).ti,ab,kw.

Primary Health Care/
OR Physicians, Family/ OR Physicians,
Primary Care/ OR
General
Practitioners/ OR exp General
Practice/ OR Community
Medicine/
OR Nurse Practitioners/ OR Family
Nurse Practitioners/
OR Primary Care
Nursing/ OR Nurses,
Community Health/
OR
Ambulatory
Care/

Exp Primary Health
Care/ OR Family
Medicine/ OR Community Medicine/ OR
Family Health/ OR
General Practitioner/
OR General Practice/ OR Ambulatory
Care/ OR Ambulatory Care Nursing/
OR Nurse Practitioner/ OR Family Nurse
Practitioner/

Note: Keywords from the above “health databases" were used for Scopus and Web of Science.

Primary Care
(MH “Primary Health
Care")
OR
(MH
“Physicians, Family")
OR
(MH
“Family Practice") OR
(MH
“Community
Medicine") OR (MH
“Community Health
Centers") OR (MH
“Nurse Practitioners")
OR (MH “Family
Nurse Practitioners")
OR (MH “Ambulatory Care") OR (MH
“Ambulatory
Care
Nursing") OR (MH
“Ambulatory
Care
Facilities")

[mh “Primary Health
Care"]
OR
[mh
“Physicians, Primary
Care"] OR [mh “Primary Care Nursing"]
OR [mh “Physicians,
Family"] OR [mh
“General
Practitioners"] OR [mh
“General
Practice"]
OR [mh “Community
Medicine"] OR [mh
“Nurse Practitioners"]
OR
[mh
“Family
Nurse Practitioners"]
OR [mh “Nurses,
Community Health"]
OR [mh “Ambulatory
Care"]
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Key Words
(MathSciNew syntax)
(“Artificial Intelligence" OR “Computer
Heuristics" OR “Expert System" OR “Fuzzy
Logic" OR “Knowledge Base" OR “Machine
Learning" OR “Natural Language Processing" OR “Support Vector Machine" OR
“Neural Network" OR “Robotic" OR “Deep
Learning" OR “Knowledge Representation"
OR “Automated Reasoning" OR “Computer
Vision" OR “Data Mining" OR “Bayesian
Network" OR “Bayes Network")
(“Primary Care" OR “Primary Health Care"
OR “Primary Healthcare" OR “Primary
Medical Care" OR “Family Medicine" OR
“Family Healthcare" OR “Family Health
Care" OR “Family Physician" OR “Family
Pract" OR “General Practitioner" OR “Nurse
Practitioner" OR “Family Doctor" OR “Family Nurse" OR “Community Medicine" OR
“Community Pract" OR “Ambulatory Care")

Concept

Artificial Intelligence

Primary Care
None.

“Artificial Intelligence" “Robotic Planning"
“Distributed Artificial Intelligence" “Computer Vision" “Machine Learning" “Machine
Learning Algorithms"

ACM Digital Library

Table C.2: Search terms for computer science databases.

Additional Search Strings:
CINAHL & Cochrane Library keyword syntax (all Table 1 keywords) to be combined
with subject headings:
(“Artificial Intelligence” OR “Computer Heuristics” OR “Expert System*” OR “Fuzzy Logic” OR
“Machine Learning” OR “Support Vector Machine” OR “Natural Language Processing” OR “Neural
Network*” OR “Robotic*” OR “Deep Learning” OR “Knowledge Representation” OR “Automated
Reasoning” OR “Computer Vision” OR “Data Mining” OR “Bayesian Network*” OR “Bayes Network*“)
(“Primary Care” OR “Primary Health Care” OR “Primary Healthcare” OR “Primary Medical Care”
OR “Family Medicine” OR “Family Healthcare” OR “Family Health Care” OR “Family Physician*”
OR “Family Pract*” OR “General Practitioner*” OR “Nurse Practitioner*” OR “Family Doctor*”
OR “Family Nurse*” OR “Community Medicine” OR “Community Pract*” OR “Ambulatory Care”)

Web of Science syntax (use advanced search page; all Table 1 keywords):
Line 1: TS=(“Artificial Intelligence” OR “Computer Heuristics” OR “Expert System*” OR “Fuzzy
Logic” OR “Machine Learning” OR “Support Vector Machine” OR “Natural Language Processing”
OR “Neural Network*” OR “Robotic*” OR “Deep Learning” OR “Knowledge Representation” OR
“Automated Reasoning” OR “Computer Vision” OR “Data Mining” OR “Bayesian Network*” OR
“Bayes Network*”) AND LANGUAGE: (English)
Line 2: TS=(“Primary Care” OR “Primary Health Care” OR “Primary Healthcare” OR “Primary
Medical Care” OR “Family Medicine” OR “Family Healthcare” OR “Family Health Care” OR
“Family Physician*” OR “Family Pract*” OR “General Practitioner*” OR “Nurse Practitioner*”
OR “Family Doctor*” OR “Family Nurse*” OR “Community Medicine” OR “Community Pract*”
OR “Ambulatory Care”) AND LANGUAGE: (English)
Line 3: #2 AND #1

Scopus search syntax (all Table 1 keywords):
(TITLE-ABS-KEY ((“Artificial Intelligence” OR “Computer Heuristics” OR “Expert System*” OR
“Fuzzy Logic” OR “Machine Learning” OR “Support Vector Machine” OR “Natural Language Processing” OR “Neural Network*” OR “Robotic*” OR “Deep Learning” OR “Knowledge Representation” OR “Automated Reasoning” OR “Computer Vision” OR “Data Mining” OR “Bayesian
Network*” OR “Bayes Network*”) AND (“Primary Care” OR “Primary Health Care” OR “Primary Healthcare” OR “Primary Medical Care” OR “Family Medicine” OR “Family Healthcare” OR
“Family Health Care” OR “Family Physician*” OR “Family Pract*” OR “General Practitioner*”
OR “Nurse Practitioner*” OR “Family Doctor*” OR “Family Nurse*” OR “Community Medicine”
OR “Community Pract*” OR “Ambulatory Care”))) AND (LIMIT-TO (LANGUAGE, “English”))

ACM Digital Libraries syntax (all Table 2 keywords and subject headings):
+(“Artificial Intelligence” “Computer Heuristics” “Expert Systems” “Fuzzy Logic” “Knowledge
Base” “Machine Learning” “Natural Language Processing” “Support Vector Machine” “Neural Network” “Robotic” “Deep Learning” “Knowledge Representation” “Automated Reasoning” “Computer
Vision” “Bayesian Network” “Bayes Network” (+acmdlCCS:(“Artificial Intelligence” “Robotic planning” “Distributed Artificial Intelligence” “Computer Vision” “Machine Learning” “Machine Learning Algorithms”))) +(“Primary Care” “Primary Health Care” “Primary Healthcare” “Primary Medical Care” “Family Medicine” “Family Healthcare” “Family Health Care” “Family Physician” “Family
Practice” “Family Practitioner” “General Practitioner” “Nurse Practitioner” “Community Medicine”
“Community Practice” “Ambulatory Care” “Family Doctor” “Family Nurse”)
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IEEE syntax (use Command Search, metadata only; subset of Table 2 keywords
(database limit is 12)):
((“Artificial Intelligence” OR “Machine Learning” OR “Data Mining” OR “Natural Language Processing”) AND (“Primary Care” OR “Primary Health Care” OR “Primary Healthcare” OR “Family
Physician” OR “General Practitioner” OR “Family Doctor” OR “Nurse Practitioner” OR “Family
Medicine”))

AAAI syntax (use ’search all categories for” line at https:// aaai.org/ ocs/ index.php/
index/ index/ search/ advanced; subset of Table 2 keywords (254 character limit)):
“Primary Care” OR “primary care” OR “Primary Health Care” OR “primary health care” OR
“Primary Healthcare” OR “primary healthcare” OR “family physician” OR “general practitioner”
OR “family doctor” OR “nurse practitioner” OR “family medicine”

arXiv API access python code (adapted from https:// arxiv.org/ help/ api/ usermanual#Architecture; all Table 2 keywords):
import urllib
url = 'https://export.arxiv.org/api/query?search_query=all:%28%22artificial+intelligence
%22+OR+%22computer+heuristics%22+OR+%22 expert+system\*%22+OR+%22fuzzy+logic%22+OR+%22
knowledge+base%22+OR+%22machine+learning%22+OR+%22natural+la nguage+processing%22+OR
+%22support+vector+machine%22+OR+%22neural+network\*%22+OR+%22robotic\*%22+OR+%22deep+
learning%22+OR+%22knowledge+representation%22+OR+%22automated+reasoning%22+OR+%22
computer+vision%22+OR+%22data+mining%22+OR+%22bayesian+network\*%22+OR+%22bayes+
network\*%22%29+AND+all:%28%22primary+care%22+OR+%22primary+health+care%22+OR+%22
primary+healthcare%22+OR+%22primary+medical+care%22+OR+%22family+medicine%22+OR+%22
family+healthcare%22+OR+%22family+health+care%22+OR+%22family+physician\*%22+OR+%22
family+pract\* %22+OR+%22general+practitioner\*%22+OR+%22nurse+practitioner\*%22+OR
+%22family+doctor\*%22+OR+%22family+nurse\* %22+OR+%22community+medicine%22+OR+%22
community+pract\*%22+OR+%22ambulatory+care%22%29&start=0&max_resul ts=2000'
data = urllib.urlopen(url).read()
print data

C.3

Additional Methods and Results
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Definition and Subfields
Last and first name of first author, year of publication, and title
Three mutually exclusive overall research purposes for AI in the study: 1. Method Development/Adaptation: Research
that created novel AI methods or modified existing AI methods to accomplish a task relevant to PC. For example,
developing a new supervised machine learning algorithm to learn a model that will predict the probability of pathological
heart murmurs using digital heart sound recording data [1]. This category includes studies that compare the performance
of AI methods to the performance of humans or that include consultation with end users to inform tool development,
as this is considered part of model testing, which may lead to further modifications before evaluating performance in
the setting that the AI is intended to support (e.g. clinical practice.) 2. Data Analysis: Existing AI methods were
used to analyze and/or extract information from data. For example, using natural language processing algorithms to
identify cases of familial hypercholesteremia from electronic health records [2]. 3. Evaluation: Research that included AI
implemented in its intended setting, possibly as part of a pilot study to assess impact or usability characteristics of a tool.
For example, assessing the impact of a machine learning-derived diagnosis model on reducing cervical intraepithelial
neoplasia overdiagnosis in a Dutch national population screening program [3].
Author affiliations as presented on the manuscript, divided into 16 categories: Biological and Biomedical Sciences,
Company, Computer Science, Engineering, Epidemiology and Biostatistics, Health Sciences, Informatics, Mathematics,
Medicine – Unspecified, Medicine – Specialty, Family Medicine and Primary Care, Nursing, Public Health, Statistics,
Other (specified), and Unknown when not enough affiliation information was provided to identify a broad discipline.
When an author had multiple affiliations, all were recorded.

Field

Citation Information

Study Purpose(s)

Author Appointment(s)

Table C.3: Data extraction field characterizations.
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The health condition of interest as stated by the study authors or inferred by reviewers, or Unknown if no condition
was stated or inferable. Conditions were extracted in full form and MZ later organized them into 27 and 10 category
formats. When a study intended for AI to be applicable for all health conditions “General” was used; specifics about
any test conditions were also extracted.
Country or next level of granularity where data were collected, or the geographical location where the study stated
implementation would occur. Unknown was used when the location of data source was not stated or when all data were
simulated.

Location
of
Data
Source(s) or intended
location of implementation

Health

Condi-

Target
tion(s)

People who the research or research end-product was stated as intended for, regardless of whether those intended end
users were involved with the research or how close the research was to being applicable for those users in practice setting:
Patient, Physician, Nurse, Nurse Practitioner, Administrator, Researcher, Other (specified), or Unknown. If the study
was developing a deployable AI method or tool (broadly defined) but more research was needed before the AI method
of interest would be ready to implement or be utilized by its intended end user, Researcher was included as a target end
user.

Author
Reported
tended End-User(s)

In-

Nine categories of PC functions or tasks that the researched AI supported or is intended to support in the future:
1. Diagnostic Decision Support: AI provided information to inform diagnosis, such as the probability that a patient has
a particular condition. 2. Treatment Decision Support: AI provided information to inform treatment decisions, whereby
treatment was interpreted broadly to include any management or care provided (or absence of unnecessary actions)
to someone with the health condition(s) or symptom(s) of interest. 3. Referral Support: AI provided information to
support decisions about referring patients to specialist services or AI assisted with technical aspects of the referral
process. 4. Future State Prediction: AI provided predictions towards future events, for example utilization of emergency
department, development of a health condition, or prognosis for an existing condition. 5. Health Care Utilization
Analyses: AI provided information about interactions with or processes within health care systems, for example frequency
or quantity of patient visits. 6. Knowledge Base and Ontology Construction or Use: Construction or use of knowledge
bases or ontologies including PC concepts. 7. Information Extraction: AI used to extract knowledge from structured
or unstructured data (e.g. electronic medical records) for further use. 8. Descriptive Information Provision: AI used
to summarize data in a meaningful way for human interpretation, for example prevalence of a condition or patterns
of patient profiles. 9. Other (specified): The PC function was not represented by the above categories; specifics were
recorded.
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149

Subfield(s) of Artificial Intelligence

Artificial Intelligence methods were organized according to 10 subfields; a single study may include one or more subfields:
1. Bayesian Network: Graphical models (directed acyclic graphs) used to describe dependency relationships among
variables that enable the efficient representation of multivariate probability distributions. The resulting distributions
can be queried to find the probability of an event occurring given a particular set of evidence. Bayesian networks can
be developed manually, such as from physician input, learned from data, or created using a combination of the two.
For example, Teles et al. (2015) use a Bayesian Network to assist the diagnosis of dengue fever disease. The model
includes variables for dengue fever risk factors, such as ‘Respiratory Distress’. For prediction, a person’s current risk
factor variable values are inputted and the conditional probability they have dengue fever is outputted [4]. 2. Computer
Vision: Includes extracting visual information and understanding it. Computer vision is distinct from image processing,
which includes modifying an existing or creating a new image without focusing on the meaning of the image. For
example, Zouridakis et al. (2015) present a smartphone app whereby a picture of a skin lesion is taken and computer
vision is used to interpret the image and assess the likelihood of malignancy [5]. 3. Data Mining: The process of eliciting
information from collections of data, such as by finding and counting pattern occurrences using inferential algorithms;
humans may then interpret these patterns. For example, Soler et al. (2015) used data mining on electronic medical
records to identify relationships between reasons for encounter and diagnoses recorded for the corresponding visit [6].
We did not consider extracting information in a structured way, such as using a database query to get a basic count
of disease X diagnoses, to be the type of data mining that falls under the umbrella of artificial intelligence. 4. Expert
System: Consists of two parts: 1) a knowledge base that contains facts and rules, such as if-then statements derived
from medical guidelines and 2) an inference engine that uses the knowledge base to arrive at conclusions or answers to
questions. For example, Lange et al. (1997) demonstrate the use of an expert system called Iliad for teaching diagnostic
reasoning to Nurse Practitioner students [7]. Illiad’s knowledge base is made up of medical facts and relationships.
Bayesian or probabilistic and Boolean or deterministic reasoning may be used with the knowledge base to arrive at a
level of confidence about a diagnosis [7]. 5. Fuzzy Models: Rely on fuzzy logic and fuzzy sets to represent problems with
uncertainty. They are often used to provide more flexibility to outcomes instead of requiring strict classification into
pre-defined groups. For example, Katigari et al. (2017) used a fuzzy model as the inference engine for an expert system
designed to support diagnosis of diabetic neuropathy.85 Model input includes parameters such as time with diabetes,
symptom severity, and laboratory blood test values; model output is an estimate of diabetic neuropathy severity [8].
6. Natural Language Processing: The ability to read language used by humans and interpret it in a meaningful way; this
is often accomplished by analysing syntactic and semantic characteristics of language. The input language may be audio
or written. For example, Koeling et al. (2011) used natural language processing to analyse free text portions of medical
records and enhance the accuracy of ovarian cancer symptom detection compared to only using the structured portion
of medical records [9]. 7. Robotics: Robotics within artificial intelligence refers to machines that can act autonomously
to navigate and alter their environment. A robot may rely on other types of artificial intelligence, such as computer
vision and natural language processing, to accomplish this. Robotics outside of artificial intelligence include machines
that are programmed by humans to perform a defined set of actions. No examples of robotics were captured by our
review.

150

Initials of the person who (re)read the full text article and assigned values for the seven key characteristics outlined
above: JKK, ALT, or DJL.
Optional free form notes from the person extracting the data.

Reviewer who extracted
the data

Reviewer notes

Note: Subfields are ordered according to appearance in the results section of the manuscript. Cited examples are from studies captured by our
scoping review. Legend: AI = Artificial Intelligence; PC = Primary Care. References: 1. Andrisevic N, Ejaz K, Rios-Gutierrez F, Alba-Flores R,
Nordehn G, Burns S. Detection of heart murmurs using wavelet analysis and artificial neural networks. J Biomech Eng. 2005;127(6):899-904. 2.
Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study. J Clin
Lipidol. 2016;10(5):1230-1239. 3. Kok MR, Boon ME, Schreiner-Kok PG, Hermans J, Grobbee DE, Kok LP. Less medical intervention after sharp
demarcation of grade 1-2 cervical intraepithelial neoplasia smears by neural network screening. Cancer. 2001;93(3):173-178. 4. Teles G, Oliveira C,
Braga R, et al. Using Bayesian networks to improve the decision- making process in public health systems. In 2014 IEEE 16th International
Conference on e-Health Networking, Applications and Services (Healthcom). 2014:565-570. 5. Zouridakis G, Wadhawan T, Situ N, et al. Melanoma

8. Supervised Machine Learning: Involves an algorithm learning to associate labels with observations. In the context of
health, the label is often an outcome, e.g. a disease state or outcome, and the observations are often patient variables.
Labels may be numeric values or categorical classifications. Supervised machine learning uses existing labelled data
which contain a collection of observations together with their correct label to produce a model that is able to assign a
label to new, previously unseen observations. Supervised machine learning techniques include Support Vector Machines,
K-Nearest Neighbours, Naïve Bayes Class ifier, and Random Forest Decision Trees. For example, Cox et al. (2016)
used supervised machine learning to help identify undiagnosed post-stroke spasticity [10]. A model was trained using
a large PC database that included the outcome of interest, post stroke spasticity events, and 72 candidate variables
to predict the outcome, such as demographic information, prescriptions, and medical diagnoses [10]. They then used
the model to identify people who had a high probability of post-stroke spasticity and checked whether the event was
recorded in their records; the results of this study suggested an under recording of post stroke spasticity in PC records
[10]. 9. Unsupervised Machine Learning: Algorithms learn patterns from unlabelled data (unlabelled meaning there
are not defined, known outcome categories as was the case for supervised machine learning). Common unsupervised
machine learning techniques include clustering data items into groups based on their similarity, association mining to
identify observations that tend to occur together, autoencoders to condense data while maintaining adequate fidelity,
and feature separation to examine different aspects of a dataset independently. For example, Newcomer et al. (2011)
used cluster analysis on data from a health care organization to identify groups of complex patients who may benefit
from targeted care strategies [11]. 10. Other (specified): There are additional types of AI not captured by the above,
such as multi-agent systems. We did not expect a high prevalence of these methods so did not create distinct categories,
but recorded details when they arose. Other was also used to classify studies that did not focus on any specific technique
of artificial intelligence. For example, Sola et al. (2018) studied physician perceptions of artificial intelligence in general
without isolating any particular artificial techniques [12].
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and other skin lesion detection using smart handheld devices. Methods Mol Bio. 2015;1256(bu3, 9214969):459-496. 6. Soler JK, Corrigan D,
Kazienko P, et al. Evidence-based rules from family practice to inform family practice; The learning healthcare system case study on urinary tract
infections. BMC Fam Pract. 2015;16(1). 7. Lange LL, Haak SW, Lincoln MJ, et al. Use of Iliad to Improve Diagnostic Performance of Nurse
Practitioner Students. J Nurs Educ. 1997;36(1):36-45. 8. Katigari MR, Ayatollahi H, Malek M, Haghighi MK. Fuzzy expert system for diagnosing
diabetic neuropathy. World J Diabetes. 2017;8(2):80-88. 9. Koeling R, Tate AR, Carroll JA. Automatically estimating the incidence of symptoms
recorded in GP free text notes. In: Proceedings of the first international workshop on Managing interoperability and complexity in health systems.
2011. 10. Cox AP, Raluy-Callado M, Wang M, Bakheit AM, Moore AP, Dinet J. Predictive analysis for identifying potentially undiagnosed
post-stroke spasticity patients in United Kingdom. J Biomed Inform. 2016;60:328-333. 11. Newcomer SR, Steiner JF, Bayliss EA. Identifying
Subgroups of Complex Patients With Cluster Analysis. Am J Manag Care. 2011;17(8):E324-E332. 12. Sola D, Borioli GS, Quaglia R. Predicting
GPs’ engagement with artificial intelligence. Br J Health Care Manag. 2018;24(3):134-140.

Table C.4: Complete author appointment counts.
Appointment Type

Number of studies with at least one author with the corresponding appointment

Biological and Medical Sciences
29
Company
49
Computer Science
97
Engineering
71
Epidemiology and Biostatistics
23
Health Sciences
33
Informatics
63
Mathematics
16
Medicine – Other
94
Medicine – Specialty
99
Medicine – Family or Primary Care
57
Nursing
4
Public Health
20
Statistics
15
Other
132
Unknown
110
Note: Each study fulfills one or more appointment type categories; each category is counted a
maximum of one time for any given study.

Figure C.2: Detailed breakdown of primary care functions.

Legend: AHR = Analyze Health Records; DCS = Descriptives; ET = Education or Training; KBO
= Knowledge Base or Ontology Construction; PD = Prediction; DxS = Diagnostic Decision
Support; RS = Referral Support; TxS = Treatment Decision Support; HU = Health Care Use; O
= Other.
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Figure C.3: Author reported end user total counts.

Note: A single study may contribute towards the count for one or more end user categories.

Figure C.4: Detailed breakdown of author reported intended end user combinations
by study.
Legend: DR = Physician; R = Researcher; U = Unknown; AD = Administrator; PT = Patient; N
= Nurse; NP = Nurse Practitioner; O = Other.
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Figure C.5: Detailed breakdown of health conditions.

Figure C.6: Most frequent locations of data source or intended implementation with
per capita rates.
Notes: Only studies with location reported are included (n=292). Number at the end of each bar
is the number of studies per 100,000,000 people, based on 2013 population estimates.
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Table C.5: Detailed breakdown of location.
Location

Number of studies

Unknown or Not Applicable
United States
United Kingdom
Netherlands
Australia
Canada
Spain
Brazil
India
Iran
Sweden
China
Germany
Italy
Slovenia
Australia and France
Croatia
France
Greece
New Zealand
Belgium
Egypt
Finland
Ireland
Japan
Norway
Singapore
Taiwan
Austria
Barcelona
Bulgaria
Canada and United States and United Kingdom and Brazil and
Netherlands and Australia
Colombia
Czech Republic
Denmark
Europe
Germany and Norway
Greece and Bulgaria and Albania and Fyrom and Turkey
Hong Kong
Israel
Kuwait
Malaysia
Malta and Netherlands
Portugal
Saudi Arabia
South Africa
Switzerland
Turkey
United Kingdom and Greece and Germany

113
79
38
26
17
13
10
9
9
8
8
6
6
5
4
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1

155

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

United States and Panama
United States and United Kingdom

1
1

Figure C.7: Most frequent subfields of artificial intelligence with median year of
publication.
Legend: SML = Supervised Machine Learning; ES = Expert System; NLP = Natural Language
Processing; UML = Unsupervised Machine Learning; DM = Data Mining; BN = Bayesian
Network; FM = Fuzzy Models; O = Other.
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Figure C.8: Detailed breakdown of artificial intelligence subfields with median year
of publication.
Legend: SML = Supervised Machine Learning; ES = Expert System; NLP = Natural Language
Processing; UML = Unsupervised Machine Learning; DM = Data Mining; BN = Bayesian
Network; FM = Fuzzy Models; O = Other.
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Objectives

Methods
Study Design

1

Introduction
Background
rationale

Title and abstract

Item
No.

Present key elements of study
design early in the paper

Explain the scientific
background and rationale for the
investigation being reported
State specific objectives,
including any prespecified
hypotheses

(a) Indicate the study’s design
with a commonly used term in
the title or the abstract (b)
Provide in the abstract an
informative and balanced
summary of what was done and
what was found

STROBE items

Introduction,
Methods – Study
population and
data source

Introduction

Introduction

Abstract

Location in
manuscript where
items are reported

RECORD 1.3: If linkage between
databases was conducted for the study,
this should be clearly stated in the title
or abstract.

RECORD 1.2: If applicable, the
geographic region and timeframe
within which the study took place
should be reported in the title or
abstract.

RECORD 1.1: The type of data used
should be specified in the title or
abstract. When possible, the name of
the databases used should be included.

RECORD items

Introduction,
Methods –
Study

Introduction

Introduction

Abstract

Location in
manuscript
where items are
reported

D.1
RECORD Checklist

5

6

Setting

Participants

(b) Cohort study - For matched
studies, give matching criteria
and number of exposed and
unexposed
Case-control study - For
matched studies, give matching

(a) Cohort study - Give the
eligibility criteria, and the
sources and methods of selection
of participants. Describe
methods of follow-up
Case-control study - Give the
eligibility criteria, and the
sources and methods of case
ascertainment and control
selection. Give the rationale for
the choice of cases and controls
Cross-sectional study - Give the
eligibility criteria, and the
sources and methods of selection
of participants

Describe the setting, locations,
and relevant dates, including
periods of recruitment, exposure,
follow-up, and data collection

Methods

Methods – Study
population and data
source; additional
details specific to
analyses are
presented under the
appropriate subheading

RECORD 6.3: If the study involved
linkage of databases, consider use of a
flow diagram or other graphical display
to demonstrate the data linkage
process, including the number of
individuals with linked data at each
stage.

RECORD 6.2: Any validation studies
of the codes or algorithms used to
select the population should be
referenced. If validation was conducted
for this study and not published
elsewhere, detailed methods and results
should be provided.

RECORD 6.1: The methods of study
population selection (such as codes or
algorithms used to identify subjects)
should be listed in detail. If this is not
possible, an explanation should be
provided.

population and
data source
Methods – Study
population and
data source;
additional details
specific to
analyses are
presented under
the appropriate
sub-heading
Methods

7

8

9
10
11

12

Variables

Data sources/
measurement

Bias

Study size

Quantitative
variables

Statistical
methods

For each variable of interest,
give sources of data and details
of methods of assessment
(measurement).
Describe comparability of
assessment methods if there is
more than one group
Describe any efforts to address
potential sources of bias
Explain how the study size was
arrived at
Explain how quantitative
variables were handled in the
analyses. If applicable, describe
which groupings were chosen,
and why
(a) Describe all statistical
methods, including those used to
control for confounding
(b) Describe any methods used
to examine subgroups and
interactions
(c) Explain how missing data
were addressed

criteria and the number of
controls per case
Clearly define all outcomes,
exposures, predictors, potential
confounders, and effect
modifiers. Give diagnostic
criteria, if applicable.

Methods

Methods,
Supplementary
Table S1

Methods

N/A

Methods,
Supplementary
Table S1

Methods,
Supplementary
Table S1

RECORD 7.1: A complete list of codes
and algorithms used to classify
exposures, outcomes, confounders, and
effect modifiers should be provided. If
these cannot be reported, an
explanation should be provided.

Methods

Methods,
Supplementary
Table S1

Methods

N/A

Methods,
Supplementary
Table S1

Supplementary
Table S1

Results
Participants

Linkage

Data access and
cleaning methods

13

(a) Report the numbers of
individuals at each stage of the
study (e.g., numbers potentially

..

(d) Cohort study - If applicable,
explain how loss to follow-up
was addressed
Case-control study - If
applicable, explain how
matching of cases and controls
was addressed
Cross-sectional study - If
applicable, describe analytical
methods taking account of
sampling strategy
(e) Describe any sensitivity
analyses
..

Supplementary
Appendix 3

RECORD 13.1: Describe in detail the
selection of the persons included in the
study (i.e., study population selection)

RECORD 12.2: Authors should
provide information on the data
cleaning methods used in the study.
RECORD 12.3: State whether the
study included person-level,
institutional-level, or other data linkage
across two or more databases. The
methods of linkage and methods of
linkage quality evaluation should be
provided.

RECORD 12.1: Authors should
describe the extent to which the
investigators had access to the database
population used to create the study
population.

Methods

No linkage

Methods,
Supplementary
Table S1

14

15

16

Descriptive data

Outcome data

Main results

eligible, examined for eligibility,
confirmed eligible, included in
the study, completing follow-up,
and analysed)
(b) Give reasons for nonparticipation at each stage.
(c) Consider use of a flow
diagram
(a) Give characteristics of study
participants (e.g., demographic,
clinical, social) and information
on exposures and potential
confounders
(b) Indicate the number of
participants with missing data
for each variable of interest
(c) Cohort study - summarise
follow-up time (e.g., average and
total amount)
Cohort study - Report numbers
of outcome events or summary
measures over time
Case-control study - Report
numbers in each exposure
category, or summary measures
of exposure
Cross-sectional study - Report
numbers of outcome events or
summary measures
(a) Give unadjusted estimates
and, if applicable, confounderadjusted estimates and their
precision (e.g., 95% confidence
Results,
Supplementary
Appendix 3

Results,
Supplementary
Appendix 3

Results,
Supplementary
Appendix 3

including filtering based on data
quality, data availability and linkage.
The selection of included persons can
be described in the text and/or by
means of the study flow diagram.

17

18
19

20

Other analyses

Discussion
Key results

Limitations

Interpretation

Give a cautious overall
interpretation of results
considering objectives,
limitations, multiplicity of
analyses, results from similar
studies, and other relevant
evidence

Summarise key results with
reference to study objectives
Discuss limitations of the study,
taking into account sources of
potential bias or imprecision.
Discuss both direction and
magnitude of any potential bias

interval). Make clear which
confounders were adjusted for
and why they were included
(b) Report category boundaries
when continuous variables were
categorized
(c) If relevant, consider
translating estimates of relative
risk into absolute risk for a
meaningful time period
Report other analyses done—
e.g., analyses of subgroups and
interactions, and sensitivity
analyses

Discussion

Discussion

Discussion

Results,
Supplementary
Appendix 1,3

RECORD 19.1: Discuss the
Discussion
implications of using data that were not
created or collected to answer the
specific research question(s). Include
discussion of misclassification bias,
unmeasured confounding, missing
data, and changing eligibility over
time, as they pertain to the study being
reported.
Discussion

Discussion

21

Accessibility of
protocol, raw
data, and
programming
code

Other Information
Funding
22

Generalisability

Give the source of funding and
the role of the funders for the
present study and, if applicable,
for the original study on which
the present article is based
..

Discuss the generalisability
(external validity) of the study
results
Declarations

N/A

RECORD 22.1: Authors should
provide information on how to access
any supplemental information such as
the study protocol, raw data, or
programming code.

Given the
sensitive nature of
the data, this
information is not
shared.

Declarations

N/A
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Extra Figures

Figure D.1: Cohort size by calendar- and observation-based time.

Notes: Active clients had at least one event during or after the year (calendar- or
observation-based) of interest (gap years counted). The number of active observation years refers
to the number of 365.25 day periods, counted from the first calendar date that an event was
recorded for that client, that clients had at least one event recorded (gap years not counted).
Length of observation refers to the number of years from the first to the last year that at least one
event was recorded during (gap years counted). Cumulative clients refers to the number of clients
who had at least one event during or before the year of interest. Legend: COPD = Chronic
Obstructive Pulmonary Disease; TIA = Transient Ischemic Attack; AD = Alzheimer’s Disease.
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195

196

197

Figure D.2: Observation-based period prevalence.

Notes: Each bar represents the proportion of clients within that observation-based cohort (years
are arbitrary 365.25 day consecutive periods between the first and last recorded events) that had
at least one indication of the condition of interest across their entire observation history.
Conditions were grouped to represent 1) Extra conditions of interest to Alliance stakeholders, 2) 20
chronic conditions, which make up multimorbidity (MM) status, and 3) Overview indicators for
the cohorts. Legend: COPD = Chronic Obstructive Pulmonary Disease; TIA = Transient Ischemic
Attack; AD = Alzheimer’s Disease.
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201

Figure D.3: Cumulative incidence plots by days of observation since the first recorded
event.
Notes: Clients eligible for this analysis must not have had any care recorded in the first
calendar-year of available data (2009). Legend: COPD = Chronic Obstructive Pulmonary Disease;
TIA = Transient Ischemic Attack; AD = Alzheimer’s Disease.
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Extra Tables
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Clinical
Hypertension
Depression or Anxiety

Food Insecurity

Household Composition
Stable Residence

Household Income

Race and Ethnicity
Year Since Arrival in Canada

Sex
Gender
Sexual Orientation
Highest Level of Education
Completed
Primary Spoken Language

Sociodemographic
Age in 2015
Geography

Variable Name

At least one ICD-10 code: i10, i11, i12, i13, i14, i15
At least one ICD-10 code: f33, f40, f41

Categories as recorded in client characteristic table
Collapsed client characteristic table categories into Stable or Unstable
(homeless, shelter, other temporary). Additional unstable residence situations were identified as the presence of at least one ENCODE-FM code:
8990, 9433, 9434, 9435, 9436, 9437, 9438, 9439, 9440, 9441, 9442, 9443,
9432, 8982, 8986, 9419, 9424, 8985, 9431, 9415, 9425, 9412, 9414, which
were given priority.
At least one ENCODE-FM code: 8972, 9782, 9802, 8971, 9568, 9805

Collapsed client characteristic table categories into the two official languages of Canada with remaining languages categorized as Other.
Collapsed client characteristic table categories
Cleaned free text entries from client characteristic table and collapsed into
5 years, 6 or more year, and None Recorded categories. None Recorded
cannot differentiate between never-immigrated and never-asked.
Collapsed client characteristic table categories

2015 minus Year of Birth
Geography of place of residence based on Forward Sortation Area: Rural if
second digit is 0; Urban if any other valid digit; NA otherwise.
Categories as recorded in client characteristic table
Collapsed client characteristic table categories
Categories as recorded in client characteristic table
Collapsed client characteristic table categories

Definition

Table D.1: Characteristic variable definitions.

[5]
[5]

List of codes are from an Alliance for Healthier Communities stakeholder

List of codes are from an Alliance for Healthier Communities stakeholder.

Note: could not reliably follow
guidelines in [2]

[3,4]

[2] followed to the extent possible

[2]

[1]

Source used to guide variable operationalization, if
any
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Kidney Disease or Failure
Chronic Urinary Problem

Chronic Musculoskeletal Conditions causing pain or limitation
Arthritis and/or Rheumatoid
Arthritis
Osteoporosis
Asthma, Chronic Obstructive Pulmonary Disease, or
Chronic Bronchitis
Cardiovascular
Disease
(angina, myocardial infarction, atrial fibrillation, poor
circulation in the lower limbs)
Heart Failure (including valve
problems or replacement)
Stroke and Transient Ischemic
Attack
Stomach Problem (irritable
bowel, Chron’s disease, ulcerative colitis, diverticulosis)
Colon Problem
Chronic Hepatitis
Diabetes
Thyroid Disorder
Any
Cancer
(including
melanoma, but excluding
other skin cancers)
[5]
[5]
[5]

[5]
[5]
[5]
[5]
[5]
[5]
[5]
[5] modified by removing the
5 year restriction; taking any
cancer indication within the
10 year period

At least one ICD-10 code: m81
At least one ICD-10 code: j40, j41, j42, j43, j44, j45, j46
At least one ICD-10 code: i20, i25, i48, i70, i71, i72, i73, i74, i75, i76, i77,
i78, i79
At least one ICD-10 code: i05, i06, i07, i08, i09, i34, i35, i36, i37, i38, i39,
i42, i43, i50
At least one ICD-10 code: g45, i62
At least one ICD-10 code: k21, k25.7, k29.5
At least one ICD-10 code: k50, k51, k52, k57, k58
At least one ICD-10 code: k70, k71, k72, k73, k74, k75, k76, k77
At least one ICD-10 code: e10, e11, e12, e13, e14
At least one ICD-10 code: e00, e01, e02, e03, e04, e05, e06, e07
At least one ICD-10 code: c00, c01, c02, c03, c04, c05, c06, c07, c08, c09,
c10, c11, c12, c13, c14, c15, c16, c17, c18, c19, c20, c21, c22, c23, c24, c25,
c26, c27, c28, c29, c30, c31, c32, c33, c34, c35, c36, c37, c38, c39, c40, c41,
c42, c43, c44, c45, c46, c47, c48, c49, c50, c51, c52, c53, c54, c55, c56, c57,
c58, c59, c60, c61, c62, c63, c64, c65, c66, c67, c68, c69, c70, c71, c72, c73,
c74, c75, c76, c77, c78, c79, c80, c81, c82, c83, c84, c85, c86, c87, c88, c89,
c90, c91, c92, c93, c94, c95, c96, c97
At least one ICD-10 code: n18, n19
At least one ICD-10 code: n03, n11, n18, n20, n21, n22, n23, n25, n26, 27,
n28, n29, n30, n31, n32, n33, n34, n35, n36, n37, n38, n39, n40, n41, n42,
n43, n44, n45, n46, n47, n48, n49, n50, n51+B38

[5]
[5]

[5]

[5]

At least one ICD-10 code: m40, m41, m42, m43, m44, m45, m46, m47,
m48, m49, m50, m51, m52, m53, m54, m60, m61, m62, m63, m65, m66,
m67, m68, m70, m71, m72, m73, m74, m75, m76, m77, m78, m79
At least one ICD-10 code: m05.9, m13.0, m13.9, m15, m16, m17, m18, m19
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# Internal Referrals
# External Referrals

# Provider Types Seen

Health Care Use
# Years of Observation

Lonely or Isolated

Substance Use

Dementia or Alzheimer’s Disease
Hyperlipidemia (high cholesterol)
Obesity
Hepatitis C
Smoking or Tobacco Use

[5] ICD-10 only; no BMI
[6]
JKK
selected
relevant
ENCODE-FM codes based
on manual review
JKK
selected
relevant
ENCODE-FM codes based
on manual review

At least one ICD-10 code: e66
At least one ICD-10 code: b18.2, b19.20, b19.21
At least one ENCODE-FM code: 10072, 5520, 679, 9910, 5339, 5340, 5341,
5342, 5343, 5344, 5345, 5346, 5347, 5348, 5349

Based on records in the service event table: Ceiling of number of days from
first to last recorded event divided by 365.25
Number of unique provider types recorded in providers involved table.
Provider types were maintained as entered except Other, Unknown, and
Undefined were collapsed
Number of records in the internal referrals table
Number of records in the external referrals table

List of codes are from an Alliance for Healthier Communities stakeholder

[5]

At least one ICD-10 code: e78

At least one ENCODE-FM code: 5304, 10004, 10005, 5305, 5306, 5307,
9754, 5308, 5309, 5310, 5311, 5312, 5313, 5314, 5315, 5316, 5317, 5318,
5319, 5320, 5321, 5322, 5323, 5324, 5325, 5326, 5327, 5328, 5329, 5330,
5331, 5332, 5333, 5334, 5335, 5336, 5337, 5338, 5350, 5351, 5352, 5353,
5354, 5355, 5356, 5357, 5358, 5359, 5360, 5361, 5362, 5363, 5364, 5365,
5366, 5367, 5368, 5369, 5370, 5371, 10007, 5372, 5373, 5374, 5375, 5376,
5377, 5378, 5379, 5380, 5381, 5382, 5383, 5384, 5385, 5386, 5387, 5388,
5389, 5390, 5391, 5392, 5393, 5394, 5395, 5396, 5397, 5398, 5399, 5400,
9845, 5401, 9844, 5401, 5402, 5403, 5404, 5405, 5406, 5407, 5408, 5409,
5410, 5411, 5412, 5413, 5414, 5415, 5416, 5417, 5418, 5419, 5420, 5421,
5422, 5423, 5424, 5425, 5426, 5427, 5428, 5429, 5430, 5431, 5432, 5433,
5434, 5435, 5436, 5437, 5438, 5439, 5440, 5441, 5442, 5443, 5444, 5445,
5446, 5447, 5448, 5449, 9277, 9278, 5450, 5451, 5452, 5453, 5454, 5455,
5456, 5457, 5458, 5459, 5460, 5461, 5462, 5463, 5464, 5465, 5466, 5467,
5468, 5469, 5470, 5471, 5472, 5473, 5474, 5475, 5476, 5477, 5478, 5479,
5480, 5481 or recorded in Disabilities Table
At least one ENCODE-FM code: 5138, 5139, 9265, 9267, 9268, 9512

[5]

At least one ICD-10 code: f00, f01, f02, f03
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Based on records in the service event table: Sum of unique calendar days
with at least one event recorded divided by Number of Years of Observation
Based on records in the service event table: Maximum of number of unique
calendar days care is accessed in a single calendar year
Based on records in the service event table: Sum of events divided by
number of calendar days care is accessed at least once
Based on records in the service event table: Maximum number of events
recorded in a single calendar day

Legend: # = Number; Avg. = Average; CHC = Community Health Centre; ENCODE-FM = Electronic Nomenclature and Classification Of Disorders
and Encounters for Family Medicine; ICD = International Classification of Disease; SD = Standard Deviation; UAR = Urban at Risk. References: [1]
Canada Post. Addressing guidelines - Forward Sortation Area (FSA). Canada Post. 2022 [cited 2022 Feb 8]. Available from: https://www.canadapostpostescanada.ca/cpc/en/support/articles/addressing-guidelines/postal-codes.page [2] CIHI. In Pursuit of Health Equity: Defining Stratifiers for Measuring Health Inequality - A Focus on Age, Sex, Gender, Income, Education and Geographic Location. Ottawa, ON: Canadian Institute for Health
Information; 2018 Apr. Available from: https://www.cihi.ca/sites/default/files/document/defining-stratifiers-measuring-health-inequalities-2018-enweb.pdf [3] CIHI. Proposed Standards for Race-Based and Indigenous Identity Data Collection and Health Reporting in Canada. Ottawa, ON: Canadian Institute for Health Information; 2020. Available from: https://www.cihi.ca/en/proposed-standards-for-race-based-and-indigenous-identity-data
[4] Flanagin A, Frey T, Christiansen SL, AMA Manual of Style Committee. Updated guidance on the reporting of race and ethnicity in medical and
science journals. JAMA. 2021;326(7):621–7. [5] Fortin M, Almirall J, Nicholson K. Development of a research tool to document self-reported chronic
conditions in primary care. J Comorb. 2017;7(1):117–23. [6] Support Path. Hepatitis C ICD-10 Codes. Gilead Sciences; 2015 [cited 2020 Sep 25].
Available from: https://www.cvph.org/data/files/mysupportpath.pdf

Max # Events per Day

Avg. # Events per Day

Max # Days per Year

Avg. # Days per Year

207

127070 (57.49)
93294 (42.21)
331 (0.15)
352 (0.16)
41352 (18.71)
340 (0.15)
29366 (13.28)
1001 (0.45)
148988 (67.40)
1578 (0.71)
708 (0.32)
57065 (25.82)
485 (0.22)
323 (0.15)
128 (0.06)
246 (0.11)
924 (0.42)
7561 (3.42)

Female
Male
Other
Missing

Female
Gender Diverse
Male
Prefer not to answer
Missing

Bisexual
Gay
Heterosexual
Lesbian
Queer
Two-Spirit
Other
Do not know
Prefer not to answer

Rural
Geography

Sex

Gender

Sexual
Orientation

49275 (22.29)
167728 (75.88)
4044 (1.83)

Rural
Urban
Missing

Age in 2015

(25.11)
(20.65)
(20.20)
(17.12)
(10.48)
(6.44)

221047

All n (%)
55505
45646
44653
37848
23162
14233

Values

25-34
35-44
45-54
55-64
65-74
75+

n

Characteristic
(9.69)
(16.40)
(24.87)
(25.65)
(15.35)
(8.05)

141 (0.73)
94 (0.49)
4703 (24.45)
45 (0.23)
14 (0.07)
40 (0.21)
21 (0.11)
113 (0.59)
565 (2.94)

3352 (17.42)
52 (0.27)
2425 (12.61)
37 (0.19)
13371 (69.51)

10647 (55.35)
8561 (44.5)
3 (0.02)
26 (0.14)

3479 (18.08)
15291 (79.49)
467 (2.43)

1864
3154
4784
4935
2952
1548

19237

UAR & MM n (%)

144 (0.86)
98 (0.58)
3744 (22.34)
25 (0.15)
20 (0.12)
40 (0.24)
13 (0.08)
88 (0.53)
312 (1.86)

2157 (12.87)
60 (0.36)
2160 (12.89)
14 (0.08)
12370 (73.8)

8052 (48.04)
8590 (51.25)
40 (0.24)
79 (0.47)

2652 (15.82)
13247 (79.03)
862 (5.14)

6112 (36.47)
4386 (26.17)
3402 (20.30)
1855 (11.07)
692 (4.13)
314 (1.87)

16761

UAR & Non-MM n (%)

549 (0.65)
212 (0.25)
24402 (29.07)
199 (0.24)
77 (0.09)
21 (0.03)
122 (0.15)
372 (0.44)
3513 (4.19)

18479 (22.02)
92 (0.11)
12308 (14.66)
339 (0.4)
52717 (62.81)

49299 (58.73)
34563 (41.18)
16 (0.02)
57 (0.07)

23339 (27.81)
59720 (71.15)
876 (1.04)

7482 (8.91)
12388 (14.76)
19198 (22.87)
20643 (24.59)
14828 (17.67)
9396 (11.19)

83935

Non-UAR & MM n(%)

Table D.2: Sociodemographic characteristics sub-strata.

744 (0.74)
304 (0.30)
24216 (23.95)
216 (0.21)
212 (0.21)
27 (0.03)
90 (0.09)
351 (0.35)
3171 (3.14)

17364 (17.17)
136 (0.13)
12473 (12.34)
611 (0.60)
70530 (69.75)

59072 (58.42)
41580 (41.12)
272 (0.27)
190 (0.19)

19805 (19.59)
79470 (78.59)
1839 (1.82)

40047 (39.61)
25718 (25.43)
17269 (17.08)
10415 (10.3)
4690 (4.64)
2975 (2.94)

101114

Non-UAR & Non-MM n(%)
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Household
Income

Years since
Arrival in
Canada

Race and
Ethnicity

Primary
Language

Highest Level
of Education

838 (4.36)
102 (0.53)
149 (0.77)
79 (0.41)
232 (1.21)
2661 (13.83)
91 (0.47)
165 (0.86)
14335 (74.52)

8861 (4.01)
3739 (1.69)
2944 (1.33)
4350 (1.97)
2046 (0.93)
567 (0.26)
3597 (1.63)
38464 (17.40)
838 (0.38)
2649 (1.20)
152992 (69.21)

Black
East/SouthEast
Asian
Indigenous
Latino
Middle Eastern
Other
South Asian
White
Do not know
Prefer not to answer
Missing

40519 (18.33)
21102 (9.55)
20877 (9.44)

337 (1.75)
248 (1.29)

167163 (75.62)
22547 (10.20)
26847 (12.15)
4490 (2.03)

English
French
Other
Missing

$0 to $14,999
$15,000 to $24,999
$25,000 to $39,999

384 (2.00)
734 (3.82)
273 (1.42)
2841 (14.77)

8507 (3.85)
4860 (2.20)
2950 (1.33)
39070 (17.67)

13654 (6.18)
51815 (23.44)
155578 (70.38)

1886 (9.80)

18941 (8.57)

0-5 years
6+ years
None recorded

6656 (34.60)

61831 (27.97)

4476 (23.27)
2095 (10.89)
1772 (9.21)

315 (1.64)
2863 (14.88)
16059 (83.48)

17036 (88.56)
554 (2.88)
1473 (7.66)
174 (0.90)

6463 (33.60)

84888 (38.40)

Post-secondary or
equivalent
Secondary or
equivalent
Less than high
school
Other
Do not know
Prefer not to answer
Missing

13501 (70.18)

152029 (68.78)

Missing

4253 (25.37)
1460 (8.71)
1216 (7.25)

876 (5.23)
2077 (12.39)
13808 (82.38)

739 (4.41)
104 (0.62)
195 (1.16)
69 (0.41)
91 (0.54)
1870 (11.16)
60 (0.36)
96 (0.57)
12913 (77.04)

388 (2.31)
236 (1.41)

14622 (87.24)
390 (2.33)
1475 (8.80)
274 (1.63)

335 (2.00)
584 (3.48)
149 (0.89)
3593 (21.44)

1380 (8.23)

5127 (30.59)

5593 (33.37)

12277 (73.25)

13281 (15.82)
8986 (10.71)
8964 (10.68)

2732 (3.25)
19859 (23.66)
61344 (73.09)

803 (0.96)
1606 (1.91)
689 (0.82)
227 (0.27)
1620 (1.93)
18843 (22.45)
396 (0.47)
1348 (1.61)
53686 (63.96)

3420 (4.07)
1297 (1.55)

62563 (74.54)
10537 (12.55)
9237 (11.00)
1598 (1.90)

3694 (4.4)
1616 (1.93)
1312 (1.56)
13320 (15.87)

8732 (10.40)

25961 (30.93)

29300 (34.91)

54468 (64.89)

18509 (18.31)
8561 (8.47)
8925 (8.83)

9731 (9.62)
27016 (26.72)
64367 (63.66)

564 (0.56)
2538 (2.51)
1013 (1.00)
192 (0.19)
1654 (1.64)
15090 (14.92)
291 (0.29)
1040 (1.03)
72058 (71.26)

4716 (4.66)
1958 (1.94)

72942 (72.14)
11066 (10.94)
14662 (14.50)
2444 (2.42)

4094 (4.05)
1926 (1.90)
1216 (1.20)
19316 (19.10)

6943 (6.87)

24087 (23.82)

43532 (43.05)

71783 (70.99)
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True

Food
Insecurity

10985 (4.97)

199349 (90.18)
2066 (10.74)

14813 (77.00)

881 (5.26)

13414 (80.03)

688 (4.10)
342 (2.04)
229 (1.37)
4247 (25.34)

110 (0.66)
1183 (7.06)
2942 (17.55)
898 (5.36)

545 (3.25)
60 (0.36)

2038 (12.16)

3479 (20.76)

966 (5.76)
1770 (10.56)
1357 (8.10)
1693 (10.10)
4046 (24.14)

Legend: CHC = Community Health Centre; MM = Multimorbidity; UAR = Urban at Risk

True

140 (0.73)
1344 (6.99)
4503 (23.41)
669 (3.48)

1622 (0.73)
14445 (6.53)
32782 (14.83)
8622 (3.90)
788 (4.10)
301 (1.56)
262 (1.36)
3278 (17.04)

578 (3.00)
187 (0.97)

7632 (3.45)
1746 (0.79)

8913 (4.03)
2475 (1.12)
3727 (1.69)
46021 (20.82)

3907 (20.31)

39664 (17.94)

Stable
Residence

Household
Composition

3280 (17.05)

(7.56)
(10.87)
(6.76)
(12.67)
(18.76)

53398 (24.16)

1455
2092
1301
2437
3609

Couple with
children
Couple without
child
Extended Family
Grandparents with
Grandchild(ren)
Siblings
Single Parent
Sole Member
Unrelated
housemates
Other
Do not know
Prefer not to answer
Missing

(7.80)
(12.89)
(6.97)
(12.50)
(22.52)

17245
28494
15408
27621
49781

$40,000 to $59,999
$60,000 or more
Do not know
Prefer not to answer
Missing

5257 (6.26)

75666 (90.15)

3414 (4.07)
978 (1.17)
1665 (1.98)
15596 (18.58)

529 (0.63)
5004 (5.96)
14094 (16.79)
2180 (2.60)

3003 (3.58)
996 (1.19)

19043 (22.69)

17433 (20.77)

7216 (8.60)
10776 (12.84)
4963 (5.91)
12453 (14.84)
17296 (20.61)

2781 (2.75)

95456 (94.4)

4023 (3.98)
854 (0.84)
1571 (1.55)
22900 (22.65)

843 (0.83)
6914 (6.84)
11243 (11.12)
4875 (4.82)

3506 (3.47)
503 (0.50)

14676 (14.51)

29206 (28.88)

7608 (7.52)
13856 (13.70)
7787 (7.70)
11038 (10.92)
24830 (24.56)
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Min, Median, Max
Mean (SD)

Avg. # Days/Year

(1, 3, 635)
3.9 (7.8)

(1, 1.2, 66)
1.3 (0.5)

(1, 10, 349)
13.7 (13)

(0.2, 6, 176.9)
8 (7.4)

(0, 1, 309)
2.9 (4.5)

(0, 0, 300)
1.7 (4.3)

(0, 4, 19)
4.5 (2.3)

36 724 (16.6)

(1, 5, 11)
5.6 (3.7)

All Clients

(1, 3, 635)
4.1 (8.2)

(1, 1.2, 29)
1.3 (0.3)

(1, 12, 245)
16.8 (16.6)

(0.2, 6.9, 129.7)
9.4 (8.9)

(0, 2, 309)
3.8 (5.9)

(0, 1, 300)
2.8 (7.0)

(0, 5, 19)
5.1 (2.6)

7976 (22.2)

(1, 6, 11)
6.1 (3.8)

UAR CHC

(1, 3, 224)
3.8 (6.1)

(1, 1.2, 31)
1.3 (0.3)

(1, 11, 349)
14.2 (12.1)

(0.2, 6.2, 120.3)
8 (6.7)

(0, 1, 46)
2.5 (3.2)

(0, 0, 51)
1.4 (2.8)

(0, 5, 14)
4.8 (2.1)

5374 (25)

(1, 7, 11)
6.7 (3.6)

Rural CHC

(1, 3, 635)
5.5 (10.7)

(1, 1.2, 31)
1.3 (0.3)

(1, 17, 349)
20.3 (14.4)

(0.3, 9.2, 176.9)
11.4 (8.4)

(0, 3, 309)
4.8 (5.5)

(0, 1, 300)
2.8 (5.7)

(0, 6, 19)
5.8 (2.2)

29 062 (28.2)

(1, 8, 11)
7.4 (3.3)

Multimorbidity

Legend: # = Number; Avg. = Average; CHC = Community Health Centre; SD = Standard Deviation; UAR = Urban at Risk.

Min, Median, Max
Mean (SD)

Min, Median, Max
Mean (SD)

# External Referrals

Max # Events/Day

Min, Median, Max
Mean (SD)

# Internal Referrals

Min, Median, Max
Mean (SD)

Min, Median, Max
Mean (SD)

# Provider Types Seen

Avg. # Events/Day

n (%)

11 Years of Observation

Min, Median, Max
Mean (SD)

Min, Median, Max
Mean (SD)

# Years of Observation

Max # Days/Year

Value

Measure

Table D.3: Health care use characteristics.

Table D.4: Provider type counts.
Provider Type

Number of Events

% of Events

Provider Involved in Care
Physician
Nurse Practitioner (RN-EC)
Nurse
Registered Practical Nurse (RPN)
Social worker
OtherUnknownUndefined
Dietitian/Nutritionist
Chiropodist
Counselor
Physiotherapist

3693760
2608238
2475621
990144
452641
448761
268395
259101
212799
171291

30.13
21.28
20.19
8.08
3.69
3.66
2.19
2.11
1.74
1.40

Internal Referral
OtherUnknownUndefined
Physician
Nurse Practitioner (RN-EC)
Dietitian/Nutritionist
Nurse
Social worker
Physiotherapist
Chiropractor
Chiropodist
Counselor

100649
73070
37333
30670
29326
28357
11210
9881
9741
6068

26.71
19.39
9.91
8.14
7.78
7.52
2.97
2.62
2.58
1.61

External Referral
OtherUnknownUndefined
Dermatologist
Surgeon - general
Gastroenterologist
Surgeon - speciality (eye, heart, brain, etc.)
Physiotherapist
E.N.T. specialist
Urologist
Gynecologist
Cardiologist

183804
41388
40736
33737
29370
27639
25791
22546
21701
20592

28.54
6.43
6.32
5.24
4.56
4.29
4.00
3.50
3.37
3.20
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Table D.5: Time series clustering of care access frequency.
Cluster ID

# Clients

% Clients

Medoid

K = 2 (SS = 0.502)
1
11552
2
26368

30.5
69.5

20, 8
6, 2

K = 3 (SS = 0.301)
1
15067
2
16791
3
6062

39.7
44.3
16.0

12, 3
4, 1
24, 9

K = 4 (SS = 0.142)
1
12931
2
13063
3
5602
4
6324

34.1
34.4
14.8
16.7

5, 1
12, 3
1, 2
25, 8

K = 5 (SS = 0.211)
1
3639
2
11533
3
11155
4
7722
5
3871

9.6
30.4
29.4
20.4
10.2

31, 8
8, 1
3, 2
12, 5
17, 11

K = 2 (SS = 0.541)
1
6068
2
31852

16.0
84.0

10, 5, 5, 7, 3
3, 1, 0, 1, 2

K = 3 (SS = 0.249)
1
10780
2
20431
3
6709

28.4
53.9
17.7

6, 3, 1, 2, 1
2, 0, 0, 0, 1
6, 1, 3, 4, 3

K = 4 (SS = 0.044)
1
14389
2
8939
3
9072
4
5520

37.9
23.6
23.9
14.6

3,
6,
2,
9,

K = 5 (SS = 0.121)
1
4163
2
7084
3
17282
4
6111
5
3280

11.0
18.7
45.6
16.1
8.6

11, 8, 4, 5, 2
3, 1, 0, 4, 1
3, 1, 0, 1, 2
5, 2, 1, 0, 1
6, 0, 1, 6, 1

K = 2 (SS = 0.553)
1
34265
2
8590

80.0
20.0

8, 3, 3, 2, 0, 1, 2, 6
15, 24, 20, 19, 20, 27, 23, 11

K = 3 (SS = 0.149)
1
15831
2
10557
3
16467

36.9
24.6
38.4

9, 4, 8, 3, 3, 2, 5, 2
24, 9, 13, 19, 12, 12, 16, 6
4, 0, 0, 1, 0, 0, 1, 4

Short Term by Year

Short Term by Quarter

0,
1,
1,
4,

1,
0,
0,
2,

1,
1,
1,
5,

1
2
2
3

Long Term by Year

K = 4 (SS = 0.155)
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1
2
3
4

2402
23637
8440
8376

5.6
55.2
19.7
19.5

18, 35, 34, 46, 34, 39, 27, 9
8, 3, 2, 2, 4, 1, 2, 3
5, 0, 0, 0, 0, 1, 13, 3
20, 8, 10, 12, 16, 11, 19, 9

K = 5 (SS = 0.136)
1
6206
2
5166
3
4716
4
11254
5
15513

14.5
12.1
11.0
26.3
36.2

17, 7, 1, 1, 2, 2, 4, 2
9, 13, 11, 11, 15, 21, 22, 9
27, 16, 11, 7, 10, 10, 13, 5
6, 2, 6, 6, 7, 7, 12, 3
3, 0, 0, 0, 0, 1, 5, 2

85.8

4,
0,
7,
5,

1,
0,
1,
3,

0,
0,
6,
5,

2, 0, 0, 0, 0, 0, 1, 4, 0, 0, 0, 0, 1, 2, 0,
0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2
2, 3, 10, 6, 4, 5, 6, 5, 5, 2, 4, 4, 7, 6, 4,
4, 7, 6, 9, 11, 6, 8, 3, 4

1,
0,
5,
0,
3,
0,

0,
0,
3,
0,
0,
0,

5,
0,
1,
1,
1,
0,

0,
0,
1,
1,
0,
0,

1,
0,
1,
1,
0,
0,

2,
0,
3,
0,
0,
0,

0,
1,
2,
1,
0,
0,

0,
0,
1,
3,
0,
0,

0,
2,
3,
4,
0,
0,

7,
0,
3,
0,
3,
0,
8,
5,

0,
2,
0,
0,
2,
0,
5,
4,

3,
2,
1,
0,
0,
0,
4,
5,

4,
1,
0,
0,
0,
0,
3,
4,

1,
6,
2,
0,
4,
0,
3,
3,

2,
2,
0,
0,
0,
0,
2,
3,

2,
3,
0,
2,
0,
0,
3,
2,

1,
9,
0,
1,
0,
0,
4,
4,

1, 1, 1, 1, 1, 0, 1, 2, 1,
20, 10, 13, 9, 12, 13, 2
1, 2, 0, 0, 0, 0, 0, 0, 0,
1, 0, 1
0, 1, 0, 0, 0, 0, 0, 0, 0,
0, 1, 6, 2, 4, 2, 5, 1, 2
2, 4, 6, 4, 5, 4, 4, 5, 3,
2, 7, 3

3,
0,
2,
0,
6,
0,
4,
0,
2,
0,

2,
0,
0,
0,
8,
2,
3,
0,
0,
0,

0,
2,
0,
0,
3,
2,
0,
0,
2,
0,

1,
1,
0,
0,
1,
1,
0,
0,
0,
0,

0,
0,
0,
0,
1,
2,
3,
3,
0,
0,

0,
1,
1,
0,
2,
2,
0,
0,
0,
1,

0,
0,
0,
5,
3,
3,
0,
0,
0,
0,

0,
0,
0,
3,
3,
2,
0,
2,
0,
2,

0,
0,
0,
0,
3,
2,
0,
4,
0,
0,

Long Term by Quarter
K = 2 (SS = 0.536)
1
36775
2

6080

K = 3 (SS = 0.007)
1
16528

14.2
38.6

2

9729

22.7

3

16598

38.7

K = 4 (SS = 0.236)
1
998

2.3

2

26775

62.5

3

10169

23.7

4

4913

11.5

K = 5 (SS = -0.031)
1
11624

27.1

2

6981

16.3

3

6448

15.0

4

5840

13.6

5

11962

27.9

Legend:

K = Number of clusters.
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3,
1,
3,
7,
2,
0,

0,
3,
0,
1,
2,
1,
0,
9,
0,
0,

0,
0,
8,
2
0,
1,

0,
1
0,
0,
6,
2
0,
5,
0,
1,

0, 0, 0, 0, 0, 0, 0,
1
3, 1, 1, 2, 1, 1, 1,
0, 0, 0, 0, 0, 0, 0,
3, 0, 1, 1, 4
1,
0,
0,
7,

0, 0, 0, 0, 1, 0, 0,
0, 0, 0, 0, 0, 0, 0,
1, 0, 0, 0, 2, 1
4, 1, 1, 3, 1, 2, 2,
0, 0, 0, 0, 0, 0, 0,
2
1, 0, 0, 0, 0, 3, 0,
0, 0, 0, 1

D.4

Extra Technical Details

Eleven-year period prevalence technical details:
Since not all clients received care from CHCs 2009-2019, they were not all at-risk of
condition indications in their electronic health record (EHR) for the entire calendarbased period of observation. Thus, the denominator required estimation of the average
or mid-point size of the population. This was challenging given that primary care
EHRs represent an open cohort with no standard expectation for frequency of care,
and the overall number of clients receiving care increased across calendar time (see
Supplementary Figure 1). We used the following process to calculate 11-year period
prevalence: Numerator: number of clients with at least one relevant code at any point
from 2009 through 2019. Denominator: First, we calculated the median number of
calendar-based years of observation across all eligible clients (i.e., median number of
“at-risk” years): 5 years. Second, we calculated the number of clients who received
any type of care at least once in each of the seven possible five-year intervals (2009-13;
2010-14; 2011-15; 2012-16; 2013-17; 2014-18; 2015-19), representing the size of the
population within each of those five-year intervals. Finally, the median size of those
seven cohorts was used as the denominator, representing the overall average size of
the population across 11 years. The same process was followed to get estimates for
the entire eligible population and for the subset of clients who receive care from urban
at risk community health centres.

214

Appendix E
Objective 3 Extended Information
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E.1

Illustrative Example: Hybrid Feature- and
Similarity- Based Model

The feature- and similarity-based parts of the model (HFSM) can represent primal
and dual forms, respectively.153 Thus, a model where some features are combined
using an unpenalized linear kernel will be equivalent to a model where all features are
entered in logistic regression. To demonstrate this, we generated 10,000 observations
according to the data generating mechanism P (Y ) = ‡(0.25 ≠ 1X1 + 2X2 ) where
X1,2 ≥ N (0, 1). Logistic regression was fit with an intercept, X1 , and X2 ; HFSM was
fit with the intercept and X1 maintained as features and X2 included with a linear
kernel.
Table E.1: Illustrative example feature coefficients

—0
—1
—2

LR

HFSM

0.24
-1.04
2.04

0.24
-1.04
NA

Table E.1 shows the learned coefficients whereby the intercept and X1 coefficients
were the same for the two models. The unpenalized –’s from HFSM ranged from
-0.001 to 0.001. As expected, predictions based on the two model forms were also
equivalent (not shown).
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E.2

Hybrid Model Code

The following Python code can be used to fit the four main models we used: logistic
regression (M1), kernel logistic regression (M2), hybrid model sequential fit (M3),
and hybrid model simultaneous fit (M4).
import numpy as np
import cvxpy as cp
from sklearn.metrics import roc_auc_score
from scipy.special import expit
#
#
#
#

Function to fit feature only model
@param Xtrain the training feature data
@param yTrain training binary outcome
@return betas and auc on training data

# Note that cp.logistic(x) is log(1 + exp(x)), not sigmoid
def FIT_M1(Xtrain, yTrain, save=False, fnHead=None):
beta = cp.Variable((Xtrain.shape[1], 1))
problemM1 = cp.Problem(cp.Maximize(cp.sum(
cp.multiply(yTrain, (Xtrain @ beta))
- cp.logistic((Xtrain @ beta)))/Xtrain.shape[0]))
problemM1.solve(verbose=False, solver=cp.ECOS)
# Get training AUC value
aucTrain = roc_auc_score(yTrain, expit(Xtrain @ beta.value))
print(f"\n *** DONE M1 FIT ***"
f"\nStatus of M1 problem: {problemM1.status}"
f"and Optimal value: {problemM1.value}"
f"and solve time: {problemM1._solve_time}"
f"\n**Training AUC: {aucTrain}"
)
if (save):
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead

+
+
+
+
+

"_Betas.npy", beta.value)
"_SolveTime.npy", problemM1._solve_time)
"_OptValue.npy", problemM1.value)
"_Status.npy", problemM1.status)
"_aucTrain.npy", aucTrain)

return beta.value, aucTrain

# Function to fit kernel only model with L1 penalty
# @param Ktrain precomputed training kernel
# @param yTrain training outcome
# @param l1 strength of L1 penalty for alphas
# @param fnHead start path to save object
# including directory and foldO
# @return alphas, auc on training data
def FIT_M2(Ktrain, yTrain, l1, save=False, fnHead=None):
alpha = cp.Variable((Ktrain.shape[1], 1))
lam = cp.Parameter(nonneg=True, value=l1)
problemM2 = cp.Problem(cp.Maximize(cp.sum(
cp.multiply(yTrain, (Ktrain @ alpha))
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- cp.logistic(Ktrain @ alpha))/Ktrain.shape[0]
- lam * cp.norm(alpha, 1)))
problemM2.solve(verbose=False, solver=cp.ECOS)
# Get training AUC value
aucTrain = roc_auc_score(yTrain, expit(Ktrain @ alpha.value))
print(f"\n *** DONE M2 FIT WITH LAM {l1} ***"
f"\nStatus of M2 problem: {problemM2.status}"
f"and Optimal value: {problemM2.value}"
f"and solve time: {problemM2._solve_time}"
f"\n**Training AUC: {aucTrain}"
)
if (save):
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead

+
+
+
+
+

"_Alphas.npy", alpha.value)
"_SolveTime.npy", problemM2._solve_time)
"_OptimalValue.npy", problemM2.value)
"_Status.npy", problemM2.status)
"_aucTrain.npy", aucTrain)

return alpha.value, aucTrain
# Function to fit HFSM-Seq with L1 penalty
# Betas are fit first and fixed while learning alphas
# @param Xtrain precomputed training kernel
# @param Ktrain precomputed training kernel
# @param yTrain training outcome
# @param l1 strength of L1 penalty for alphas
# @param fnHead start path to save object
# including directory and foldO
# @return betas, alphas, auc on training data
def FIT_M3(Xtrain, Ktrain, yTrain, l1, fixedBeta=None, save=False, fnHead=None):
if (fixedBeta==None):
# learn the betas ignoring alphas
fixedBeta, aucNotUsed = FIT_M1(Xtrain, yTrain,
save=True, fnHead=fnHead + "_m1Part")
# betas are set up as fixed parameter for learning alphas
betaM1 = cp.Parameter(fixedBeta.shape, value=fixedBeta)
# Alphas are learned
alpha = cp.Variable((Ktrain.shape[0], 1))
# L1 penalty strength is fixed parameter
lam = cp.Parameter(nonneg=True, value=l1)
# problem to solve
problemM3 = cp.Problem(cp.Maximize(cp.sum(
cp.multiply(yTrain, (Ktrain @ alpha + Xtrain @ betaM1))
- cp.logistic(Ktrain @ alpha + Xtrain @ betaM1))
/ Ktrain.shape[0]
- lam * cp.norm(alpha, 1)))
# call the solver; default max iters is 10,000
problemM3.solve(verbose=False, warm_start=True, solver=cp.ECOS)
aucTrain = roc_auc_score(yTrain,
expit(Xtrain @ betaM1.value + Ktrain @ alpha.value))
print(f"\n *** DONE M3 FIT WITH LAM {l1} ***"
f"\nStatus of problem: {problemM3.status}"
f"and Optimal value: {problemM3.value}"
f"and solve time: {problemM3._solve_time}"
f"\n**Training AUC: {aucTrain}"
)
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if (save):
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead

+
+
+
+
+
+

"_BetasM1.npy", betaM1.value)
"_Alphas.npy", alpha.value)
"_SolveTime.npy", problemM3._solve_time)
"_OptimalValue.npy", problemM3.value)
"_Status.npy", problemM3.status)
"_aucTrain.npy", aucTrain)

return betaM1.value, alpha.value, aucTrain
# Function to fit HFSM-Sim with L1 penalty
# @param Xtrain precomputed training kernel
# @param Ktrain precomputed training kernel
# @param yTrain training outcome
# @param l1 strength of L1 penalty for alphas
# @param fnHead start path to save object
# including directory and foldO
# @return betas, alphas, auc on training data data
def FIT_M4(Xtrain, Ktrain, yTrain, l1, save=False, fnHead=None):
# Variables can be scalars, vectors, or matrices
beta = cp.Variable((Xtrain.shape[1], 1))
# vector of values (n,1) to fit
alpha = cp.Variable((Ktrain.shape[0], 1))
# Parameter - this one is positive scalar for lam
lam = cp.Parameter(nonneg=True, value=l1)
# problem to solve
problemM4 = cp.Problem(cp.Maximize(cp.sum(
cp.multiply(yTrain, (Ktrain @ alpha + Xtrain @ beta))
- cp.logistic(Ktrain @ alpha + Xtrain @ beta))
/ Ktrain.shape[0]
- lam * cp.norm(alpha, 1)))
# call the solver; default max iters is 10,000
problemM4.solve(verbose=False, warm_start=True, solver=cp.ECOS)
aucTrain = roc_auc_score(yTrain,
expit(Xtrain @ beta.value + Ktrain @ alpha.value))
print(f"\n *** DONE M4 FIT WITH LAM {l1} ***"
f"\nStatus of problem: {problemM4.status}"
f"and Optimal value: {problemM4.value}"
f"and solve time: {problemM4._solve_time}"
f"\n**Training AUC: {aucTrain}"
)
if (save):
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead
np.save(fnHead

+
+
+
+
+
+

"_Betas.npy", beta.value)
"_Alphas.npy", alpha.value)
"_SolveTime.npy", problemM4._solve_time)
"_OptimalValue.npy", problemM4.value)
"_Status.npy", problemM4.status)
"_aucTrain.npy", aucTrain)

return beta.value, alpha.value, aucTrain
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E.3
E.3.1

Simulation Study Details
RBF kernel sigma selection

Three candidate hyperparameter values for the RBF kernel were selected to provide
a range of diagonal dominance as assessed by the following equation:
DD =

ÿ

|diagonals|
|off ≠ diagonals|

For a matrix with i, j = n observations:
DD =

ÿ
i,j

|ai,i |
|ai,j | ≠ |ai,i |

For a kernel matrix ai,i = 1 and the range will be

Ë

2

n
,Œ
(n≠1)

.

In addition to looking at the above scalar measure, we generated heat plots for RBF
kernels with a range of ‡ values on a random sample of 1000 observations of the six
variables in MONK’s data problems. Example plots in Figure E.1 provide another
view at how varying the ‡ values alters the similarity captured by the RBF kernel.

‡ = 0.01

‡ = 0.1

‡=1

Figure E.1: Heatmap demonstrating similarity of RBF kernel with various ‡ on a
random sample.
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E.3.2

Selected hyperparameters and model coefficients
Table E.2: Synthetic data scenario 1: selected hyperparameters
Fold 1

Fold 2

Fold 3

Fold 4

Fold 5

Sigma for RBF Kernel
LR
NA
NA
KLR
1.000
1.000
HFSM-Seq
0.100
1.000
HFSM-Sim 0.100
1.000

NA
1.000
0.100
0.100

NA
1.000
0.100
0.100

NA
1.000
1.000
0.100

L1 Penalty Strength
LR
NA
NA
KLR
0.032
0.001
HFSM-Seq
0.001
0.001
HFSM-Sim 0.001
0.001

NA
0.001
0.001
0.001

NA
1.000
0.001
0.001

NA
1.000
0.001
0.001

Table E.3: Synthetic data scenario 1: model interpretation
(a) Average Feature Coefficients

—0
—1
—2
—3
—4

LR

HFSM-Sim

True

-1.263
0.320
0.440
0.568
0.695

-1.021
0.319
0.444
0.567
0.695

-1.500
0.300
0.400
0.600
0.700

(b) Average Kernel Coefficients
Non-0
Max
Min
Mean
Median
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KLR

HFSM-Seq

HFSM-Sim

262.600
0.000
-0.019
-0.004
-0.003

197.400
0.014
-0.014
0.000
-0.002

180.400
0.005
-0.019
-0.005
-0.006

Table E.4: Synthetic data scenario 2: selected hyperparameters
Fold 1

Fold 2

Fold 3

Fold 4

Fold 5

Sigma for RBF Kernel
LR
NA
NA
KLR
1.000
1.000
HFSM-Seq
1.000
1.000
HFSM-Sim 1.000
1.000

NA
1.000
1.000
1.000

NA
1.000
1.000
1.000

NA
1.000
1.000
1.000

L1 Penalty Strength
LR
NA
NA
KLR
0.001
0.001
HFSM-Seq
0.001
0.001
HFSM-Sim 0.001
0.001

NA
0.001
0.001
0.001

NA
0.001
0.001
0.001

NA
0.001
0.001
0.001

Table E.5: Synthetic data scenario 2: model interpretation
(a) Average Feature Coefficients

—0
—1
—2
—3
—4

LR

HFSM-Sim

True

-0.844
0.185
0.377
0.443
0.566

-0.557
0.198
0.408
0.457
0.605

-2.100
0.300
0.400
0.600
0.700

(b) Average Kernel Coefficients
Non-0
Max
Min
Mean
Median

KLR

HFSM-Seq

HFSM-Sim

1696.200
0.082
-0.098
-0.002
0.001

1732.800
0.085
-0.096
-0.001
0.001

1631.000
0.082
-0.109
-0.010
-0.006

Table E.6: Synthetic data scenario 3: selected hyperparameters
Fold 1

Fold 2

Fold 3

Fold 4

Fold 5

Sigma for RBF Kernel
LR
NA
NA
KLR
1.000
1.000
HFSM-Seq
1.000
1.000
HFSM-Sim 1.000
1.000

NA
1.000
1.000
1.000

NA
1.000
1.000
1.000

NA
1.000
1.000
1.000

L1 Penalty Strength
LR
NA
NA
KLR
0.001
0.001
HFSM-Seq
0.001
0.001
HFSM-Sim 0.001
0.001

NA
0.001
0.001
0.001

NA
0.001
0.001
0.001

NA
0.001
0.001
0.001

Table E.7: Synthetic data scenario 3: model interpretation
(a) Average Feature Coefficients

—0
—1
—2
—3
—4

LR

HFSM-Sim

True

-0.459
0.150
0.163
0.235
0.280

0.414
0.160
0.203
0.325
0.385

-3.200
0.300
0.400
0.600
0.700

(b) Average Kernel Coefficients
Non-0
Max
Min
Mean
Median
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KLR

HFSM-Seq

HFSM-Sim

2575.800
0.094
-0.264
-0.004
0.006

2599.600
0.102
-0.269
-0.003
0.006

2546.400
0.092
-0.297
-0.021
-0.013

E.4
E.4.1

Clinical Case Study Details
Cohort overview

Loss to Follow Up Of the 10,687 people excluded for having less than three years
between their first and last care records, 6,276 (58.7%) had their first event in 2017
or later so there was not enough calendar time for sufficient observation; bias due to
their exclusions is expected to be minimal. The remaining 4,411 (41.3%) were “true”
loss to follow-up under a more traditional research study paradigm; we do not know
if they stopped receiving care altogether of if they switched to another health care
organization. After applying additional eligibility criteria there were 1,430 clients
and among them there were 108 cases of the outcome of which 22 (16.9%) occurred
at least one year from the first recorded event. If our study was more application
than methods testing focused we would perform sensitivity analyses to assess whether
there is bias due to these lost to follow up as in a real world setting the future length
of care when applying a predictive model is unknown.
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Figure E.2: Clinical case study cohort flow diagram
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Table E.8: Clinical case study baseline features.
Feature

Values

n (%)

Sex

Female
Male

2379 (46.92)
2691 (53.08)

Rural Residence

Rural
Urban
Missing

1011 (19.94)
3942 (77.75)
117 (2.31)

Household Income

$0 to $14,999
$15,000 to $24,999
$25,000 to $34,999
$35,000 to $59,000
$60,000 or more
Do not know
Prefer not to answer
Missing

1254 (24.73)
454 (8.95)
274 (5.40)
535 (10.55)
600 (11.83)
274 (5.40)
587 (11.58)
1092 (21.54)

Household Composition

Couple
Other Family
Unrelated housemates
Sole Member
Do Not Know or Other
Prefer not to answer
Missing

1897 (37.42)
519 (10.24)
217 (4.28)
1205 (23.77)
255 (5.03)
57 (1.12)
920 (18.15)

Education Completed

Post-secondary or equivalent
Secondary or equivalent
Less than high school
Do Not Know or Other
Prefer not to answer
Missing

1717 (33.87)
1849 (36.47)
395 (7.79)
269 (5.31)
54 (1.07)
786 (15.50)

Language

English
French
Other

4691 (92.52)
82 (1.62)
297 (5.86)

LGBTQ

Lgbtq
Non-Lgbtq
Missing

67 (1.32)
1084 (21.38)
3919 (77.30)

Years in Canada

True

627 (12.37)

Physical Disability

True

240 (4.73)

Depression or Anxiety

True

410 (8.09)

Chronic Urinary Problem

True

852 (16.80)

Obesity

True

737 (14.54)

Personality Disorder

True

145 (2.86)

Stable Housing

True

556 (10.97)

Substance Use

True

753 (14.85)

Smoking or Tobacco Use

True

1454 (28.68)

Food Insecurity

True

200 (3.94)
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E.4.2

Application 1: prediction
Table E.9: Clinical case study selected hyperparameters.
Fold 1

Fold 2

Fold 3

Fold 4

Fold 5

L1 Penalty Strength
KLR
1e-04
HFSM-Seq 1e-04
HFSM-Sim 1e-03

1e-03
1e-03
1e-03

1e-04
1e-03
1e-03

1e-04
1e-03
1e-03

1e-04
1e-04
1e-04

Kernel Function & Data
KLR
SCR_PIST2
HFSM-Seq SCR_ST
HFSM-Sim J_ST

J_ST
SCR_PIST2
SCR_PIST2

J_PIST2
J_ST
J_PIST2

SCR_PIST2
SCR_PIST2
SCR_PIST2

SCR_PIST2
J_PIST2
J_PIST2

Legend: J = Jaccard similarity; SCR = Common and rare code similarity;
PI = Provider type data; ST = Service type data; PIST2 = both.
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E.4.3

Application 2: inference/interpretation
Table E.10: Feature coefficients for models re-trained on all data
Variable

Values

Intercept

HFSM-Seq

HFSM-Sim

-4.275

-5.268

Sex

Male

-0.261

-0.202

Rural Residence

Urban
Missing

0.462
0.774

0.227
0.636

Household Income

$15,000 to $24,999
$25,000 to $34,999
$35,000 to $59,000
$60,000 or more
Do not know
Prefer not to answer
Missing

0.137
-0.492
-0.948
-1.640
0.517
-0.627
-0.310

0.036
-0.444
-0.781
-1.508
0.446
-0.521
0.061

Household Composition

Other Family
Unrelated housemates
Sole Member
Do not know or other
Prefer not to answer
Missing

0.659
0.743
0.909
0.069
0.443
0.742

0.608
0.677
0.833
-0.056
0.455
0.462

Education Level

Secondary or equivalent
Less than high school
Do not know or other
Prefer not to answer
Missing

0.011
0.127
0.292
0.081
-0.268

-0.075
0.056
0.294
0.334
-0.156

Primary Language

French
Other

0.114
0.448

0.671
0.509

LGBTQ

Non-Lgbtq
Missing

-0.031
0.593

0.009
0.534

Years in Canada

True

0.277

0.102

Physical Disability

True

-0.249

-0.188

Depression or Anxiety

True

0.629

0.379

Chronic Urinary Problem

True

0.098

0.079

Obesity

True

0.145

0.019

Personality Disorder

True

0.179

0.114

Stable Housing

True

0.934

0.626

Substance Use

True

0.225

0.114

Smoking or Tobacco Use

True

0.178

-0.063

Food Insecurity

True

0.116

-0.106
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Table E.11: Client characteristics stratified by kernel coefficient
Variable

Values

# of Clients

Zero Alpha

Positive Alpha

Negative Alpha

5038 (100%)

13 (100%)

19 (100%)

Loneliness/Social Isolation

Present

270 (5.36%)

6 (46.15%)

0 (0.00%)

Sex

Female
Male

2362 (46.88%)
2676 (53.12%)

7 (53.85%)
6 (46.15%)

10 (52.63%)
9 (47.37%)

Rural Residence

Rural
Urban
Missing

1010 (20.05%)
3912 (77.65%)
116 (2.30%)

1 (7.69%)
11 (84.62%)
1 (7.69%)

0 (0.00%)
19 (100.00%)
0 (0.00%)

Household Income

$0 to $14,999
$15,000 to $24,999
$25,000 to $34,999
$35,000 to $59,000
$60,000 or more
Do not know
Prefer not to answer
Missing

1240 (24.61%)
451 (8.95%)
272 (5.40%)
533 (10.58%)
596 (11.83%)
273 (5.42%)
584 (11.59%)
1089 (21.62%)

7
3
1
1
0
0
1
0

(53.85%)
(23.08%)
(7.69%)
(7.69%)
(0.00%)
(0.00%)
(7.69%)
(0.00%)

7
0
1
1
4
1
2
3

(36.84%)
(0.00%)
(5.26%)
(5.26%)
(21.05%)
(5.26%)
(10.53%)
(15.79%)

Household Composition

Couple
OtherFamily
Unrelated housemates
Sole Member
Do not know/Other
Prefer not to answer
Missing

1886 (37.44%)
516 (10.24%)
214 (4.25%)
1197 (23.76%)
254 (5.04%)
55 (1.09%)
916 (18.18%)

5
0
2
5
0
1
0

(38.46%)
(0.00%)
(15.38%)
(38.46%)
(0.00%)
(7.69%)
(0.00%)

6
3
1
3
1
1
4

(31.58%)
(15.79%)
(5.26%)
(15.79%)
(5.26%)
(5.26%)
(21.05%)

Education Level

Post-secondary or equiv
Secondary or equivalent
Less than high school
Do not know/Other
Prefer not to answer
Missing

1705 (33.84%)
1837 (36.46%)
392 (7.78%)
266 (5.28%)
54 (1.07%)
784 (15.56%)

4
5
1
3
0
0

(30.77%)
(38.46%)
(7.69%)
(23.08%)
(0.00%)
(0.00%)

8
7
2
0
0
2

(42.11%)
(36.84%)
(10.53%)
(0.00%)
(0.00%)
(10.53%)

Primary Language

English
French
Other

4660 (92.50%)
81 (1.61%)
297 (5.90%)

13 (100.00%)
0 (0.00%)
0 (0.00%)

18 (94.74%)
1 (5.26%)
0 (0.00%)

LGBTQ

Lgbtq
Non-Lgbtq
Missing

66 (1.31%)
1077 (21.38%)
3895 (77.31%)

1 (7.69%)
2 (15.38%)
10 (76.92%)

0 (0.00%)
5 (26.32%)
14 (73.68%)

Years in Canada

True

624 (12.39%)

2 (15.38%)

1 (5.26%)

Physical Disability

True

239 (4.74%)

1 (7.69%)

0 (0.00%)

Depression or Anxiety

True

408 (8.10%)

2 (15.38%)

0 (0.00%)

Chronic Urinary Problem

True

848 (16.83%)

2 (15.38%)

2 (10.53%)

Obesity

True

732 (14.53%)

1 (7.69%)

4 (21.05%)

Personality Disorder

True

144 (2.86%)

1 (7.69%)

0 (0.00%)

Stable Housing

True

549 (10.90%)

4 (30.77%)

3 (15.79%)

Substance Use

True

745 (14.79%)

4 (30.77%)

4 (21.05%)
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Smoking or Tobacco Use

True

1443 (28.64%)

8 (61.54%)

3 (15.79%)

Food Insecurity

True

195 (3.87%)

4 (30.77%)

1 (5.26%)

Following are the top 10 codes for each topic from non-negative matrix factorization
on provider type and service type (PIST2) data for sub-cohorts of clients with positive,
negative, and zero – coefficients.
Negative –
Topic 1 with top 10 weights [(‘Diagnostic test request’, 1.46), (‘Intermediate assess-

ment’, 1.46), (‘Physician’, 1.42), (‘Nurse’, 1.30), (‘Discussion regarding the treatment plan’, 1.30),
(‘Health advice/instructions’, 1.23), (‘Case management/coordination’, 1.17), (‘Minor assessment’,
1.03), (‘Discussion regarding the diagnostic findings’, 0.96), (‘General assessment’, 0.91)]

Topic 2 with top 10 weights [(‘discussion’, 1.41), (‘Recommendation/assistance’, 1.29),
(‘Basic support’, 0.88), (‘Forms completion’, 0.87), (‘internal referral’, 0.78), (‘Information provision about community resources’, 0.75), (‘counselling’, 0.72), (‘Internal consultation’, 0.54), (‘Case
management/coordination’, 0.44), (‘Counselor’, 0.42)]

Topic 3 with top 10 weights [(‘Counselor’, 0.75), (‘Individual counselling’, 0.74), (‘Forms

completion’, 0.73), (‘Foot care’, 0.66), (‘Chiropodist’, 0.66), (‘Client intake/interview’, 0.59), (‘Service access coordinator’, 0.49), (‘Blank Services (grandfathered)’, 0.48), (‘Preventive care’, 0.47),
(‘medication prescription’, 0.47)]

Topic 4 with top 10 weights [(‘Periodic health examination’, 1.10), (‘Client intake/inter-

view’, 0.88), (‘medication prescription’, 0.75), (‘Nurse Practitioner (RN-EC)’, 0.65), (‘discussion’,
0.64), (‘Discussion regarding the diagnostic findings’, 0.46), (‘Discussion regarding the treatment
plan’, 0.43), (‘Diagnostic test request’, 0.37), (‘Intermediate assessment’, 0.37), (‘Preventive care’,
0.37)]

Topic 5 with top 10 weights [(‘Individual counselling’, 1.47), (‘Nurse Practitioner (RN-

EC)’, 1.05), (‘internal referral’, 0.60), (‘Minor assessment’, 0.58), (‘External referral’, 0.57), (‘Dietitian/Nutritionist’, 0.55), (‘assessment’, 0.55), (‘Health advice/instructions’, 0.52), (‘Discussion
regarding the treatment plan’, 0.41), (‘Medication renewal’, 0.41)]

Positive –
Topic 1 with top 10 weights [(‘Consultation (grandfathered)’, 1.25), (‘Health advice/in-

structions’, 1.12), (‘referral’, 1.05), (‘discussion’, 1.05), (‘Advocacy’, 1.05), (‘Internal consultation’,
1.05), (‘Physician’, 1.02), (‘Nurse’, 1.02), (‘assessment’, 0.97), (‘Basic support’, 0.97)]

Topic 2 with top 10 weights [(‘External consultation’, 0.74), (‘External referral’, 0.61),

(‘Minor assessment’, 0.60), (‘Social worker’, 0.57), (‘Transportation assistance’, 0.49), (‘Individual
counselling’, 0.49), (‘Intermediate assessment’, 0.45), (‘Information provision about community resources’, 0.41), (‘medication prescription’, 0.39), (‘Community Health Worker’, 0.35)]

Topic 3 with top 10 weights [(‘Preventive care’, 0.93), (‘Client intake/interview’, 0.68),

(‘Discussion regarding the treatment plan’, 0.61), (‘Chronic illness monitoring’, 0.60), (‘Discussion
regarding the diagnostic findings’, 0.60), (‘assessment’, 0.58), (‘Basic support’, 0.58), (‘Community
Health Worker’, 0.57), (‘care’, 0.55), (‘Health advice/instructions’, 0.54)]
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Topic 4 with top 10 weights [(‘Social worker’, 0.80), (‘Registered Practical Nurse (RPN)’,
0.80), (‘Individual counselling’, 0.79), (‘Case management/coordination’, 0.66), (‘health examination’, 0.59), (‘Minor assessment’, 0.55), (‘External referral’, 0.5), (‘Physician’, 0.46), (‘Nurse’, 0.46),
(‘Outreach Worker’, 0.45)]

Topic 5 with top 10 weights [(‘Minor assessment’, 0.85), (‘Outreach Worker’, 0.62),
(‘Case management/coordination’, 0.60), (‘Social worker’, 0.59), (‘General assessment’, 0.56), (‘Dietitian/Nutritionist’, 0.46), (‘Foot care’, 0.46), (‘Diagnostic test request’, 0.46), (‘Discussion regarding the diagnostic findings’, 0.46), (‘Registered Practical Nurse (RPN)’, 0.37)]

Zero –
Topic 1 with top 10 weights [(‘Health advice/instructions’, 5.89), (‘Nurse Practitioner

(RN-EC)’, 5.34), (‘Discussion regarding the treatment plan’, 4.96), (‘Intermediate assessment’, 4.85),
(‘Minor assessment’, 4.46), (‘Nurse’, 4.29), (‘Physician’, 3.85), (‘Diagnostic test request’, 3.79),
(‘medication prescription’, 3.75), (‘Discussion regarding the diagnostic findings’, 3.61)]

Topic 2 with top 10 weights [(‘Basic support’, 2.98), (‘Advocacy’, 2.90), (‘Recommendation/assistance’, 2.74), (‘discussion’, 2.58), (‘counselling’, 2.32), (‘Consultation (grandfathered)’,
2.26), (‘assessment’, 2.04), (‘Triage’, 1.85), (‘referral’, 1.82), (‘Internal consultation’, 1.63)]

Topic 3 with top 10 weights [(‘General assessment’, 2.99), (‘internal referral’, 2.77), (‘In-

dividual counselling’, 2.56), (‘Physician’, 2.29), (‘Internal consultation’, 2.21), (‘Dietitian/Nutritionist’, 2.16), (‘Nurse’, 2.13), (‘External referral’, 1.93), (‘Diagnostic test request’, 1.81), (‘Consultation
(grandfathered)’, 1.73)]

Topic 4 with top 10 weights [(‘care’, 2.42), (‘Mental health care’, 2.08), (‘Preventive care’,
1.93), (‘Chronic illness monitoring’, 1.88), (‘Individual counselling’, 1.85), (‘Dietitian/Nutritionist’,
1.40), (‘assessment’, 1.36), (‘Blank Services (grandfathered)’, 1.36), (‘Dispensing medication’, 1.33),
(‘counselling’, 1.33)]

Topic 5 with top 10 weights [(‘Information provision about community resources’, 3.65),

(‘Community Health Worker’, 2.09), (‘Client intake/interview’, 2.01), (‘Case management/coordination’, 1.99), (‘Forms completion’, 1.96), (‘Recommendation/assistance’, 1.86), (‘Social worker’,
1.50), (‘Individual counselling’, 1.24), (‘internal referral’, 1.23), (‘Health advice/instructions’, 1.21)]
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Appendix F
Frequent Visitor Analyses
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Objective: To describe the characteristics of frequent visitors to primary care
providers (PCPs: nurse practitioner or medical doctor), and risk factors for a period
of frequent visits.
Rationale: Clients on the highest end of the visit frequency spectrum may be accessing care more than necessary and benefit from interventions such as social prescribing
that address upstream drivers of care access patterns [1]. Community Health Centres
(CHCs) within the Alliance for Healthier Communities provide individual and group
programs from a variety of disciplines to support clients in this way, so understanding
the needs of frequent visitors is a key area of interest.

F.1

Methods

Two analyses were performed: one to compare all-time frequent visitors with remaining clients and one to explore risk factors for a quarter-year period of frequent visits.
Note that in contrast to the care frequency analyses in Chapter 4, which included
care visits to any type of care provider, the following two analyses calculated client
observation time and care frequency based solely on PCP-associated visits. Cut-offs
to classify “frequent visitors” were CHC-specific such that the same definition was
used across CHCs, but the resulting values were allowed to differ by CHC.

F.1.1

All-time frequent visitor characteristic comparison

For each CHC, frequent visitors included clients in the top 10% of average days of
PCP care per observation year. Table-based comparisons of frequent visitors with
remaining clients, grouped across all CHCs, were performed for sociodemographic,
clinical, and healthcare use characteristics that have over 50% completeness and perceived importance. Characteristics were defined as in Chapter 4 except categories
with less than 1% were treated as missing. Eligible clients must have had at least one
PCP-associated visit in their care history.
Categorical variables were compared using chi-squared test of independence. The
exact P-values were reported and the chi-square value converted to Cohen’s w effect
size. A one-sided 95% confidence interval was provided; the upper-bound was fixed.
Continuous variables were compared using Cohen’s d with P-value and two-sided 95%
confidence interval reported. Guidelines were used to interpret the Cohen’s d and w
effect sizes [2,3].

F.1.2

Risk factors for a period of frequent visits

The risk factor analysis considered each quarter-year, not including the first year that
care is recorded, as a period where a client may have been a frequent visitor. The
frequent visitor cut-off for a given CHC was the top 10% of the maximum quarter-year
care access frequencies (not including the first year due to it being distinctly different
in terms of care needs) across all clients from that CHC. Any given client may have
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had zero or more “frequent visitor” quarter-years of observation based on their CHCspecific cut-off. Note the maximum year was used instead of the average as was
done for the first analysis because of the sparsity of data; over 60% of clients had at
least one quarter-year in the top decile of their CHC average client days/observationquarter, which suggested a lot of clients had some higher quarter(s) but this analysis
was intended to focus on the extremes. Eligible clients required at least one visit with
a PCP that was over one year from their first recorded PCP visit.
To estimate the risk of frequent visitor status in the next quarter-year (after year one),
we performed multilevel modelling using logistic regression and blocked variable entry.
Quarter-years were nested within clients, the intercept was random, and the estimated
effects of risk factors were fixed. Characteristics from above with expected importance
and under 50% missingness were included as candidate risk factors, entered in three
sequential blocks based on expected ordering of effect:
1. Sociodemographic baseline factors: Age, Rural residence, Sex, Education,
Language, Household income, Number of people supported, Length of time in
Canada.
2. Clinical conditions or issues addressed: Stable residence, Food insecurity,
Substance use, Lonely or isolated, Smoking or tobacco use, Number of chronic
conditions, Hep C.
3. Past healthcare use: Average number of events/day, Number of External
referrals, Number of provider types seen.
To operationalize each risk factor, data up to and including the “baseline quarter”,
or quarter prior to the outcome quarter, were used. Block 1 factors were timeinvariant except for age. For block 2, the count of chronic conditions (20 possible)
was cumulative while the remaining conditions (e.g., substance use) were considered
present or absent depending on care received only in the baseline quarter. All block 3
measures were cumulative. We used the bam method from R package mgcv to fit the
models using a Maximum Likelihood estimator to allow use of likelihood ratio tests
to compare the nested models [4,5]. An intercept-only model wqs also compared.

F.2
F.2.1

Results
All-time frequent visitor characteristic comparison

Of the 210,488 eligible clients there were 2,608,238 (41.4%) nurse practitioner- and
3,693,760 (58.6%) medical doctor-associated events. CHC-specific “frequent visitor”
cut-offs ranged from 4.5 to 26.8 days per observation year (Figure F.1).
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Figure F.1: Frequent visitor cut-off for all-time access.
Table F.1 shows the crude characteristic comparisons; effect estimates were in Table
F.2. Number of chronic conditions, number external referrals by PCP, and number
of provider types seen had large effect sizes; age had a moderate effect size; and
remaining characteristics had small effect sizes.
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Table F.1: Frequent visitor univariate characteristic comparisons.
Characteristic

Values

n

Frequent Visitor

Non-Frequent Visitor

21447 (100%)

189041 (100%)

Age in 2019

min, median, max
mean (sd)

(30, 61, 113)
60.6 (17.3)

(30, 51, 113)
52.3 (15.4)

Rural Residence

Urban
Rural
Missing

16719 (77.95%)
4349 (20.28%)
379 (1.77%)

142144 (75.19%)
43535 (23.03%)
3362 (1.78%)

Sex

Male
Female
Missing

7038 (32.82%)
14376 (67.03%)
33 (0.15%)

81855 (43.3%)
106621 (56.4%)
565 (0.3%)

Education Level

Post-secondary or equivalent
Secondary or equivalent
Less than high school
Other
Do not know
Prefer not to answer
Missing

6589 (30.72%)
6798 (31.7%)
2738 (12.77%)
787 (3.67%)
634 (2.96%)
350 (1.63%)
3551 (16.56%)

74720 (39.53%)
52436 (27.74%)
15183 (8.03%)
7360 (3.89%)
3844 (2.03%)
2489 (1.32%)
33009 (17.46%)

Household Income

$0 to $14,999
$15,000 to $24,999
$25,000 to $39,999
$40,000 to $59,999
$60,000 or more
Do not know
Prefer not to answer
Missing

5203
2795
2070
1233
1334
1627
2743
4442

32705
17184
17957
15454
26459
12934
23974
42374

Primary Language

English
French
Other
Missing

16432 (76.62%)
2273 (10.6%)
2406 (11.22%)
336 (1.57%)

142883 (75.58%)
19510 (10.32%)
22817 (12.07%)
3831 (2.03%)

Years in Canada

0-5 years
6+ years
None recorded

1136 (5.3%)
4543 (21.18%)
15768 (73.52%)

11545 (6.11%)
44121 (23.34%)
133375 (70.55%)

# Chronic Conditions

min, median, max
mean (sd)

(0, 6, 18)
5.8 (3.4)

(0, 2, 16)
2.8 (2.5)

Hepatitis C

True

602 (2.81%)

1817 (0.96%)

Smoking or Tobacco Use

True

5475 (25.53%)

31628 (16.73%)

Substance Use

True

4032 (18.8%)

16457 (8.71%)

Food Insecurity

True

2798 (13.05%)

7878 (4.17%)

Lonely or Isolated

True

4580 (21.35%)

12989 (6.87%)

Stable Residence

True

16542 (77.13%)

173121 (91.58%)

# Provider Types

min, median, max
mean (sd)

(1, 6, 19)
6.4 (2.6)

(1, 4, 19)
4.4 (2.2)

min, median, max

(0, 3, 182)

(0, 1, 54)

# Ext Refs by PCP
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(24.26%)
(13.03%)
(9.65%)
(5.75%)
(6.22%)
(7.59%)
(12.79%)
(20.71%)

(17.3%)
(9.09%)
(9.5%)
(8.17%)
(14%)
(6.84%)
(12.68%)
(22.42%)

mean (sd)

4.9 (6)

1.8 (2.8)

Avg. # PCP Events/Day

min, median, max
mean (sd)

(1, 1.1, 3.1)
1.1 (0.1)

(1, 1, 36)
1 (0.1)

# Years Obsv

min, median, max
mean (sd)

(1, 5, 11)
5.8 (3.7)

(1, 5, 11)
5.4 (3.7)

Table F.2: All-time frequent visitor univariate statistical comparisons.
Characteristic
Age in 2019
Rural residence
Sex
Education Level
Household Income
Primary Language
Years Since Arrival in Canada
# Chronic Conditions
Hepatitis C
Smoking or Tobacco Use
Substance Use
Food Insecurity
Lonely or Isolated
Stable Residence
# Provider Types
# Ext Refs by PCP
Avg. # PCP Events/Day
# Years Obsv

F.2.2

Chi-Square

P-value

Effect Estimate

NA
83.6
894.2
1103.7
1899.7
36.4
83.7
NA
576.0
1026.1
2232.6
3151.9
5280.2
4509.1
NA
NA
NA
NA

NA
0
0
0
0
0
0
NA
0
0
0
0
0
0
NA
NA
NA
NA

-0.535
0.020
0.065
0.072
0.095
0.013
0.020
-1.172
0.052
0.070
0.103
0.122
0.158
0.146
-0.896
-0.930
-0.202
-0.101

95% CI

Interpretation

(-0.55, -0.52)
(0.02, 1)
(0.06, 1)
(0.07, 1)
(0.09, 1)
(0.01, 1)
(0.02, 1)
(-1.19, -1.16)
(0.05, 1)
(0.07, 1)
(0.1, 1)
(0.12, 1)
(0.15, 1)
(0.14, 1)
(-0.91, -0.8)
(-0.94, -0.92)
(-0.22, -0.19)
(-0.11, -0.09)

moderate
very small
very small
very small
very small
very small
very small
large
very small
very small
small
small
small
small
large
large
small
very small

Risk factors for a period of frequent visits

Of the 163,230 eligible clients and 4,132,848 client-quarters of observation, 21,339
(13.1%) had at least frequent visit quarter-year and 8,398 (39.4%) had more than
one frequent visitor quarter-year. Cut-offs for a frequent visitor quarter ranged from
three to 17 (Figure F.2).

236

Figure F.2: Frequent visitor cut-off for quarter-year.
Odds ratios for all three models are in Table F.3. In general, odds ratio magnitudes
were attenuated as more variables entered the model. Likelihood ratio tests between
sequential models were all statistically significant (P-value < 2.2e-16 ).
Table F.3: Frequent visitor risk factor analyses.
Variable

Value

Block 1

Block 2

Block 3

Quarter Age

Years

1.02

1.00

1.00

Rural

Rural
Missing

0.78
1.41

0.89
1.06

0.92
1.07

Sex

Female
Missing

1.50
1.42

1.48
1.27

1.45
1.33

Secondary or equivalent
Less than high school
Other

1.17
1.41
1.29

1.05
1.27
1.17

1.06
1.27
1.20

Education
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Do not know
Prefer not to answer
Missing

1.40
1.53
1.10

1.20
1.31
1.11

1.22
1.33
1.14

Household Income

$40,000 to $59,999
$25,000 to $39,999
$15,000 to $24,999
$0 to $14,999
Do not know
Prefer not to answer
Missing

0.75
0.56
0.41
0.32
0.77
0.58
0.62

0.87
0.79
0.62
0.52
0.96
0.80
0.86

0.88
0.80
0.64
0.54
0.94
0.82
0.90

Language

French
Other
Missing

0.75
0.77
0.77

0.94
0.81
0.79

0.96
0.79
0.78

Year in Canada

6+ years
0 to 5 years

1.00
1.26

0.86
0.93

0.79
0.87

# Chronic Conditions

Count

-

1.27

1.20

Hepatitis C

Present

-

2.84

2.65

Smoking or Tobacco Use

Present

-

1.95

1.91

Substance Use

Present

-

3.95

3.83

Food Insecurity

Present

-

1.77

1.66

Lonely or Isolated

Present

-

2.15

2.00

Stable Housing

Present

-

2.50

2.24

Cumulative # Provider Types

Count

-

-

1.07

Cumulative # External Referrals

Count

-

-

1.03

Average # Events/Day

Count

-

-

1.40

F.3

Discussion

Univariate comparisons between frequent visitors based on all-time healthcare use
found large effect sizes for frequent visitors having more provider types involved in
care, external referrals, and chronic conditions. There were no large effect sizes for
sociodemographic conditions in these analyses; however, some associations did emerge
in the risk factor analysis based on discrete periods of healthcare use. In general
findings further support the limited existing research on care frequency of primary
care in Canada showing the importance of both social and medical complexity in
general [6,7]. Specific findings in contrast with other populations include a positive
association of female sex [6] and housing stability [7] with the outcome. Future work
should include causal analyses to identify the potential impact on intervenable risk
factors, or the development of a predictive model to identify individual clients who
are at high risk of frequent healthcare use in the future. Future work could explore
how to identify specific clients that are expected to experience higher than necessary
care frequency in the future and whether interventions such as social prescribing may
be beneficial.
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